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Abstract

IDENTIFICATION AND CHARACTERIZATON OF ETHANOL RESPONSIVE GENES
IN ACUTE ETHANOL BEHAVIORS IN CAENORHABDITIS ELEGANS
By: Joseph Thomas Alaimo
A Dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University 2012
Directed by: Jill C. Bettinger, Ph.D.
Associate Professor, Department of Pharmacology and Toxicology

Alcohol abuse and dependence are complex disorders that are influenced by
many genetic and environmental factors. Acute behavioral responses to ethanol have
predictive value for determining an individual’s long-term susceptibility to alcohol abuse
and dependence. These behavioral responses are strongly influenced by genetics.
Here, we have explored the role of genetic influences on acute behavioral responses to
ethanol using the nematode worm, Caenorhabditis elegans. First, we explored the role
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of ethanol metabolism in acute behavior responses to ethanol. Natural variation in
human ethanol metabolism machinery is one of the most reported and reproducible
associations found to alter drinking behavior. Ethanol metabolism is conserved across
phyla and alteration in this pathway alters acute behavioral responses to ethanol in
humans, mice, rats, and flies. We have extended these findings to the worm and have
shown that loss of either alcohol dehydrogenase or aldehyde dehydrogenase results in
an increase in sensitivity to the acute effects of ethanol.
Second, we explored the influence of differences in basal and ethanol-induced
gene expression in ethanol responsive behaviors. We identified a set of candidate
genes using the basal gene expression differences in npr-1(ky13) mutant animals to
enrich for genes involved in AFT. This analysis revealed ethanol changes to the
expression of genes involved in a variety of biological processes including lipid
metabolism. We focused on a gene involved in the metabolism of fatty acids, acs-2.
acs-2 encodes an acyl-CoA synthetase that activates fatty acids for mitochondrial !oxidation. Animals carrying mutant acs-2 have significantly reduced AFT and we
explored the role of genes in the mitochondria !-oxidation pathway for alterations in
ethanol responsive behaviors. We have shown that knockdown of ech-6, an enoyl-CoA
hydratase, enhances the development of AFT. This work has uncovered a role for fatty
acid utilization pathways in acute ethanol responses and we suggest that natural
variation in these pathways in humans may impact the acute alcohol responses to
alcohol that in turn influence susceptibility to alcohol abuse and dependence.

xvii

Chapter 1
Background and Significance

Alcohol Use, Abuse, and Dependence - Epidemiology
Alcohol abuse and alcohol dependence are commonly referred to as alcohol use
disorders (AUDs), and are serious, pervasive, and debilitating disorders. Alcohol misuse
is responsible for 2.5 million or 3.8% of total deaths each year worldwide and individuals
suffering from an AUD live 10 to 15 years shorter than those who do not have an AUD
(WHO, 2010; Schuckit, 2009). It is estimated that as many as 80% of men and 60% of
women in developed countries drink at some time during their lives (Tesson et al., 2006)
and that AUD are more prevalent in men than in women (Tesson et al., 2006; Hasin et
al., 2007; Mertens et al., 2005; Schuckit, 2009). In the United States, 8.5% or 17 million
people either abuse or are dependent on the drug, where as 76 million are suffering
from an AUD globally (Grant et al., 2004).
Alcohol use is a leading contributor to the global burden of disease. The degree
of disease burden is measured as years lost to disability (YLD) and AUDs rank 4th
amongst low and middle-income countries and 3rd for high-income countries for YLD
(WHO, 2008) The high number of YLD due to alcohol use stems from a variety of
different disease and injury conditions including infectious disease, cancer, diabetes,
cardiovascular disease, and unintentional and intentional injuries (Rehm et al., 2011)
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Impact of Alcohol Use Disorders in Costs to Society
The costs associated with AUDs are astronomical, accounting for 1- 3% of the
gross domestic product in high-income countries (WHO, 2010; Rehm et al., 2009). In
2006, AUDs cost the United States $223.5 billion and 40% of these costs were paid by
the government (Bouchery et al., 2011). This cost far out paced the excise tax revenue
generated from the sale of alcoholic beverages. The Federal Government received
about $8.9 billion from alcohol excise taxes, while State level governments collected an
additional $5.1 billion (Xu and Chaloupka, 2011). The majority of the economic cost was
due to lost productivity, increases in health care costs, and increases in criminal justice
costs. Lost productivity accounted for a total of $161.3 billion. Impaired work productivity
was the top cost and a national survey has found that 19.2 million workers, or 15% of
the work force, drink enough alcohol to lead to workplace impairment. The top two
behaviors that contribute to this impairment are employees working with a hangover
(11.6 million) and drinking during the workday (8.9 million) (Frone, 2006). Health care
costs accounted for $24.6 billion and the majority of the cost was for specialty care for
abuse and dependence. Criminal justice costs accounted for $20.9 billion and the
majority of costs came from increases in police protection. The government covered
99% of the increase in costs for health care and criminal justice (Bouchery et al., 2011).
There is also a range of social distress caused by alcohol use. When one
individual in a marriage suffers from an alcohol use disorder, the decision to divorce or
separate is about 10% higher than couples where an individual does not suffer from an
alcohol use disorder (Ostermann et al., 2005). The major contributor to divorces rates is
the lack of participation of the alcoholic spouse in everyday household tasks and the
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financial stress they place on the relationship (Zewben 1986; Leonard and Roberts,
1998; Lichter et al., 1992). In addition, alcohol use is correlated with child abuse (Miller
et al., 1993). Studies have shown that parental alcohol abuse is associated with
physical abuse of a child (Miller et al., 1997; Vogeltanz et al., 1999). Also, children who
have been sexually abused were more likely to have a family history of alcoholism and
a majority of the victims were abused by another family member or by a stranger who
was intoxicated (Miller et al., 1997).

Neuropharmacology of Ethanol
Acute Ethanol exposure results in a wide range of neurobehavioral effects. At
high doses ethanol produces sedative effects and at low doses produces stimulating
effects (Pohorecky 1977; Holdenstock and de Wit 1998). Over the decades, many
studies have been completed to determine the neuropharmacological mechanisms of
action of ethanol. These studies have implicated from in vitro and in vivo work that
several neurotransmitter systems, including the GABAergic system, glutamatergic
system, opioid system, the mesocorticolimbic dopaminergic system, and many
intracellular signaling pathways are modulated by ethanol.
GABA is an inhibitory amino acid that acts to decrease a neurons action potential
and therefore inhibits neurotransmission. Acute ethanol primarily affects the GABA
system by activating GABAA receptors. GABAA receptors are heteropentameric ligandgated ion channels that are composed of 2 !(1-6), 2 "(1-3) and either a # (1-3), $, %, &,
', or ((1–3) subunit (Olsen and Sieghart 2008; Sieghart and Sperk 2002). GABAA
receptors can exist as either synaptic or extrasynaptic receptors. When GABA binds to
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GABAA receptors, the conformation of the channel changes and allows chloride ions to
pass down an electrochemical gradient. The influx of chloride ions hyperpolarizes the
membrane leading to neuronal inhibition. (Kumar et al., 2009). The synaptic GABAA
receptor !1 subunit is the most abundant ! subunit in the brain and is expressed
thought out most brain regions. In addition, 50% of all synaptic GABAA receptors
contain the !1 subunit (Kralic et al., 2002). The !4 subunit predominantly occurs in
extrasynaptic GABAA receptors (Olsen and Sieghart 2009).
Genetically modified mouse models have contributed greatly to uncovering the
role of GABAA receptors in acute behavioral responses to ethanol. In particular, many
studies have focused on synaptic GABAA receptors subunit composition and their
effects on ethanol sensitivity at high and low doses of ethanol (Wallner et al., 2003).
Knockout of the !1 subunit of GABAA receptors results in an increase in ethanol’s
stimulating effects (Blendov et al., 2003; Karlic et al., 2003) However, knockout of the
!1 subunit of GABAA receptors in male mice displayed a reduced loss of right reflex
(LORR) duration to a sedative dose of ethanol (Blendov et al., 2003), but this result has
not been replicated in other studies (Karlic et al., 2003). Knockout of the !2 subunit of
GABAA receptors in mice also display a reduced LORR to a sedative dose of ethanol
(Boehm et al., 2004). Collectively these studies suggest that synapses containing !1 or
!1 subunits are important for specific ethanol-induced behavioral effects.
In addition, work has implicated the role of specific extrasynaptic GABAA receptor
subunits in the effects of ethanol. Several studies have shown that !4 containing
extrasynaptic GABAA receptors have an enhanced inhibition to low dose ethanol, but #2
containing extrasynaptic GABAA receptors are less sensitive to low dose ethanol
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(Wallner et al., 2003; Wei et al., 2004). !4 and $ containing extrasynaptic GABAA
receptors have been reported to be inhibited at a high dose of ethanol (Liang et al.,
2008). Finally, knockout mice of the "2 subunit of extrasynaptic GABAA receptors are
less sensitive to the sedative effects of ethanol measured by LORR (Blendov et al.,
2003). Together these studies indicate a role for extrasynpatic GABAA receptors as a
molecular target for ethanol and particular subtypes are involved in ethanol-related
behaviors.
The expression of GABAA receptor subunits is regulated by ethanol. Studies
have shown that the GABAA receptor !1 subunit expression is decreased following
chronic ethanol exposure (Devaude et al., 1997), while acute ethanol causes increases
in expression of GABAA receptor !1 subunits (Kumar et al., 2012; Liang et al., 2007).
This suggests that different doses of ethanol change the expression of different receptor
subtypes of GABAA and further suggests that ethanol induced changes in expression
can lead to genes that are involved in ethanol’s mechanism of action.
Glutamate receptors are ligand-gated ion channels that are widely expressed
throughout the brain. There are two types of glutamate receptors; ionotropic and
metabotropic. Ionotropic glutamate receptors excite neurons during fast synaptic
transmission and modulate the strength of neurotransmission. Metabotropic glutamate
receptors have several effects including reducing synaptic transmission (Ozama et al.,
1998). N-methyl-d-aspartate (NMDA) receptors are heterotetrameric receptors that
contain two obligatory GluN1 subunits and any combination of the following: GluN2A-D
and GluN3A-B (Collingridge et al., 2009; Traynelis et al., 2010). NMDA receptors
contain a Mg2+ block within the ion channel and the Mg2+ block is removed by
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depolarization of the neuron. Removal of the block allows the channel to pass Ca2+ ions
and Ca2+ influx serves as an indicator of the strength of synaptic transmission
(Möykkynen and Korpi 2012).
The effects of ethanol on ionotropic glutamate receptors, especially NMDA
receptors have been widely studied. Studies have shown that acute ethanol inhibits
NMDA receptors in a dose dependent manner over a range of 5-50 mM (Lovinger et al.,
1989). A study using brain slices of the hippocampus of adult rats with intact NMDA
receptors observed potent inhibition at 25mM ethanol (Lovinger et al., 1990). In
addition, the subunit composition of NMDA receptors respond differently to acute
ethanol. GluN2A-B subunits are more sensitive to ethanol inhibition than GluN2C-D
subunits (Kuner et al., 1993). This suggests that like GABAA receptors particular NMDA
subunits are important in ethanol effects.
There is evidence that intracellular calcium plays a role in ethanol inhibition of
NMDA receptors. The obligatory GluN1 subunit at the C-terminal tail contains a C0
domain that binds calmodulin and !-actinin-2. Both of these proteins compete to bind to
the C0 domain of the GluN1 subunit and elevated calcium levels results is !-actinin-2
displacement from the C0 domain and allows calmodulin to bind (Krupp et al., 1999).
Studies have shown that ethanol inhibition is stronger if calcium and calmodulin
dependent inactivation of NMDA receptors occurs (Anders et al., 2000). Other studies
have tried to identify the binding site of ethanol within NMDA receptors by inducing point
mutations that alter the ethanol sensitivity of the receptor. Point mutations Met813Ala
and Leu819Ala in transmembrane region 4 of the GluN1 subunit enhances ethanol
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inhibition, where as point mutation Phe639Ala in transmembrane region 3 reduces
ethanol sensitivity (Smothers et al., 2006; Ren et al., 2003).
Genetically modified mice have contributed greatly to understanding ethanol’s
effects on NMDA receptors. Acute ethanol administration has shown to cause an
enhancement of NMDA receptor function by phosphorylation of the GluN2B subunit of
the receptor. Mice lacking a functional tyrosine kinase, Fyn, are more sensitive to the
depressive effects of ethanol. These animals displayed enhanced sensitivity in a dose
dependent manner using the LORR assay (Miyakawa et al., 1997). Pharmacological
inhibition of NMDA receptor glutamate biding sites in mice and rats results in an
enhanced sensitivity to ethanol measured by LORR assay (Yaka et al., 2003; Ramirez
et al., 2011). In addition, studies have that shown NMDA antagonists reduced the
development of acute functional tolerance (AFT) (Khanna et al., 2002). Taken together
these results suggest that ethanol directly affects NMDA receptors by inhibiting their
function and the inhibition is occurring in a subunit specific manner, which can alter
ethanol-related behaviors.
The midbrain dopamine system has been widely studied for its role in
reinforcement (Olds and Milner 1954, Schultz 2007; Wise 2004). The mesocorticolimbic
dopaminergic pathway consists of three major brain regions: the ventral tegmental area
(VTA), nucleus accumbens (NAC), and prefrontal cortex (PFC). Midbrain dopamine
neurons involved in the initiation of reinforcement processes originate in the VTA and
project to structures closely associated with the limbic system, most prominently the
NAC shell region and the PFC. Acute ethanol administration stimulates dopamine
release from the NAC shell region (Di Chiara and Imperato 1988; Imperato and Di
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Chiara 1986, Pontieri et al., 1995) and studies have shown that acute low dose ethanol
causes increases in the firing rate of dopaminergic neurons in the mesolimbic pathway
(Di Chiara and Imperato 1988; Gessa et al., 1985). In addition, studies have shown that
alcohol preferring rats will directly self-administer alcohol into the posterior region of the
VTA (Gatto et al., 1994; Rodd et al., 2004). This suggests that ethanol can modify the
function of the dopaminergic neurons in the mesolimbic pathway. Self-administration of
ethanol into the VTA can be decreased when dopamine neurons in the VTA are
inhibited by quinpirole. Rats treated with the quinpirole had a decrease in the firing rates
of the VTA dopamine neurons suggesting that alcohol is reinforcing by activation of
these neurons (Rodd et al., 2004). Together, this data indicates that ethanol can
induced the release of dopamine, which plays a role in the reinforcing effects of the
drug.
The opioid system is widely distributed thought the CNS and is involved in
learning and memory, emotional behavior, and reward processing (Bodnar 2012) Opioid
receptors and peptides can be found in the PFC, hypothalamic nuclei, NAC, VTA, and
the amygdala (Mansour et al., 1994; Mansour et al., 1995). All opioid receptors are Gprotein-coupled receptors and act mainly via inhibitory G proteins leading to a reduction
in neurotransmitter release and inhibition of neuronal activation (Kieffer and Evans
2009). Acute ethanol has been shown to stimulate the release of the endogenous opioid
peptides "-endorphin, enkephalin and dynorphin (Marinelli et al., 2003; Marinelli et al.,
2005; Marinelli et al., 2006). "-endorphin and enkephalin bind to µ and $ receptors,
respectively and can decrease the release of dopamine from the NAC (Hillmacher et al.,
2011). Ethanol consumption causes an increase in extracellular dopamine levels and
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when the µ and $ receptors are antagonized, the dopamine enhancing effect of ethanol
is significantly decreased (Acquas et al., 1993; Benjamin et al., 1993) (See Current
Treatments for Alcohol Disorders). This suggests that the dopamine enhancing effect of
ethanol is dependent on opioid induced neurotransmitter reduction. This points to the
complexity of the molecular mechanisms induced by ethanol where different but multiple
neuronal systems are required to produce cellular effects. µ-receptor knockout mice do
not display the reinforcing effects of ethanol and ethanol induce dopamine in the NAC is
attenuated in these animals (Roberts et al., 2000). $-receptors knockout mice show
elevated ethanol consumption (Roberts et al., 2001). Dynorphin binds to the )-receptor
and pharmacological inhibition of the )-receptor shows no effect on alcohol selfadministration, but studies have suggested that the )-receptor may be involved in the
negative reinforcing effects of alcohol (Williams and Woods 1998, Doyon et al., 2006;
Nguyen et al., 2012). Together, these results suggest that the opioid system is an
integral part for the reinforcing effects of ethanol and that alterations in this system can
limit ethanol’s rewarding effect.
There are a numerous signaling pathways that are affected by acute ethanol.
The signal transduction within the NAC following the release of dopamine enhances the
activity of adenylyl cyclase, which is coupled to the stimulatory G protein Gαs (Neer
1995, Diamond and Gordon 1997; Ron and Jurd 2005). Acute ethanol exposure (20 –
500 mM) potentiates the receptor-mediated stimulation of adenylyl cyclase activity
(Saito et al., 1985.). Adenosine triphosphate becomes converted to cyclic adenosine
monophosphate (cAMP) by adenylyl cyclase, which subsequently activates protein
kinase A (PKA) signaling (Diamond and Gordon 1997). PKA is a tetramer composed of
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a homodimer of regulatory subunits (RIα-" and RIIα-") and two catalytic subunits (Cα
and C") (Mckinght 1991). Mice haploinsufficient for Gαs have low adenylyl cyclase
activating and voluntarily consume less alcohol (Wand et al., 2001). PKA RII" knockout
mice have decreased ethanol induced LORR, but increase ethanol consumption (Thiele
et al., 2000). Drosophila mutants carrying a hypomorphic PKA RII also have a reduced
sensitivity to the depressive effects of ethanol (Parke et al., 2000), Recent work has
shown that acute ethanol administration produces dose-dependent increases in the
expression of PKA and GABAA receptors α1 subunits and that pharmacologically
blocking PKA inhibited the ethanol induced increases in GABAA receptors α1 subunits
suggesting that both PKA and GABAA receptors may function in network communication
(Kumar et al., 2012).
PKA signaling leads to the phosphorylation of the transcription factor cAMP
response element-binding protein (CREB). Phosphorylation of CREB results in
increased transcription of genes containing cAMP response elements (CRE) within their
promoter region (Lonze and Ginty 2002; Moonat et al., 2010). CREB regulates many
genes, which include genes that control neurotransmission, cell structure, signal
transduction, transcription and metabolism (Lonze and Ginty 2002). Acute ethanol
treatment has been shown to lead to increased expression and phosphorylation of
CREB (Yang et al., 1996), but chronic ethanol treatment has been shown to decrease
CREB phosphorylation (Yang et al., 1998). Mice halploinsufficient for CREB display
increased ethanol preference and have decreased expression of Neuropeptide Y (NPY)
and brain-derived neurotrophic factor (BDNF) (Pandey et al., 2004). Together this work
suggests that both acute and chronic ethanol can induce changes in gene expression
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that lead to widespread cellular changes. This population of genes that have differential
expression due to ethanol may reveal mechanisms by which cells are changing their
function due to ethanol exposure that may provide insight into ethanol responsive
behaviors.
In addition to PKA signaling, the protein kinase C (PKC) signaling pathway is
stimulated by acute ethanol exposure (25-200 mM)(Diamond and Gordon 1997;
Depetrillo and Swift, 1992; Kumar et al., 2006). There are several isoforms of PKC that
are expressed thought the brain (Naik et al., 2000; Choi et al., 2002). PKC !, ", # are
activated by calcium and diacylglycerol where as PKC $, %, *, & is only activated by
diacylglycerol (Newton and Ron 2007). PKC signaling has been widely studies for its
regulatory role of GABAA receptor function and various PKC isoforms associate with
GABAA receptor. PKC" has been shown to associate with GABAA receptor " subunits
(Connolly et al., 1999) and studies have shown by western blot analysis that acute
ethanol administration causes a decrease in phosphorylation of GABAA receptor "
subunits in rats (Kumar et al., 2006). Reduced phosphorylation of the GABAA receptor
#2 subunit enhances the action of ethanol and mice lacking PKC% have reduced
phosphorylation at this subunit (Qi et al., 2007). Genetic manipulation of PKC isoforms
has been fruitful in delineating the role of PKC activity in acute ethanol effects. PKC#
null mice display reduced sensitivity to the effects of ethanol on LORR (Harris et al.,
1995). PKC% knockout mice display increased ethanol sensitivity to the effects of
ethanol measured by LORR (Hodge et al., 1999). PKC $ null mice showed a reduced
ataxia to ethanol (Choi et al., 2008). Taken together these studies suggest that PKC
isoforms have distinct roles in mediating acute ethanol behavioral effects.
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Current Treatments for Alcohol Use Disorders
Despite the negative physiological and socioeconomic consequences, individuals
continue to drink. Currently, three government approved pharmacological therapies
designed for treating AUDs are available; disulfiram, naltrexone, and acamprosate
(Krishnan-Sarin et al., 2008)
Disulfiram targets ethanol metabolism by inhibiting aldehyde dehydrogenase
(ALDH) enzyme function. When an individual drinks alcohol while on this drug, ethanol
is successfully converted into acetaldehyde, but inhibition of ALDH results in an
increase in acetaldehyde concentrations. The increases in acetaldehyde concentrations
cause extremely unpleasant effects, such as difficulty breathing, tachycardia, nausea,
vomiting, and headaches that could last for days. These adverse effects result in very
low rates of medication adherence, and therefore this method of drug treatment is
ineffective without supervision (Fuller et al., 1986, Buonopane and Petrakis, 2005).
Naltrexone antagonizes the µ-opioid receptor. This causes a decrease in the
positive reinforcing effects of alcohol (Douaihy at al., 2013). Clinical trials using
naltrexone for treatment of AUDs have manifested mixed results. Naltrexone has been
shown to reduce drinking and increase abstinence in non-treatment seeking heavy
drinkers (Garbutt, 2009), but treatment amongst more severe alcohol dependent
patients was ineffective (Krystal et al., 2001). As in the case for disulfiram, adherence is
an issue with naltrexone treatment and low adherence significantly promotes higher risk
for returning to heavy drinking (Minozzi et al., 2006; Swift et al., 2011). To circumvent
this, a monthly injection that causes slow release of the drug has been shown to be
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effective in reducing heavy drinking outcomes (Garbutt et al., 2005). However, the
effectiveness of naltrexone as a treatment for an AUD is dependent on an individual’s
genetic background. Genetic variation at the µ-opioid receptor can either enhance or
suppress the effects of naltrexone treatment for some individuals (Arias et al., 2006). In
addition, a major drawback for patients using naltrexone is the ineffectiveness of opioidbased analgesics.
Acamprosate is thought to act primarily by modulating glutamatergic transmission
and acts as a coagonist or modulator of NMDA receptors (Kiefer and Mann, 2010, Olive
et al., 2012). Clinical trials have reported mixed results. In a US study, acamprosate
was not effective for alcohol dependent patients, but in a European study, acamprosate
was extremely effective in maintaining abstinence (Anton et al., 2006, Mason et al.,
2006). Taken together, the three government-approved treatments provide evidence
that improved and perhaps even personalized pharmacological interventions are
needed. One way to facilitate this approach is to uncover and better understand the
mechanisms of action of alcohol.
There are other types of therapies used to treat AUDs. One of the most popular
platforms of intervention is Alcoholics Anonymous (AA). As of 2013, there are 59,321
AA groups and 1,295,656 members in the United States (AA, 2013). AA is a self-driven
12-step recovery program for individuals that want to stop drinking. Individuals attend
meeting sessions at their own discretion and engage in group discussions. Studies have
shown that the frequency of attendance is highly correlated with alcohol abstinence
(Kaskutas et al., 2005). There are also behavioral treatments that are commonly used to
deter alcohol use. Behavioral therapies for couples and families focus on the
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incorporation of positive activities, communication skills training, and identification of
potential relapse trigger points (McCrady, 2012). This treatment has shown to
significantly reduce the frequency of use (Powers et al., 2008). Coping skills training
and cognitive behavioral therapy help individuals to cope with risky situations that
promote alcohol-seeking behaviors. These therapies have also been shown to reduce
alcohol use (Magill and Ray, 2009).
Behavioral programs and therapy have seen more success with managing an
individuals drinking problem, however our work will help contribute to informing patients
on their potential abuse liability. Informing patients about their abuse liability may allow
individuals to take precautionary behavioral measures possibly before or when drinking
becomes an issue.

Genetic Susceptibility of Alcohol Use Disorders
Susceptibility to developing an AUDs has a significant genetic component.
Familial inheritance of alcoholism is a well-known and documented factor of risk for
alcoholism (Cotton, 1979, Kendler et al., 1997, Lieb et al., 2002). Initial studies
compared the concordance rates for alcohol abuse and dependence amongst
monozygotic twins, which have identical genomes, and dizygotic twins who only share
on average half of their genetic material. These studies have shown higher
concordance rates amongst monozygotic twins, indicating that there is a genetic
contribution to the risk for alcohol dependence (Pickens et al., 1991, Agrawal and
Lynskey, 2008). This research and other studies have suggested that 40-60% of the risk
is inherited (Prescott and Kendler, 1999; Heath et al., 1999; Schuckit et al., 2001;
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Schuckit and Smith, 2006). However, these studies have suggested that other factors
such as environmental influences also contribute to this risk. Some of these factors
include peer influence and availability of alcohol (Prescott and Kendler, 1999; Schuckit
and Smith, 2006, Youg-Wolff et al., 2011).
Since the familial and twin studies have suggested that genetics plays a role in
risk for developing AUD, researchers have employed three different approaches to
identify which genes in particular influence this risk. These approaches are linkage
studies, genetics association studies.
Initially, linkage studies were performed on multiple families having two or more
alcoholic members. DNA was isolated from families and genotyped for genetic markers
to identify loci that cosegregated with the disorder. Multiple studies have revealed
regions of the genome that contribute to the risk of alcoholism and these regions of the
genome are referred to as quantitative trait loci (QTL). The Collaborative Study on the
Genetics of Alcoholism (COGA) was one of the first large-scale initiatives to define
QTLs contributing to alcohol dependence (Begleiter et al., 1995). COGA and others
have shown evidence that multiple regions from across the genome contribute to this
risk suggesting that alcohol dependence is a complex disorder. There have been 12
different chromosomes implicated in AUDs that include chromosomes 1, 2, 4, 6, 7,10,
11, 12,14,16,17 (Hill et al., 2004; Dick et al., 2002; Hill et al., 1999; Edenberg and
Foroud 2006). Over the years of collecting linkage results for families with multiple
alcoholic members or for other phenotypes including alcohol dependence and alcohol
consumption, chromosomal region 4q22-4q32 is the most consistently reported region
across studies (Prescott et al., 2004, Hill et al., 2004; Dick et al., 2002; Hill et al., 1999).
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This genomic region contains a subset of the alcohol dehydrogenase (ADH) genes
(Prescott et al., 2004). There is considerable genetic variation in the ethanol
metabolizing enzymes ADH and ALDH and other work has shown that individuals
carrying specific alleles either have an increased or decreased risk for developing an
AUD (Chen et al., 2009; See Discussion). Despite the identification of ADH in the risk of
AUDs there are still major drawbacks to these studies. Most studies have implicated
broad chromosomal regions for AUDs still leaving researchers with thousands of
candidate genes.
Another approach for identifying specific genes influencing the risk of developing
an AUD are genetic association studies. There are two types of genetic association
studies; targeted genetic association studies and genome wide association studies
(GWAS). Targeted genetic association studies ascertain individuals and test for the
frequency of alleles or genotypes in both cases and control groups and are typically
used to investigate regions and genes of prior interests or candidate genes. Replication
of findings is important to validate since these studies are done with a smaller
population. However, there have been reports of subpopulation differences in alleles
that contribute to specific phenotypes as possible causes for why some findings from
one population cannot be replicated in other populations (Riestchel and Treutlein 2012).
One great example of this is the association of an ALDH variant that is only found in
Asian populations (See Chapter 2). To date, genes that have shown reproducibility
across multiple association studies for alcohol dependence are as follows: dopamine
receptor D2 (DRD2), ankyrin repeat and kinase domain containing 1 (ANKK1),
serotonin transporter (SLC6A4), catechol-O-methyltransferase (COMT), tryptophan
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hydroxylase 1 (TPH1) (See Genes Mediating Acute Ethanol Responsive Behaviors in
C. elegans and Other Species in this chapter), dopamine transporter (SLC6A3),
interleukin-1 receptor, type II (IL1RA), interleukin-10 (IL10), tumor necrosis factor (TNF),
alcohol dehydrogenase 1B (ADH1B), alcohol dehydrogenase 1C (ADH1C), and
aldehyde dehydrogenase 2 (ALDH2) (see Chapter 2) (Rietschel and Treutelin, 2013).
GWAS analyze several hundred thousand or millions of markers across the
entire genome to detect difference in allele or genotype frequencies in a systematic
manner for cases and controls. One of the major limitations to this approach is the
extreme level of significance required because of the level of correction for multiple
testing (Cichon et al., 2009). As with the targeted genetic association studies, genes or
regions replicated in independent sample sets raises the confidence of the region or the
gene in the disorder. Many genes have been implicated through these studies, but only
a few have actually reached significance. Those genes include, alcohol dehydrogenase
1B (ADH1B), alcohol dehydrogenase 1C (ADH1C), aldehyde dehydrogenase 2
(ALDH2), near peroxisomal trans-2-enoyl-CoA reductase (PECR), and autism
susceptibility candidate 2 (AUTS2) (Rietschel and Treutelin, 2013).

Alcohol Endophenotypes – Low Level of Response
Despite numerous human studies, very few definitive genetic loci have been
implicated in AUDs. This is chiefly due to the complex nature of the disorder (Chesler et
al., 2005, Koob and Volkow 2010, Schuckit 2002; Schuckit and Smith 2004, Dick and
Foroud 2003). The diagnosis of AUDs is based on a range of reported symptoms
according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
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(DSM-IV). However, most are typically treated as a binary outcome of affected or
unaffected, which can severely limit the detection of more subtle and variable
phenotypes. Certain risk factors such as genetics may affect individuals differently,
which may results in differences in the severity of the disease or a particular set of
symptoms. This most likely is attributed to clinical heterogeneity, polygenic
determinants, reduced penetrance, and epistatic effects (Hines et al., 2005). One way to
identify biological attributes or intermediate phenotypes is to study a subset of
characteristics that are closely related or contribute to the outcome of the disease. This
approach is only effective if the studied characteristcs correlate of influcne the outcome
of the disease (Schuckit, 1994). This approach focuses on particular components of the
disease spectrum and is referred to as endophenotypes. The hypothesis behind using
endophenotypes is to increase the ease in identifying genetic and environmental factors
that contribute to particular components of the disease spectrum because the number of
factors influencing each is fewer than the number affecting the clinical syndrome
(Carlson et al., 2004).
One well-known and established AUD endophenotype is level of response (LR)
to alcohol. An individual’s naive LR to ethanol has been shown to be correlated with
their abuse liability later in life (Shuckit, 1994). LR is a measure of the acute effects of
ethanol on a variety of measures which include, in different studies, level of change in
subjective feelings of intoxication (assessed using the Subjective High Assessment
Scale), motor performance, hormone levels, electrophysiological measures observed at
specific blood alcohol concentrations, self reporting of the number of drinks required for
specific effects (assessed using the Self-Rating of the Effects of Alcohol – SRE), and
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the effects of 3 beverages consumed over 10 minutes (alcohol challenge) (Schuckit and
Smith, 2000; Schuckit 1998, Schuckit et al., 1997). These models measure a variety of
variables, but all measure acute alcohol sensitivity, which is a composite phenotype
influenced by acute sensitivity and the development of acute functional tolerance
(Newlin and Thomson, 1994, Schuckit 1994). Acute sensitivity is a measure of the
maximal effect of the drug. Acute functional tolerance was first described by Mellanby
(1919). These studies showed that dogs treated with a single dose of ethanol displayed
more motor impairment at a given blood ethanol concentration on the rising portion of
the blood ethanol concentration curve than at the same blood ethanol concentration on
the falling portion. Therefore, AFT reflects rapid cellular adaptations to the effects of
ethanol on neurons that are required for certain behaviors (Mellanby 1919; Keir and
Deitrich 1990; Newlin and Thomson 1990; Hu et al., 2008). It is thought that functional
tolerance reflects homeostatic adaptations that attempt to restore normal neuronal
activity (Le Moal and Koob 2006).
Initially, studies examined participants that were sons of alcoholics and matched
comparison subjects for their naïve LR and found that individuals with an initially low LR
to alcohol from this cohort were more likely to have developed alcohol dependence than
individuals with a high LR. (Schuckit 1994, Schuckit and Smith 1996). Other studies
have replicated these findings across different populations (Heath et al., 1999, Volavka
et al., 1996). These results suggest that LR of is a strong endophenotype for predicting
the long term drinking behavior of naïve individuals. These results also suggest the
importance of individual differences in initial alcohol sensitivity and much work has been
done to uncover some of the genetic factors associated with the LR in humans. It is
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estimated that 40% of offspring of alcoholics have a low LR to alcohol providing further
evidence that genetics can influence LR (Schuckit et al., 1996)
Association studies have been completed and a few regions have been
implicated in influencing the LR. These regions include genes encoding neuropeptide Y
(NPY), the potassium-BK channel (KCNMA1), the alcohol dehydrogenase gene cluster
found on chromosome 4, brain-derived neurotropic factor (BDNF), the dopamine-2
receptor (DDR2), catechol-O-methyltransferase (COMT), serotonin 1D receptor (5HT1D), Glutamate receptor 5 (GRM5) and others (Wilhelmsen et al., 2003; Schuckit et
al., 2004; Schuckit et al., 2005).
Furthermore, this phenotype has been heavily investigated in model organisms
that can recapitulate aspects of the LR phenotype such as initial sensitivity and acute
functional tolerance (Newlin and Thomson 1994, Hu et al., 2008; Ponomarev and
Crabbe, 2002). Work in animal models has shown that these traits are genetically
influenced and therefore model organisms serve as a powerful resource to understand
how genes can influence these responses (See Ethanol Responsive Behavioral Assays
in C. elegans section in this chapter and Chapters 2-4 of this document).

The Utility of C. elegans as a Model Organism for Behavior
Caenorhabditis elegans are an outstanding model organism to study a variety of
biological processes and mechanisms. The characterization of worm physiology,
development, neurobiology, and genome is very extensive and fundamentally
distinguishes the model from any other.
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C. elegans naturally dwell in soil and develop rapidly, going from egg to adult in 3
days, and grow in broods of 300-350 animals. Animals grow to 1.5 mm in length and are
reared very easily in a laboratory setting on an agar plate that contains a food source of
E. coil (we use the strain OP50 to feed worms in our laboratory). They can be reared at
20°C or at 15°C for a reduced growth rate. They are cultured using a dissecting
microscope for visualization and a platinum pick for transfer. For long-term storage,
animals can be frozen in a similar fashion as mammalian cell lines (Sulston and
Hodgkin 1988). Stocks have been shown to retain viability for up to 25 years when
frozen in liquid nitrogen and 12 years when frozen at -80°C. This is essential because
laboratory strains maintained in growing cultures for long periods of time in a laboratory
setting can diverge. This occurs through fixation of a random mutation into a population
by a population bottleneck. This typically happens by picking an animal that is carrying a
mutation and through self-fertilization, expanding the mutation in the population each
generation. The costs associated with culturing and storing animals is also extremely
inexpensive, another advantage for scientists in these challenging economic times.
There are two C. elegans sexes, a self-fertilizing hermaphrodite and males. The
possibility of self-fertilization and the ability to cross hermaphrodites with males makes
genetic manipulation easy. Hermaphrodites have two sex chromosomes, XX, and males
have one, XO. Males occur in a population at a 0.2% frequency by a spontaneous nondisjunction event of one of the sex chromosomes. After mating between a
hermaphrodite and a male, 50% of the progeny will be males because 50% of the male
sperm are null for the sex chromosome (Akerib and Meyer 1994). The anatomical
structure of worms is exquisitely simple. Hermaphrodites contain 959 somatic cells of
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which 302 of those cells are neurons and 95 are body wall muscles. The male is slightly
different and has 1031 somatic cells and 381 neurons. The increase in cell number in
males is concentrated to the tail structure and is required for mating functions (White
1988).
Work completed by Sulston et al., in 1983 revealed the complete lineage of cells
during development. This work found that the cell lineage or cell fate decisions are
invariant. This provided a great foundation to study the genetics of development since
the number and positions of cells are consistent between animals and manipulations
that cause subtle changes in the lineage could be detected. Additional work allowed the
mapping of all synaptic connections in the animal and the generation the first
“connectome” (White et al., 1986). The worm genome was the first sequenced genome
of all multicellular species and was completed in 1998 (C. elegans Sequencing
Consortium, 1998). The worm genome encodes 20,513 protein-coding genes
(WormBase, 2013; Release WS238) and about 40% of these genes are orthologous to
human genes (Shayne and Greenwald 2011).
There are a variety of genetic tools readily available to the C. elegans
community. Forward genetic screens are often employed to uncover mechanistic insight
into phenotypes of interests. These mutations can be identified through mapping,
comparative genomic hybridization, or by whole genome sequencing. There are many
ways to manipulate the expression of genes in C. elegans. These methods include
classic transformation by injection of exogenous DNA, microparticle bombardment of
exogenous DNA, and Mos1-mediated single copy insertion of exogenous DNA (Boulin
and Hobert, 2012). Reverse genetic approaches include utilizing two RNA interference
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(RNAi) libraries that are administered to animals by feeding (See Chapter 2 -3 and
Appendix B) and cover about 95% of the genome (Kamath et al., 2003; Rual et al.,
2004). The community also has a Deletion Mutant Consortium that has created more
than 6,841 deletions in 6,013 genes in the genome. Recently, the completion of the
million-mutation project provides the community with 2,007 mutagenized strains that
have been extensively characterized at the molecular level and contain more than
800,000 single nucleotide variants, 14,800 insertions and deletions, and 1,400
chromosomal rearrangements (Thompson et al., 2013, C. elegans Deletion Mutant
Consortium, 2012, Fraser et al., 2000, Kamath et al.,2003, Rual et al., 2004).
C. elegans have a simple nervous system that contains about 5000 chemical
synapses, 2000 neuromuscular junctions and 600 gap junctions (White 1998).
Completed sequencing of the worm and human genome reveal conserved gene
systems for neurotransmitter biosynthetic enzymes, synaptic release mechanisms, and
neurotransmitter receptors, including both ligand-gated ion channels and G-proteincoupled receptors. Worms contain two major classes of potassium channels: the inward
rectifier channels and voltage-regulated potassium channels and they also have
voltage-activated calcium channels. At the neurotransmitter levels, all major molecules
are well represented. C. elegans use acetylcholine, dopamine, serotonin, y-aminobutric
acid (GABA), glutamate, and neuropeptides. Neurotransmitter synthesis, packaging
into synaptic vesicles, and reuptake or destruction is also similar in worms and
vertebrates. Ligand-gated ion channels are also represented in the worm (Bargmann,
1998). The conservation of the nervous system between the two species and the
overlap of signaling pathways affected by ethanol makes using C. elegans as a model
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for understanding the genetic contributions to ethanol responses extremely
advantageous.
Therefore, we use C. elegans to study the genetics of acute ethanol responsive
behaviors because animals dose dependently become intoxicated to ethanol for a
variety of behaviors at concentrations that are similar to humans (Davies et al., 2003;
Alaimo et al., 2012).

Ethanol Responsive Behavioral Assays in C. elegans
Previously studies have shown that worms dose dependently respond to a
variety of different measureable phenotypes induced by either acute or chronic ethanol
treatment or during withdrawal from the drug. The following are behavioral assays
currently used in the field to understand the influence of genes on ethanol responsive
behaviors.

Locomotion-based
Locomotion assays are the standard assay for measuring the acute responses to
alcohol In our laboratory. These assays involve recording and analyzing two-minute
movies of animals in the absence and presence of alcohol and comparing the treated
and untreated speeds (See Appendix B, and Methods Section of Chapters 2-4). This
assay primarily tests a well defined neuromuscular network and its associated
neurotransmitters. Worms move in a sinusoidal wave that requires 95 body-wall
muscles cells that receive excitatory inputs at cholinergic neuromuscular junctions and
inhibitory inputs at GABAeric neuromuscular junctions (Chalife and White, 1988). To
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generate the sinusoidal pattern of movement, the contraction of the dorsal and ventral
body muscles must be out of phase. To turn the body dorsally, the dorsal muscles
contract while the opposing ventral muscles relax. This pattern of alternating dorsal and
ventral contractions is produced by interactions between excitatory cholinergic inputs
and inhibitory GABAeric inputs (Riddle et al., 1997). We derive from this assay two
measures of the acute locomotor responses to ethanol; initial sensitivity and acute
functional tolerance (AFT) (Figure 1), both of which are important components of the
mammalian phenotype of LR. We have shown that worms become maximally
intoxicated in 6 minutes (See Chapter 2, Figure 3, Alaimo et al., 2012) and that
locomotion between 6 minutes and 10 minutes is not different and therefore we
measure initial sensitivity at 10 minutes of continuous exposure. We measure the
locomotion of the animals at 30 minutes of continuous exposure for their ability to adapt
to drug treatment and calculate the degree of AFT (Figure 1), by subtracting the speed
at 30 minutes from the speed at 10 minutes.
A variation of the above locomotion assay, commonly referred to as a dispersal
assay or food race assay, measures the ability of the animals to navigate towards the
food source, E. coli OP50. In this assay, animals are placed at the opposite side of the
plate from a point source of food. Over time the worms navigate towards the food and
the efficiency of navigation can be quantified by counting the percentage of worms that
reach the food at a given time interval. This behavioral measure requires animals to rely
on sensorimotor processing, but the food race assay analysis does not take basal
speed differences of mutant animals into account in the data analysis (Mitchell et
al.,2010). In addition, chemosensory neurons required for odorant detection in the
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Figure 1. Acute locomotor response to 400mM continuous ethanol exposure of
wild type N2 animals. The x-axis represents the relative speed expressed as percent
of untreated (treated speed/untreated speed x 100). The y-axis represents time of
continuous ethanol exposure. By 10 minutes animals become maximally intoxicated and
severs as a measure of initial sensitivity. By 30 minutes of continuous exposure,
animals are moving significantly faster. The observed behavioral change is called acute
functional tolerance. In the right panel we calculate the degree of AFT animals develop
by subtracting their relative speed at 30 minutes from their speed at 10 minutes. N2
typically recover about 8-12% of their untreated speed (n = 4) Error bars are standard
error of the mean.
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environment may be affected by ethanol and may complicate the analysis
(Kapfhamer et al., 2008.
The food race assay has also been used to measure a withdrawal-like syndrome.
In this assay, animals are pretreated with ethanol for at least 6 hours and immediately
after treatment are tested in the food race assay. During the assay, few animals reach
the food source. However, when a low dose of ethanol is added to the plate, a
significant number of animals are able to reach the food source (Mitchell et al., 2010).
This is interpreted as ethanol induced relief of withdrawal and most likely reflects
chronically induced neuroadapations. This suggests that the chronic ethanol exposure
has altered the balance of neuronal signaling required for locomotion. The addition of
ethanol may add relief because it is restoring the balance of neuronal signaling.
A second measure of withdrawal-like behavior has been studied by our
laboratory. Wild type animals were exposed to 350 mM exogenous ethanol for 18-22
hours. When these animals were removed from the drug, there was a significant
increase in bordering and clumping behavior (Davies et al., 2004). Wild-type animals
are solitary feeders and therefore have little tendency to engage in social feeding
behavior such as clumping and typically do not prefer the thicker parts of the bacterial
lawn (bordering) (de Bono and Bargmann, 1998). The increase in bordering and
clumping after withdrawal of long-term ethanol exposure of wild type animals
photocopies neuropeptide Y like receptor 1 (npr-1) loss of function animals. This work
suggests that the NPR pathway is involved in this withdrawal phenotype (Davies et al.,
2004).
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A distinct locomotion-type assay of ethanol responses is to measure the rate of
swimming or (“thrashing”) of a worm in liquid. Swimming is the behavior of lateral
movements or head bends that the animals make while immersed in liquid and this
behavior requires dopamine and serotonin. These assays can be done visually under a
microscope or by recoding movies and analyzing the behavior in a high-throughput
manner using ImagePro software. (See Chapter 2 Methods) (Buckingham and Sattelle,
2009, Vidal-Gadea et al.,2011).

Egg-laying
C. elegans can produce about 300 progeny over the course of their adult life. A
wild type young adult hermaphrodite will store about 10-15 eggs in its uterus at any
given time and it continuously generates new eggs and lays the oldest eggs. The egglaying motor circuit requires synaptic input from two classes of motor neurons and 16
muscle cells. This circuit is modulated by serotonin and requires acetylcholine (Schfer,
2005). Egg laying frequency is typically decreased by ethanol intoxication (Davies et al.,
2003), but in some cases, egg laying is stimulated by low doses of ethanol. Assays are
performed on and off ethanol in the presence of food. The number of eggs laid are
determined at 45 minutes.

Pharyngeal Pumping
The C. elegans pharynx consists of radial muscle, which rhythmically pumps
(coordinated waves of contraction and relaxation) to maintain the feeding activity of the
animals. The pharynx uses 3 different groups of neurons that are modulated by
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serotonin, glutamate and acetylcholine (Franks et al., 2006). Electropharyngeogram
(EPG) recording of the activity of the pharyngeal muscle in the presence of serotonin
and presence and absence of ethanol has been performed over a time course of 3-5
minutes (Mitchell et al.,2007) and a low dose of ethanol has been shown to inhibit
pharyngeal pumping.

Chemotaxis/Preference Assays
The preferences assay is a variation of a simple chemotaxis assay. Animals are
pre-treated with ethanol for 4 hours and then removed to a plate in which they are given
the option to discriminate between an ethanol containing quadrant and a non ethanolcontaining quadrant. The attraction to ethanol is quantified by measuring the preference
index which is the number of animals in the ethanol containing quadrant minus the
number of animals in the non-ethanol containing quadrant divided by the total number of
animals tested. A positive preference index is indicative of more animals in the ethanol
containing quadrants and a negative preference index indicates more animals in the
non-ethanol containing quadrants. A preference index close to zero indicates no
preference (Lee et al.,2009).

Genes Mediating Acute Ethanol Responsive Behaviors in C. elegans and Other Species
SLO-1
The voltage -and calcium- activated potassium (BK) channel, SLO-1, is a major
ethanol target protein in worms. Previous work has shown that ethanol activates SLO-1
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causing a large efflux of potassium ions, hyperpolarizing the cell and depressing
neuronal excitability, which is a major cause of intoxication (Davies et al., 2003). slo-1
loss-of-function animals are profoundly resistant to the sedative effects of ethanol and
do not develop significant acute functional tolerance, where as slo-1 gain-of-function
animals off of ethanol display some phenotypes of intoxication (Davies et al., 2003,
Bettinger et al., 2012). slo-1 null animals do not display resistance to the acute effects
of ethanol in the food race assay nor does it exhibit an altered ethanol withdrawal
phenotype (Mitchell et al., 2010). This suggests that the food face assay may not be
sensitive enough to capture particular phenotypes of mutant animals.
The Drosophila ortholog of slo-1, slowpoke, which gave the gene its name, has
also been characterized for its role in ethanol responses. A loss of function of slowpoke
in Drosophila results in the failure of animals to develop rapid tolerance to ethanol
(Cowmeadow et al., 2005, 2006). The protein structure of SLO-1 is different between
invertebrates and vertebrates. In vertebrates, SLO-1 contains ! and " subunits. The !
domains contain 7 transmembrane regions, 2 regulator domains that are involved in
pore formation, and a calcium binding region. There are 4 " subunits and each channel
exists as an assembly of 4 ! subunits and 4 " subunits (Treistman and Martin 2009). In
mice, knockout of the "4 subunit of the channel results in the enhancement of tolerance
to ethanol, suggesting that this subunit inhibits acute tolerance (Martin et al., 2008).
The human ortholog to slo-1, KCNMA-1, has also been shown to be associated with
alcohol dependence and LR in human studies (Kendler et al., 2011, Schuckit et al.,
2005).

30

NPR-1
The G protein-coupled neuropeptide Y receptor-like protein, npr-1, negatively
regulates AFT in worms. Loss-of-function npr-1 mutants display an enhanced
development of AFT to ethanol and are initially resistant (Davies et al., 2004; Bettinger
et al., 2012). Overexpression of npr-1 results in opposite ethanol responsive behaviors
where these animals display a reduced AFT phenotype relative to wild type (Davies et
al., 2004). In the food race assay, npr-1 mutants did not exhibit any behavioral
differences from wild type nor did npr-1 mutants respond differently to ethanol
withdrawal (Mitchelle et al., 2010). However, earlier studies have implicated npr-1
signaling in ethanol withdrawal showing that N2 animals exposed to ethanol for 18
hours and subsequently withdrawn from the drug phenocopy npr-1 mutant bordering
and clumping behavior (Davies et al., 2004). This strongly suggests that ethanol is
acting to down regulate the npr-1 pathway.
A role for of neuropeptide Y-like signaling in acute behavioral responses to
ethanol is very well conserved across flies and mice. The Drosophila homolog of
neuropeptide Y is the neuropeptide F, NPF, and its receptor is neuropeptide F receptor,
NPFR1. NPF acutely mediates sensitivity to ethanol sedation. Knockdown of NPFR1 or
NPF by RNA interference showed decrease alcohol sensitivity, and overexpression
results in opposite behaviors (Wen et al., 2005). In vertebrates, neuropeptide Y (NPY)
null mice show decreased sensitivity to ethanol on LORR and increased ethanol
consumption. Overexpression of NPY results in opposite phenotypes (Thiele et al.,
1998). Genetic manipulation of NPY Y1 and Y2 receptors in mice modulate ethanol
intake. Knockout Y1 mice display an increase in consumption of ethanol and are less
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sensitive to the sedative effects of ethanol (Thiele et al., 2002). Y2 knockout mice drink
significantly less ethanol and have normal sensitivity to sedative effects of ethanol
(Thiele et al., 2004). Finally, in human association studies, NPY receptor
polymorphisms are significantly associated with alcohol dependence and alcohol abuse
(Lappalainen et al., 2002, Schuckit et al., 2004).

Synaptic Transmission Machinery - RAB-3, AEX-3, UNC-18, JUD-4
In C. elegans, rab-3 encodes a protein that is associated with synaptic vesicles
and is required for proper synaptic transmission (Nonet et al., 1997, Mahoney et al.,
2006). Animals carrying a loss-of-function mutation of rab-3 display a decrease in
sensitivity to the sedative effects of ethanol. Animals carrying a loss-of-function mutation
of aex-3, a guanine triphosphate exchange factor that interacts with rab-3 to promote
synaptic transmission (Iwasaki et al, 1997, 2000) results in a decrease in sensitivity to
ethanol, implicating synaptic transmission in acute ethanol responses (Kapfhamer et al.,
2008, Davies et al., 2012). In mice, animals that are either null or haploinsufficient for
Rab3A demonstrate a decrease to the ataxic effects of ethanol in the stationary dowel
test and also display resistance in the loss of righting reflex assay. Interestingly, Rab3A
haploinsufficient mice voluntary increase their ethanol intake while Rab3A null mice do
not (Kapfhamer et al., 2008).
In worms, unc-18 encodes a protein that functions as a chaperone for syntaxin
and enables the docking of vesicles to synaptic regions before priming and fusion
(Weimer et al., 2003). Animals carrying a point mutation in unc-18 are resistant to the
sedative effects of ethanol for swimming behavior (Graham et al., 2009). However at
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lower concentrations of ethanol, unc-18 mutants display a loss of ethanol-induced
hyperactivity. Interestingly, the point mutation induced at the unc-18 locus in this study
is from a previously mapped QTL for ethanol preference drinking in mice (Fehr et
al.,2005). It should be noted that another study that measured swimming/thrashing
behavior did not observe the ethanol induced activation effect of low dose ethanol
treatment (Mitchell et al.,2007). The sole difference between these two studies was the
wild-type animal of the first study carried a control transgene (Graham et al., 2009) and
the other wild-type strain was unmodified. This suggests that the observed ethanol
induced behavioral activation effect may be an artifact of the type of transgene insertion.
We have shown that the osmolarity of the solution used in the measure of the
intoxicated effects on swimming, Dent’s saline solution, can alter swimming behavior (
Alaimo et al., 2012). In Drosophila, mutations in Syntaxin 1A, a gene that encodes a
protein that is part of the soluble N-ethlymaleimide-sensitive factor attachment protein
receptor (SNARE) and is required for synaptic vesicle fusion, is required for the
development of rapid tolerance. A mutation in Dynamin, a gene involved in synaptic
vesicle recycling, is also required for the development of rapid tolerance to ethanol
(Krishnan et al., 2012).
Human studies have looked for changes in the protein levels of synaptophysin I,
syntaxin 1A, synaptsome associated protein 25 (SNAP-25), and vesicle-associated
membrane protein (VAMP) in the prefrontal and motor cortices between chronic
alcoholics and control subjects. This work reports only an elevation of synaptophysin I
protein levels (Henriksson et al., 2008).
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In worms, jud-4 encodes a protein of unknown function, but putative loss-offunction mutants display profound resistance to a lethal dose of ethanol measured by
swimming assays. jud-4 is weakly homologous to the mammalian Home protein which
is integral to the assembly of proteins regulating glutamate signaling and synaptic
plasticity. In Drosophila, homer mutants display an enhanced sensitivity to the sedative
effects of ethanol and are impaired in their ability to develop rapid tolerance (Urizar et
al., 2007) In mice, Homer2 knock-out mice do not develop place preference or
locomotor sensitization to repeated ethanol exposures (Szumlinksi et al., 2005).

SEB-3
In worms, seb-3 encodes a corticotropin-releasing factor (CRF) G-protein
coupled receptor that is homologues to mammalian CRF. CRF receptors are typically
involved in the negative emotional state induced by stress in vertabrates, which has
been implicated in excessive drinking and withdrawal. Worms harboring a gain-offunction mutation of seb-3 have an enhanced development of AFT to the sedative
effects of ethanol using standard locomotion assays and during swimming(Jee et al.,
2012). A loss-of-function mutation in seb-3 results in the failure to develop AFT during
swimming (Jee et al., 2012). Interestingly, seb-3 gain-of-function mutants display an
increase in body tremors while in liquid. This effect can be induced in wild type animals
exposed to ethanol for 4 hours and subsequently withdrawn from the drug. The
withdrawal effect was diminished when ethanol was added back to the liquid. In mice,
seb-3 is orthologus to CRF1. Mice treated with a selective pharmacological CRF1
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receptor antagonists displayed similar initial sensitivity, but developed less AFT than
wild-type mice (Jee et al., 2012).

UNC-79
In worms, unc-79 encodes a protein that localizes and regulates the activity of
the NCA cation channel (Speca et al., 2010). Animals carrying the e1089 allele of unc79 display an enhanced sensitivity to the depressive of effect of ethanol during
swimming. Work has also shown mutants in either of the NCA cation channels, nca-1
and nca-2, are resistant to the effects of ethanol in swimming (Speca et al., 2010). A
different allele of unc-79, ec1, displays a hypersensitivity to the low dose effects of
ethanol when measured by locomotion, but does not alter behavioral responses at
higher doses of the drug (Davies et al., 2011). In vertebrates, mice that are null for unc79 are lethal. Haploinsufficiency at this locus results in altered acute responses to
ethanol as well. These mice display a similar hypersensitivity to the acute sedative
effects of ethanol relative to wild type littermates measured by the loss of righting reflex
test (Speca et al., 2010).

LIPS-7
In worms, lips-7 encodes a lipase that is involved in the cleavage process of fatty
acids from triacylglycerols (TAGs) complexes. TAGs can consist of a combination of
any 3 fatty acids linked to glycerol backbone and are utilized in cellular membrane
structure and function (Coleman and Mashek, 2011). Animals carrying a loss-of-function
mutation for lips-7 display a reduced initial sensitivity and an enhanced development of
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AFT (Bettinger et al., 2012). Previous studies have shown that slo-1 gain-of-function
animals display a phenotype that mimics some aspects of intoxication. These animals
have reduced locomotion off of ethanol (Davies et al., 2003; Bettinger et al., 2012).
However, animals harboring a loss-of-function of lips-7 and a gain-of-function of slo-1
display an increase in basal speed (Bettinger et al.,2012). Previous studies have shown
in vitro that the components of the lipid bilayer can alter ethanol access to SLO-1 in a
variety of ways including through membrane thickness and structure shape changes
due to phospholipid features (Treistman and Martin, 2009; Crowley et al., 2009; Yuan
et al., 2008; Yuan et al., 2007; Lin et al., 2006). Together this suggests that lips-7 can
alter the structure of the lipid bilayer, which can affect the function of proteins in the
cellular bilayer structure.

TPH-1, SER-4
In C. elegans, tph-1 encodes tryptophan hydroxylase. This enzyme is required
for the rate-limiting first step in serotonin biosynthesis. Animals harboring a loss-offunction mutation of tph-1 display a reduced sensitivity to the depressive effects of
ethanol during locomotion analysis, suggesting that serotonin plays a role in this
response (Wang et al., 2011). ser-4 encodes a G-protein metabotropic serotonin
receptor and animals harboring a deletion of this receptor also display a reduced
sensitivity to the depressive effects of ethanol (Wang et al., 2011). Studies in mice have
shown that knockout of the D2 serotonin receptor results in a reduced sensitivity to the
depressive effects ethanol (Phillips et al., 1998; Palmer et al., 2003).
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After a single drinking session, levels of serotonin metabolites can be found in
human urine and blood suggesting that ethanol can induce the release of the
neurotransmitter. (LeMarquand et al.,1994). Serotonin has been widely implicated in
human association studies for AUDs (See Genetic Susceptibility of Alcohol Use
Disorders in this section).

The Utility of Gene Expression Microarrays in Ethanol Research
The traditional approaches for dissecting genes involved in complex disorders
typically rely on gene mapping. These studies have been used to identify susceptibility
loci by linking genetic variants to the disease (See Genetic Susceptibility of Alcohol Use
Disorders), but fail to get at the underlying biological mechanisms induced by alcohol
use.
Microarrays allow for the unbiased and parallel monitoring of mRNA expression
across the whole genome. The application of microarrays to study complex disease has
dramatically increased over the years and has been essential in identifying gene
expression that is correlated with the diseases or subtypes of the disease (Ginsberg et
al., 2012, Colombo, et al., 2011, Seo et al., 2006; Middleton et al., 2002; Latil et al.,
2003). These disease-related genes are likely to reflect a combination of genetic factors
such as individual variation and the results of dynamic interactions of environmental
factors that ultimately contribute to the disease state (Chesler et al., 2005). Thus, the
gene expression response holds valuable information regarding underlying cellular
mechanisms that contribute to disease pathology and etiology.
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Over the past decade, this approach has been used in AUD studies. These
studies include postmortem analysis of specific brain regions of alcoholic and nonalcoholic individuals (Lewohl et al., 2000; Mayfield et al, 2002) and examining the
genetic differences between inbred strains of mice that have opposite ethanol response
phenotypes such as initial sensitivity, acute tolerance, and alcohol consumption (Xu et
al., 2001, Tabakoff et al., 2003; Mulligan et al., 2008, 2011; Treadwell and Singh 2004;
Wolstenholme et al., 2011, Kerns et al., 2005).
Each of these studies is unique and has taken different approaches in identifying
genes involved in ethanol behavioral responses. Naïve inbred strains of mice that
display differences in their initial sensitivity to ethanol showed differences in basal gene
expression of 41 genes (Xu et al., 2001) These early results linked the idea that basal
gene expression differences can possibility explain the differences in behavior observed
between these two mice. Basal gene expression differences in specific brain regions
that contribute to ethanol behavioral phenotypes are also being investigated (Kerns et
al., 2005; Letwin et al., 2006), however whether these can altered the acute behavioral
responses to ethanol has not been reported.
Acute behavioral responses to alcohol have been shown to correlate with abuse
liability and dependence in humans (Schuckit, 1994). Studies have focused on the
acute ethanol induced gene expression changes because it is hypothesized that they
represent a measure of signaling events leading to changes in ethanol response
behaviors (Kerns et al., 2005). Therefore, other studies have focused on ethanol
induced gene expression differences in animals that have basal genetic differences.
Studies have been completed using two inbred strains of mice, DBA/2J and C57BL/6
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mice that differ greatly in acute locomotor responses and ethanol consumption (Phillips
et al., 1994). Whole brain studies of these mice acutely treated with a high dose of
ethanol identified 61 genes that were differentially expressed (Treadwell and Singh,
2004). This small number of genes that responded to ethanol was found to be involved
in cell signaling, gene regulation, and homeostasis and stress responses. Other studies
have focused on basal and acute ethanol-response differences in the ventral tegmental
area, nucleus accumbens, and prefrontal cortex between DBA/2J and C57BL/6 mice.
This study highlighted that acute ethanol induces coordinated changes in gene
expression that have an overall functional role in neuroplasticity (Kerns et al., 2005).
To date, there is a void in studies characterizing the role of genes whose
expression changes due to acute ethanol treatment and their involvement in mediating
acute behavioral responses to ethanol. Other studies have established that ethanol
treatment causes changes in gene expression in mostly humans and mice. Investigating
the role of these genes in ethanol responsive behaviors has been limited because of the
time and cost to generate mutant mice of interest. Using worms to study ethanol
mediated gene expression and the effects of these genes on behavior is advantageous
compared to other model organisms because of the large and readily available supply
of animals carrying a range of mutations in a majority of genome. Furthermore, worms
display two key components of LR, which is a predictive measure of long-term abuse
liability, initial sensitivity and AFT. Establishing the role of acute ethanol responsive
gene expression in acute ethanol responsive behaviors will provide candidate genes
involved in influencing risk for alcohol abuse and dependence in humans. Furthermore
establishing a link between ethanol gene expression changes and acute ethanol
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behaviors may also reveal novel cellular mechanism involved in ethanol response. The
work in this dissertation is designed to identify novel ethanol responsive target genes by
performing a whole genome gene expression microarray analysis in Caenorhabditis
elegans. We hypothesized that ethanol responsive genes would provide a basis of the
underlying biology by which cells are compensating due to ethanol exposure. We
predict that these compensatory changes are important mechanisms the cell induces to
limit the depressive effects of ethanol. Identify genes that contribute to the
compensatory changes are ideal candidates to test for their role in the acute behavioral
responses. We also predict that genetic alterations of ethanol responsive genes would
affect behavioral responses to ethanol by altering pathways that are involved in a
specific ethanol response. The genetic alterations induced may change the initial
function of that pathway and therefore alter how the cell compensates to limit the
depressive effects of the drug. Other work in this dissertation was set out to understand
the contributions of ethanol metabolism to acute behavioral responses to ethanol and to
dissect tissue ethanol concentrations in our model.
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Chapter 2
Ethanol Metabolism and Osmolarity Modify Behavioral Responses to Ethanol in
C. elegans

A majority of this material has appeared in the article “Ethanol metabolism and
osmolarity modify behavioral responses to ethanol in C. elegans” by J.T. Alaimo, S.J.
Davis, S.S. Song, C.R. Burnette, M. Grotewiel, K.L. Shelton, J.T. Pierce-Shimomura,
A.G. Davies, J.C. Bettinger (2012) in Alcoholism Clinical and Experimental Research
36(11): 1840-1850 and is used here by permission.

Introduction
Alcohol abuse is a common disorder influenced by both genetics and
environment. Despite strong evidence of a role for genetics in abuse liability, few
specific susceptibility candidate genes for alcoholism have emerged. Natural variations
in components of the ethanol metabolism machinery are among the very few identified
genetic causes of the variation in alcohol abuse liability in humans (recently reviewed by
Pautassi et al., 2010). Ethanol is metabolized to acetaldehyde by alcohol
dehydrogenase (ADH); subsequently, acetaldehyde is metabolized to acetate by an
aldehyde dehydrogenase (ALDH). Certain isoforms of ADH that are more enzymatically
active are protective for susceptibility for alcoholism. Similarly, ALDH isoforms with
decreased enzymatic activity also decrease disease liability. Both types of alleles are
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predicted to increase acetaldehyde levels, which appear to be aversive, suggesting a
mechanism for the decrease in susceptibility to alcohol abuse disorders in individuals
carrying them. While there are significant correlations between inheritance of these
ADH or ALDH alleles and rates of alcohol abuse (Chen et al., 2009; Crabb et al., 2004;
Edenberg et al., 2006; Kuo et al., 2008), there is little experimental detail on the
behavioral consequences during acute ethanol treatment of variation in alcohol
metabolism.
The nematode worm, C. elegans, has been increasingly exploited as a
behavioral model for understanding the genetic contributions to ethanol responses
(Bettinger and McIntire, 2004; Davies et al., 2003, 2004; Davis et al., 2008; Graham et
al., 2009; Kapfhamer et al., 2008; Lee et al., 2009; Mitchell et al., 2007, 2010; Morgan
and Sedensky, 1995; Speca et al., 2010). Worms are an excellent model for this work
because of the extremely well conserved neurobiology between worms and humans
(Bargmann, 1998). Worms show a dose-dependent depression of several behaviors
when treated with ethanol (Davies et al., 2003, 2004; Morgan and Sedensky, 1995).
Several laboratories are now exploring the mechanisms by which ethanol exerts its
behavioral or developmental effects, but little effort has been made to determine if
metabolism has a significant role in modulating behavioral responses to ethanol in this
model. Here, we directly examine the effect of altering ethanol metabolism on the
behavioral response to ethanol in the worm.

Materials and Methods
Nematode culture and strains
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C. elegans were maintained using standard methods (Brenner, 1974). Strains used
were: N2 var. Bristol, sodh-1(ok2799), sodh-1(bet20).

Phylogenetic analysis
Human liver ADH proteins were accessed using PubMed. ADH1A (Accession:
NP_000658.1), ADH1B (Accession: NP_000659.2), and ADH1C (Accession:
NP_000660.1) were BLAST against the C. elegans genome and all protein sequences
were loaded into CLC Sequences Viewer (version 6.4). All protein sequences were
aligned using default program conditions for the most accurate alignment. We used this
alignment to infer evolutionary relationships between Human and worm ADHs by using
the programs tree view feature. When creating the phylogenic tree we used the
neighbor joining algorithm, which infers that evolution rates are free to differ in different
lineages.

RNAi
RNAi induction was performed as described (Kamath et al., 2001). Cultures of bacteria
containing RNAi vectors from the RNAi feeding library generated by J. Ahringer at the
University of Cambridge (Geneservice, Cambridge, UK) were grown in LB
supplemented with 50 +g/mL ampicillin for 12 - 18 hours at 37˚C with shaking.
Nematode Growth Medium (NGM) plates containing 1mM IPTG and 25 +g/mL ampicillin
were seeded with bacteria containing RNAi vectors, and were incubated at room
temperature for 24 hours. 3-5 L4 stage wild-type N2 or sodh-1(ok2799) worms were
placed on the seeded plates and incubated at 20˚C for 36-40 hours. Adult worms were
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moved to new RNAi plates and allowed to lay eggs for 1-2 hours. Plates were incubated
at 20˚C to allow worms to develop to adulthood. First day adults were collected and
subjected to allyl-alcohol survival assays. Knockdown of target gene expression levels
was confirmed using quantitative RT-PCR (Table 1). Primers used in quantitative RTPCR experiments are in Table 2.

Allyl-alcohol survival assays
Allyl-alcohol survival was used to assay the function of ADH as described (Williamson et
al., 1991).

Analysis of Locomotion (crawling)
Age-matched 55 hour-old adult animals reared at 20˚C were used. Locomotion on
plates was assayed as described (Davies et al., 2003). Ten worms for each strain were
tested. Two minute movies were recorded, and movies were analyzed using ImagePro
Plus Version 6 (Media Cybernetics, Bethesda, MD, U.S.A.). To account for differences
in basal speeds, we calculated a relative speed (ethanol-treated average speed /
untreated average speed x 100).
Test strains were compared to controls assayed simultaneously on the same
plates. A one-way ANOVA was performed with a significance value of P < 0.05 with
Dunnett’s post-hoc tests comparing each mutant and knockdown strain to N2. t-tests
were performed to determine significant differences between timepoints.
Time course analysis was performed as above except that single animals were
placed on plates and video images were recorded every 0.5 seconds for 15 minutes.
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Table 1. Gene expression ratios of wild type worms treated with RNAi targeted for ADH or ALH
Strain
Target gene
Gene expression ratio
SEM
sodh-1(RNAi)
sodh-1
0.30
0.09
D2063.1(RNAi)
D2063.1
0.02
0.01
H24K24.3(RNAi)
H24K24.3
0.39
0.04
alh-1(RNAi)
alh-1
0.17
0.01
alh-3(RNAi)
alh-3
0.08
0.03
alh-5(RNAi)
alh-5
0.25
0.03
alh-6(RNAi)
alh-6
0.40
0.04
alh-7(RNAi)
alh-7
0.47
0.08
alh-8(RNAi)
alh-8
0.09
0.01
alh-9(RNAi)
alh-9
0.02
0.01
alh-10(RNAi)
alh-10
0.50
0.07
alh-11(RNAi)
alh-11
0.45
0.06
alh-13(RNAi)
alh-13
0.33
0.05
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Table 2. Primer sequences used for detection of mRNA levels by qRT-PCR
Gene
Sequence
Forward primer
Reverse primer
symbol
name
act-1
T04C12.6
GCTGGACGTGATCTTACTGATTACC GTAGCAGAGCTTCTCCTTGATGTC
sodh-2
K12G11.4
GATCACGCATGGATGTTGATGA
ATTGGAACATGCACAATTCCACG
D2063.1
D2063.1
AGCCGTCAATGTCCCATTAG
CTTTCCATCGTGCATTTTTGTG
H24K24.3
H24K24.3
GCAGGGAAATGGATTTATGC
TTCACTGAACGTGGAGCATC
alh-1
F54D8.3
GGCATCTTTGGAATCTTTGGA
TCCGGCGTAATAACGAAGAG
alh-3
F36H1.6
TTCCCACCAACGATTCTGTC
AAACTCCAGCAGCAAGTCC
alh-5
T08B1.3
ATGCCAAGGAGAGCAAAGAC
CATTTCCAGCAAGCACGAC
alh-6
F56D12.1
TCGCCGAGAATTTGGATAAC
GGATGGATGCACAAAGTGG
alh-7
F45H10.1
CTTGATGTCGCTGTGAATGGAA
CATGGACGTAGATTCGATTGGC
alh-8
F13D12.4
CGGAATCCAGTTCTACACTC
CTGTGGGAACGACATTTGTG
alh-9
F01F1.6
TGGAGGCAGTACATGAGACG
TTAATTCCCTGAGCCAAAGG
alh-10
C54D1.4
CAGTTTGGTGCAACACTTGG
TCGTGGAGACCTTCTCTTCC
alh-11
F42G9.5
CAGGATTCGGACGTGAAAAC
TTGACAAAGACCGACTTCAGG
alh-13
T22H6.2
TTCCAACAAAGAACGTGGTG
ATCGAGTCCAGCAGATTTGG
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Amplicon
size
114
66
77
94
97
160
105
86
98
91
74
91
70
121

The speed for each interval was averaged for 6 worms. The speeds were binned
for each 1-minute period and an average was calculated. A one-way ANOVA was
performed with a significance value of P < 0.01 using Prism v5.0 (GraphPad Software),
with Bonferroni post-hoc tests comparing all bins. The effects of osmolarity on crawling
were assessed as above, except that assay plates were either made of standard NGM
or of Dent’s Saline Solution (10 mM D- glucose, 10 mM HEPES, 140 mM NaCl, 6 mM
KCl, 3 mM CaCl2, 1 mM MgCl2, pH 7.4) with 2% agar.

Analysis of Locomotion (swimming)
The effect of ethanol on swimming was assessed for both individuals and groups of
animals. Individuals were video recorded (30 frames per second) in liquid medium (3
mL) over a 2% agarose surface in 6 cm diameter plates to promote continuous
swimming. The midlines of the worms were determined with a custom-written image
analysis macro using ImagePro as described (Pierce-Shimomura et al., 2008). Animals
were gently transferred to identical conditions that contained 400 mM ethanol. Groups
of animals were video recorded in identical conditions. The number of head bends
made by each individual in a 30-second time window was quantified at 5, 10, 15 and 20
minutes of exposure to ethanol.

Internal Ethanol Concentration calculations
Exposure to ethanol:
55-hour old worms reared at 20˚C were used. Several hundred worms were placed on
unseeded plates containing the appropriate concentration of ethanol (prepared as for
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locomotion assays, see above) for 10 or 50 minutes. Worms were photographed for
subsequent size analysis. Exactly 200 worms were picked from plates to a tube
containing 20 !l ddH2O. Tubes were placed at -80˚C until analysis. Worms were thawed
on ice and ground in the tube with a pestle (Kontes pellet pestle, Fisher Scientific, USA).
Worm homogenate was stored at -20˚C.
For 200 worms: Picking took an average of 1.5 minutes per condition. Picking itself
caused a loss of between 0 !L and 0.25 !L of the water, evaporation in that time
caused an undetectable loss of volume.

Size calculation:
Photographs were analyzed using ImagePro Plus v6. Ten worms were used per strain
per condition. A midline was drawn to determine the height, h. Three diameters were
drawn, one at the vulva (the approximate center of the animal), one each at the
approximate midpoint between the vulva and head or tail (Figure 2a), these lengths
were averaged and used as the diameter, " of this length was the radius, r. Volume
was determined as for a cylinder: volume = #r2h.

Calculation of internal ethanol concentration:
We calculated the internal ethanol concentration using the equation C1V1 = C2V2, where
C1 = concentration of ethanol in homogenate, V1 = (20 !L + volume of 200 worms), V2 =
volume of 200 worms. We solved for C2.

Gas Chromatography ethanol concentration analysis
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Homogenates were tested for ethanol concentration using a Hewlett Packard model
5890A gas chromatograph (GC) equipped with a flame ionization detector and 2 meter
5% Carbowax 20M 80/120 mesh packed column (Restek, Bellefonte, PA). Samples
were kept frozen at -20˚C until analysis. Injections were accomplished manually with a
10 !l gas-tight glass syringe. The GC parameters were: 5 !l injection volume, 7 minute
sample run time, injector temperature 200˚C, oven temperature isothermal 90˚C,
detector temperature 220˚C, helium carrier gas flow rate 30 ml/min, hydrogen flame flow
rate 25 ml/min and air flow rate 400 ml/min. Data were collected and analyzed by Clarity
GC software (Apex Data Systems, Prague, CZ) using a linear regression analysis with
no weighting. A 7 point calibration curve preceded the analysis of ethanol
concentrations. Ethanol concentrations were calculated by the external standard
method. Quality control ethanol standards preceded and followed each pair of samples.
Accuracy of results was inferred if the assayed ethanol concentrations from quality
control ethanol standards varied by no more than 10% from actual concentrations. All
quality control standards met this criterion. If sufficient homogenate was available, each
sample was tested in duplicate and a mean of the two values was used in subsequent
calculations. Each ethanol concentration data point represents a mean (±SEM)
generated from three independent samples.

Internal Ethanol concentration analysis using spectrophotometric analysis
C. elegans homogenates were tested for ethanol concentration according to the
manufacturer’s directions using an Alcohol Reagent Kit (Pointe Scientific, Canton, MI,
USA). 1.5 !L of worm homogenate was added to 300 !L ice-cold alcohol reagent,
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incubated for five minutes at 30˚C, and the reaction was stopped by putting the tube into
an ice-cold aluminum block. Alcohol concentration was determined by measuring the
absorbance at 340 nm.

Results
Identification and inactivation of alcohol dehydrogenase genes
There are many genes with homology to human ADH in the C. elegans genome, and
ADH activity has been directly demonstrated in worms using a spectrophotometric
assay (Williamson et al., 1991). Our goal was to examine the behavioral consequences
of impairing alcohol metabolism, and therefore we chose a subset of the genes with
strong homology to human liver ADHs as good candidates for subsequent analysis. We
used two methods to identify potential ADHs that metabolize ethanol in the worm. First,
we identified sodh-1, a gene that showed transcriptional regulation in response to a
prolonged treatment with very high concentrations (7%) of ethanol (Kwon et al., 2004)
and has been annotated as an ADH. We also tested the two genes with highest
homology to sodh-1: sodh-2 and D2063.1. Second, we used the primary amino acid
sequence of human liver ADH (Human liver ADH proteins, ADH1A (Accession:
NP_000658.1), ADH1B (Accession: NP_000659.2), and ADH1C (Accession:
NP_000660.1)) in BLAST searches to identify homologous C. elegans proteins. We
then created a dendogram to identify which protein were the most evolutionally
conserved (Figure 2). H24K24.3 was selected as a candidate because it had the
strongest relationship with human liver ADH proteins. sodh-1, sodh-2, and D2063.1
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Figure 2. Phylogenic tree of Homo sapiens Liver ADH and C. elegans ADH. The evolutionary relationship between
Human Liver ADH proteins and C. elegans ADH proteins are depicted. C. elegans proteins found in bold were candidate
genes tested in allyl-alcohol assays.
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were also identified by using this approach. Previous work had identified transcripts
from both sodh-1 and H24K24.3 as being expressed from ADH-encoding genes, these
genes have not previously been functionally characterized (Glasner et al., 1995;
Waterston et al., 1992). The phylogenetic analysis identified other genes, but they were
not selected because of reagent availability or lethality phenotypes.

Disruption of either of two ADH genes, sodh-1 or H24K24.3, confers resistance to
allyl-alcohol toxicity
We tested a subset of the genes identified by homology above for their ability to
metabolize ethanol using an allyl-alcohol toxicity assay that has been previously used
extensively to identify mutants with defects in ethanol metabolism in worms and in other
organisms (Williamson et al., 1991). Allyl-alcohol is metabolized by ADH into the toxin
acrolein, and wild-type worms that are grown on allyl-alcohol plates die within 24 hours,
whereas worms with defects in ADH function are resistant to allyl-alcohol toxicity
((Williamson et al., 1991) and Table 3). Inactivation of sodh-1 conferred profound
resistance to allyl-alcohol-induced lethality (Table 3). Previously, Williamson et al.,
(1991) performed a genetic selection using allyl-alcohol survival to isolate mutations in
putative ADHs in the worm, and identified AL2B, and we replicated the allyl-alcohol
resistance of this mutant (Table 3). We identified a G to A point mutation in sodh-1 in
AL2B, which would result in a Glycine 158 to Glutamate missense mutation (for
consistency of nomenclature, AL2B is hereafter referred to as sodh-1(bet20)).
Additionally, RNA inactivation of H24K24.3 conferred resistance to allyl-alcohol,
however, knock-down of function with RNAi of neither sodh-2 nor D2063.1 was able to
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confer strong resistance to allyl-alcohol (Table 3). It is important to note that these RNAi
experiments do not unambiguously rule out a role for sodh-2 or D2063.1 in the
metabolism of ethanol. This RNAi treatment does not completely eliminate the mRNA
for either candidate ADH (Table 1), and the residual mRNA may be sufficient to confer
function of the candidate. In addition, C. elegans tissues are differentially susceptible to
RNAi. Worm neurons are quite refractive to RNAi using this method, and it is possible
that expression of the candidate gene is preserved in neurons. In this case, expression
of the gene in neurons may be sufficient to provide function. Because inactivation of
both sodh-1 and H24K24.3 altered allyl-alcohol sensitivity, we therefore used strains
inactivated for sodh-1 and H24K24.3 in our subsequent studies.

Determination of the timecourse of intoxication in wild-type animals
To determine the appropriate time points during ethanol treatment at which to assess
the biochemical and behavioral effects of compromising ADH function, we observed the
kinetics of the onset of intoxication in wild-type animals. We placed individual worms
(n=6) in a copper ring on a plate with 500 mM exogenous ethanol, and recorded their
locomotion continuously for 15 minutes, starting immediately after the animals had been
placed on the plate. Animals rapidly decrease speed in the first few minutes of ethanol
exposure, and reach a plateau at 6 minutes, suggesting that the animals accumulate
enough ethanol in this time to become maximally impaired (Figure 3A). When we
examined the data in 1-minute bins, we found that the neighboring bins were not
different after 6 minutes (P > 0.05, Figure 3B). We chose 10 minutes exposure as an
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Figure 3. Time course for ethanol effects on speed of locomotion. (A) The mean
speed (!m/sec ± SEM) of young adult wild-type animals (n = 6) exposed to 500 mM
exogenous ethanol in the absence of food is shown for every 0.5 seconds over a 15minute period beginning immediately after ethanol exposure. (B) Speeds within each
minute of ethanol exposure were binned and a mean (n = 120) calculated for each bin.
Significant decreases in speed are only seen in the first 5 minutes when each bin is
compared with the previous bin (*, P < 0.01). Bin 6-7 minutes is not significantly different
from any bin that follows. n.s., not significantly different.
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initial time point for biochemical and behavioral testing for convenience and consistency
with previous experimental designs (Davies et al., 2003, 2004; Kapfhamer et al., 2008).

Determination of the internal ethanol concentration in wild-type and ADHcompromised animals
Worms generate a cuticle that is impermeable to many pharmacological agents
(Burns et al., 2010; Cox et al., 1981), and we have previously measured internal
concentrations approximately 20x lower than the exogenous dose (Davies et al., 2003,
2004; Kapfhamer et al., 2008). However, the determination of internal ethanol
concentration has been the subject of some conflicting reports; using different
methodology, others have reported that more than half of the exogenous ethanol
accumulates in internal tissues within 20 minutes (Mitchell et al., 2007). To
unambiguously determine the internal concentration of ethanol that animals achieve in
our behavioral assays, we exposed animals to ethanol on plates as we would for
behavioral assays, picked exactly 200 worms from the plate into a known volume of
liquid, homogenized them, and performed gas chromatography analysis on the
homogenate. All ethanol in the solution would come from the worms, and all ethanol
that was brought with the worms should be captured in the solution, so by determining
the volume of the worms we could calculate the ethanol concentration of the worms.
This calculation of internal ethanol concentration is dependent on the size of the worms
tested and animals of different genotypes differed considerably in size. We estimated
the volume of the worms by calculating the volume of a cylinder of the length and
average diameter of the worms we tested (Figure 4A). Consistent with our previously
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Figure 4. Determination of internal ethanol concentration in wild-type and ADH
compromised animals. (A) An example of worm volume measurements. The volume
of a worm was determined by taking photographs of animals immediately before they
were used for the biochemical analysis. Each animal was traced (n=10 for each strain)
to determine the length, h. The diameter of the animal, d, was the average of three
widths, one at the vulva, and one each at the midpoint between the vulva and head or
tail. The volume was calculated using formula for the volume of a cylinder (volume =
"r2h). (B) There is no difference in internal ethanol concentration measurements using
gas chromatograph (GC) and spectrophotometric analysis at 500 mM when actual
worm volume was used in the calculation (n = 3). A significant difference is observed
between time points (GC: 10 minutes vs. 50 minutes P < 0.05; Spectrophotometric
analysis: 10 minutes vs. 50 minutes P < 0.05). (C) Internal ethanol measurements of
200 worms, treated with 400 mM exogenous ethanol, calculated from
spectrophotometric analysis (n = 4). sodh-1(ok2799) was different from N2 at 10
minutes but not at 50 minutes. H24K24.3(RNAi) was not different from N2 at either
timepoint. sodh-1(ok2799);H24K24.3(RNAi) was not different from N2 at either
timepoint. * Significantly different from N2 at the same timepoint (P < 0.05) †
Significantly different from the same strain across timepoints (P < 0.05). Error bars are
SEM.
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reported results, we found that internal ethanol concentration remains much lower than
the exogenous dose. However, using this very precise method, we determined that the
internal concentration of ethanol in these experiments is approximately 2x what we have
observed in the past using different tissue preparation methods. For wild-type N2
animals exposed to 500 mM exogenous ethanol, at 10 minutes of exposure the tissue
concentration was 67.5 ± 7.1 mM. The tissue concentration of ethanol increased over
time; at 50 minutes of exposure, the tissue concentration was 89.3 ± 8.8 mM (P = 0.02
vs. 10 minutes; Figure 4B). This indicates that the development of acute tolerance that
we observe over 50 minutes of exposure (Davies et al., 2004) does not reflect a
decrease in internal tissue ethanol.
We sought an explanation for the differences in our previously published
concentrations and what we have found here using this very sensitive protocol (Davies
et al., 2003, 2004; Kapfhamer et al., 2008). Examining our previous protocol, we
identified a major confound in the estimation of worm volume in the assay; we made an
assumption that, in a pellet of worms that remains following centrifugation and removal
of the supernatant, worms made up the vast majority of the volume of the pellet.
However, when we calculated the volume of worms in a pellet by counting the worms
and determining their volume, we found that this volume could vary by more than 2 fold
depending on the size of the pellet and adult age of the worms, and at the most
accounted for less than half of the volume (data not shown). When we used a known
number of worms of known volume, our original spectrophotometric assay protocol
closely recapitulated the internal ethanol concentration determined by gas
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chromatography (Figure 4B), demonstrating that use of this simple protocol is
acceptable for future internal ethanol concentration measurements in C elegans.
We predicted that the internal concentration of ethanol would be higher in
animals in which ethanol metabolism is compromised. We determined the effect of
inactivation of the two ADHs both singly and in combination on the accumulation of
ethanol at the dose of exogenous ethanol at which we tested behavior, 400 mM. We
determined the internal ethanol concentration after 10 and 50 minutes of ethanol
exposure, to observe an acute accumulation of ethanol (10 minutes) as well as
accumulation that could potentially be altered by the development of acute tolerance (50
minutes). Loss of sodh-1 significantly increased the internal ethanol concentration in
animals relative to wild type (Figure 4C). However, inactivation of H24K24.3 did not
significantly increase the internal ethanol concentration (Figure 4C). Interestingly, when
we examined animals in which both ADHs were inactivated,
sodh-1(ok2799);H24K24.3(RNAi), the concentration of ethanol that the animals
accumulated was similar to that of wild type at 10 minutes (Figure 4C), suggesting the
possibility that loss of H24K24.3 may trigger a compensatory response that minimizes
the effect seen for loss of sodh-1 alone.

Assessment of the ethanol-responsive behavioral consequences of
compromising ADH function
We assessed the behavioral effects of altering ethanol metabolism on the
locomotion of worms. We exposed wild-type and ADH-defective animals to exogenous
ethanol and recorded their locomotion on plates after 10 minutes of exposure. 400 mM
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was chosen as the upper dose for locomotion analyses using mutant or knockdown
strains rather than 500 mM because we hypothesized that the metabolism-defective
animals might show hypersensitivity to ethanol and we wanted to eliminate possible
floor effects at 500 mM. Loss of sodh-1 conferred mild but significant hypersensitivity to
ethanol when the animals were tested on low (200 mM) and high concentrations (400
mM) of the drug (Figure 5A and 5B). Reduction of function of H24K24.3 did not change
the effects of ethanol on locomotion significantly, although there may be a trend towards
increased sensitivity. Inactivating both sodh-1 and H24K24.3 did not increase the effect
of ethanol on locomotion compared with the sodh-1(ok2799) mutation alone (Figure
4A). These results indicate that the difference in ethanol accumulation seen with sodh1(ok2799) mutant animals is sufficient to alter the behavior of the animals when they are
exposed to ethanol. Surprisingly, the measured internal ethanol concentration for
animals with a loss of both sodh-1 and H24K24.3 was not different from wild-type
animals (Figure 3C) and yet these animals show a significant increase in ethanol
sensitivity compared with wild-type animals (Figure 5A).

Assessment of the ethanol-responsive behavioral consequences of
compromising ALDH function
The second step of ethanol metabolism is the oxidation of acetaldehyde to
acetate, catalyzed by aldehyde dehydrogenase (ALDH). We tested the effects of
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Figure 5. ADH compromised animals demonstrate behavioral sensitivity to
ethanol, and develop acute functional tolerance to ethanol. Animals were treated
continuously with exogenous ethanol, beginning at 10 minutes and at 50 minutes of
exposure, two-minute digital movies were recorded, and speed was determined by
ImagePro image analysis software. A % relative speed was calculated by dividing
treated speed by untreated speed, to account for any baseline speed differences. (A)
Animals treated with 400 mM exogenous ethanol (n = 12). Locomotion of wild-type N2
worms is strongly suppressed by this dose of ethanol. sodh-1(ok2799) and
sodh-1(ok2799);H24K24.3(RNAi) strains are more strongly affected than N2 by ethanol
at this dose, but H24K24.3(RNAi) animals are not significantly different from N2.
Additionally, at this dose of ethanol, ADH mutant animals develop acute functional
tolerance; each strain moved significantly faster at 50 minutes than at 10 minutes. (B)
Animals treated with 200 mM exogenous ethanol (n = 14). At this dose, sodh-1(ok2799)
and sodh-1(ok2799);H24K24.3(RNAi) strains showed enhanced behavioral sensitivity to
ethanol relative to N2, but H24K24.3(RNAi) was not different from N2. At this dose, we
do not observe development of acute functional tolerance. Error bars are SEM.
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knocking down function of each of 10 C. elegans ALDH-like enzymes using RNAi.
Inactivation of either alh-6 or alh-13 caused ethanol hypersensitivity (Figure 6A).
If ADH and ALDH act in a linear pathway, the phenotype of loss of the upstream
gene should not be enhances by loss of the downstream gene. We tested this by
knocking down function of either alh-6 or alh-13 in a sodh-1(ok2799) background, and
found that the phenotype of the combinations was not different from that of sodh-1
alone (Figure 6B, 6C). This result provides further support for the linear nature of the
metabolism pathway, and further strongly suggests that the ethanol hypersensitivity
phenotypes of sodh-1(ok2799), alh-6(RNAi) and alh-13(RNAi) are due to changing
ethanol metabolism.
The action of ADH is reversible; one possibility for the increase in ethanol
sensitivity in alh-6 and alh-13 knock down animals is that the excess acetaldehyde in
these animals is converted back to ethanol, thereby increasing the internal ethanol
concentration. We observed an increase in internal ethanol concentration alh-6(RNAi)
and alh-13(RNAi) but not alh-1(RNAi) (which did not show a change in behavior on
ethanol) (Figure 7), suggesting that one effect of loss of ALDH function may be through
increasing the effective ethanol dose.

Ethanol responses in C. elegans are sensitive to osmolarity
We next determined how ethanol affects C. elegans swimming in liquid. We
found that ethanol inhibits swimming, although at a substantially higher dose
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Figure 6: Behavioral effects of intoxication in wild-type and ALDH compromised
animals. Animals were treated with exogenous ethanol for 10 minutes, two-minute
digital movies were recorded, and speed was determined by ImagePro image analysis
software. A % relative speed was calculated by dividing treated speed by untreated
speed, to account for any baseline speed differences. In each case, the alh knockdown
strain was compared to N2 animals tested on the same plates. (A) Knockdown of either
alh-6 or alh-13 conferred hypersensitivity to the effects of ethanol on locomotion (*, P <
0.05). (B, C) Knockdown of neither alh-6 (n = 6) nor alh-13 (n =10) in the background of
sodh-1(ok2799) was able to enhance the ethanol sensitivity beyond that of sodh1(ok2799) alone. Error bars are SEM
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Figure 7. Determination of internal ethanol concentration in wild-type and ALDH
compromised animals. Internal ethanol measurements of 200 worms, treated with 500
mM exogenous ethanol, calculated from spectrophotometric analysis (n = 3). alh1(RNAi) served as a control for RNAi delivery and was not different from N2 at 10
minutes. Alh-6 (RNAi) and alh-13(RNAi) are significantly different from N2. *
Significantly different from N2 (P < 0.05). Error bars are SEM.
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than is required to inhibit crawling (Figure 8). While our results are in agreement with
the first study of ethanols effects on swimming in C. elegans (Morgan and Sedensky,
1995), they differ significantly from those reported by Mitchell and colleagues (2007),
who used slightly different conditions. We found that differences in our results from
those of Mitchell and colleagues (2007) could be explained by the buffers used in our
swimming analyses. Our study used NGM, which contains the same salts as the
medium that animals are cultured on (Brenner, 1974), whereas the Mitchell study used
Dent’s buffer, a physiological saline normally used to record the electrical activity of
dissected muscle (Avery et al., 1995). While the basal swimming behavior of worms in
the two buffers was indistinguishable (data not shown), we observed a striking
difference in behavior in the two buffers when ethanol was added. Figure 8A shows the
time course of intoxication in 500 mM ethanol in the two buffers. Swimming movement
was quantified as the number of head swings during a 10 second time window. The
motion of the animals exposed to ethanol decreased in both conditions by 5 minutes of
exposure. However, animals assayed in Dent’s buffer became essentially immotile by
10 minutes, whereas animals assayed in NGM buffer decreased motion but remained
motile during the entire 20 minutes of treatment.
To examine the time course of intoxication during swimming more closely, we
plotted matrices that represent body curvature along the anterior-posterior

67

"#$%"&'(()*""+,-"./0.
"1)230"&'(()*"4--"./0.

#$
#"
%$
%"

!!

$

!!
!

"
"

C

B

$

%"

3-4'*54-.6

%$

!"

&'()*+,-./+*0'1*%"*+'2

>

!"

&'()*+,-./+*0'1*%"*+'2

B

"#$%"&'(()*""+,-"./0.
"1)230"&'(()*"4--"./0.
"56*&7368"""""""4--"./0.
"#$%"+,-"./0.9"56*&7368"+4-"./0."

#$
#"
%$
%"
$

!!

"

#"

"

89:*;<=='1

$

%"

!!

3-4'*54-.6

%$

#"

>'.?@+*;<=='1

A.?1'(?')

A
B
%*4-.
A
B
$*4-.
A
B
%"4-.
A
B
%$*4-.
A
B
#"*4-.
A

D
:'*;<3'*)"
=>)?*))0@

%*+'2
$"

$"

"

"

7$"

7$"

%*+'2

68

Figure 8. Sensitivity to intoxication while swimming depends on exogenous
osmolarity. (A) Time course of intoxication while animals were swimming in 500 mM
ethanol. Animals become significantly more immobilized by the same concentration of
ethanol in Dent’s buffer than in NGM buffer (**, P <0.001). (B) Body curvature matrices
during intoxication for one representative animal in NGM buffer and one representative
animal in Dent’s buffer. Color intensity along the anterior-posterior (A-P) axis versus
time represents the amount of bending at given points along the body (red = ventral,
white = no bend, blue = dorsal). (C) Plots of neck curvature versus time. Untreated
(grey) and 20 minute treatment in ethanol (black). (D) Time course of intoxication while
animals were swimming in 500 mM ethanol. NGM and Dent’s buffer data are replotted
from panel (A). Animals treated with NGM + sorbitol or sorbitol alone were as sensitive
to ethanol as those animals treated in Dent’s buffer.
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axis versus time (Figure 8B). In this scheme, upward slanting red and blue “waves” in
the matrix represent ventral and dorsal bends that pass from head to tail to generate
forward motion. The representative plot for an animal swimming in NGM buffer (Figure
8B, left column) shows little difference from its untreated condition even after 10
minutes in ethanol aside from a slight decrease in frequency and dampening of bends,
which is evident in the muted red and blue color code. By contrast, the representative
plot for an animal swimming in Dent’s buffer (Figure 8B, right column) shows severe
impairment of coordination, beginning at 5 minutes of exposure, reflected in the fact that
many of the bends fail to propagate fully from head to tail. Portions of the animal also
become immobile by 15 minutes, which is reflected in the fixed color pattern versus
time. We also compared the swimming of untreated (grey line) versus 20-minute
exposure to ethanol (black line) by plotting the “neck” curvature versus time (Figure 8C).
The animal treated with ethanol in NGM buffer showed a slowing in frequency, while the
animal in Dent’s buffer showed a much slower bend frequency and a rise in maximal
bend amplitudes.
While searching for factors that could explain the vastly different results obtained
in the different buffers, we noticed that the two buffers differed greatly in osmolarity:
NGM is 160 mOsm, while Dent’s buffer is 300 mOsm. We tested if C. elegans’
sensitivity to intoxication while swimming depends on osmolarity, and found that worms
became rapidly intoxicated when assayed in NGM buffer in which we had adjusted the
osmolarity to match Dent’s buffer by adding 130 mOsm sorbitol (Figure 8D). Assaying
worms in only 300 mOsm sorbitol without any salts reproduced a dose response for
intoxication that was characteristic of Dent’s buffer (Figure 8D). Moreover, we found that
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pre-incubation for 20 minutes in Dent’s buffer or 300 mOsm sorbitol conferred enhanced
sensitivity to intoxication when the animals were assayed in 150 mOsm NGM buffer
(data not shown). Together, these results suggest that acute sensitivity to exogenous
ethanol in C. elegans depends on osmolarity, that this sensitivity can be dynamically
adjusted, and that this is an explanation that can resolve the conflicting reports of dose
response sensitivity to ethanol while swimming.
We tested the effect of osmolarity on the dose effect for ethanol on crawling, and
found that the effect was significant, but more subtle than for swimming. At 10 minutes
of exposure to 100 mM ethanol, the behavior of worms tested on NGM was less
affected compared with worms tested on plates made with Dent’s Saline (Figure 9A).
We asked if the effect of osmolarity on the dose response for ethanol was due to
altering the acute accumulation of ethanol. At 10 minutes of 100 mM ethanol exposure,
worms on NGM plates accumulated significantly less ethanol than did animals on Dent’s
saline plates (Figure 9B).

Discussion
The ADH enzymatic pathway is shared throughout evolutionary history.
Modulation of ethanol metabolism has been shown to have a variety of biological effects
across phyla when animals ingest large quantities of exogenous ethanol. In Drosophila
melanogaster, functional variations in both ADH (Geer et al., 1989; Ogueta et al., 2010)
and ALDH (Wolf et al, 2002; Fry and Saweikis, 2006; Fry et al., 2008) contribute to
variation in ethanol sensitivity. In humans, functional variants of both ADH and ALDH
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Figure 9. Sensitivity to intoxication and tissue accumulation of ethanol while
crawling depends on exogenous osmolarity. (A) Animals were treated with
exogenous ethanol for 10 minutes, two-minute digital movies were recorded, and speed
was determined by ImagePro image analysis software. A % relative speed was
calculated by dividing treated speed by untreated speed, to account for any baseline
speed differences. Animals exposed to 100 mM exogenous ethanol for 10 minutes on
NGM plates were less affected than animals exposed on Dent’s Saline plates (100 mM
n = 13; 500 mM n = 7). (B) Animals exposed to ethanol on NGM plates accumulated
significantly more tissue ethanol than animals exposed on Dent’s Saline plates (n = 3). *
Significantly different from nematode growth meida (P < 0.05). Error bars are SEM.
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have been correlated with altered susceptibility to becoming alcoholic. We have
assessed the behavioral effects of altering alcohol metabolism in C. elegans.
We identified two ADHs in worms using a method described by Williamson et al.,
(1991), in which we exploited the fact that ADH metabolizes allyl-alcohol to the toxin
acrolein. Inactivation of either sodh-1 or H24K24.3 them conferred resistance to allylalcohol – induced lethality. We inactivated these two genes, both singly and in
combination, in our analysis of ADH pathway function in the behavioral responses to
ethanol.
To determine if altering ADH function results in differences in tissue levels of
ethanol, we developed a method to accurately measure the internal ethanol
concentration in ethanol-exposed C. elegans, in which we used a known volume of
worm tissue and measured ethanol concentration using gas chromatography. The
concentrations that we measured reflect the relative lack of permeability of these
nematodes to chemicals in their environment; for 500 mM exogenous ethanol, the wildtype internal concentration is in the range of 70–90 mM (Figure 4B). This translates to
blood alcohol concentration (BAC) values of 0.32–0.41%, which would cause profound
intoxication in a naïve human drinker. The degree of intoxication associated with these
concentrations in C. elegans is also profound, on an agar medium worms exposed to
500 mM ethanol move at approximately 20% of their untreated speeds (Davies et al.,
2003, 2004 and see Figure 5A) the amplitude of their body bends is significantly
reduced (Davies et al., 2003), and their movement becomes severely uncoordinated.
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Previously, we reported internal ethanol concentrations that were approximately
half of the concentrations that we observe here (Davies et al., 2003, 2004; Kapfhamer
et al., 2008). We found that we had overestimated the volume of worms in a pellet
derived from spinning worms out of a solution because we assumed that the vast
majority of the pellet was made of worm tissue, which we have found here to be
incorrect. This observation can also explain why Mitchell et al., (2007) vastly
overestimated the internal concentration in their animals; in their paradigm, they
incubated worms in a high concentration of ethanol and then tested a pellet consisting
of the resulting worm + ethanol solution. Our results suggest that the mixture probably
contained relatively less worm tissue and more ethanol solution than they estimated,
which would have contributed a significant amount of ethanol to the final concentration.
There is substantial evidence from human studies that an individual’s naïve level
of ethanol response is a predisposing factor in the development of alcoholism (Heath et
al., 1999; Rodriguez et al., 1993; Schuckit et al., 2001; Schuckit, 1994; Volavka et al.,
1996). Factors influencing an individual’s LR to ethanol include both acute sensitivity as
well as the magnitude and rate of development of acute tolerance during the ethanol
exposure (Hu et al., 2008; Ponomarev and Crabbe, 2002). Here we show that altered
ethanol metabolism in C. elegans affects the acute sensitivity of the worms but not the
development of acute tolerance. First, ethanol tissue concentrations do not decrease
during a single constant exposure (Figure 4B), so metabolism is not sufficient to reduce
the concentration of ethanol below that seen at an early time point. Therefore, any
reduction in the behavioral effects over this time course is likely to be due to
compensatory mechanisms that act in the opposite direction to ethanol or directly limit
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the action of ethanol. Second, ADH mutant animals develop acute tolerance similar to
that displayed by wild-type animals showing that a reduction in metabolism does not
impact the mechanisms of acute tolerance development (Figure 5A). This provides
further support for the idea that acute tolerance is occurring at the level of the affected
tissues, which in C. elegans includes the nervous system (Davies et al., 2003) rather
than through a systemic metabolic process.
Our investigation into the reported differences in ethanol sensitivity for swimming
behavior led to the unexpected finding that the worms’ sensitivity to ethanol depends on
the osmolarity of the external medium, and that the worms are able to change their
sensitivity to the effects of osmolarity based on experience. Therefore, the constituents
of the exogenous medium are critical to note in future alcohol studies using C. elegans.
We speculate that the permeability of the worm to exogenous ethanol might change
depending on the history of exposure. Dynamic permeability may be adaptive for an
animal that must occasionally encounter dangerous chemicals, such as ethanol, while
roaming through its natural soil environment. Future study of this phenomenon in
C. elegans may give rise to novel strategies to alter excess permeation of ethanol into
specific tissues to prevent toxicity.
In both vertebrates and C. elegans, ethanol metabolism makes important
contributions to ethanol responsive behaviors. Our results suggest that both metabolism
and environmental conditions should be considered in the analysis of mechanisms that
contribute to ethanol responsive behaviors.
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Chapter 3
Microarray Analysis of Ethanol Responsive Genes Reveals Role for ACS-2 in
Acute Functional Tolerance in C. elegans

Introduction
Gene expression microarrays have been used extensively to capture mRNA
changes associated with autism, breast cancer, cardiovascular and neurological
diseases and many others (Ginsberg et al., 2012, Colombo, et al., 2011, Seo et al.,
2006; Middleton, et al., 2002). The goal of these studies is to identify genes whose
expression correlates with the disease. Among these will be disease-related genes that
are likely to reflect a combination of genetic factors such as individual variation and the
results of dynamic interactions of environmental factors that ultimately contribute to the
disease state (Chesler et al., 2005). Thus, the gene expression response holds valuable
information regarding underlying cellular mechanisms that contribute to disease
pathology and etiology.
Over the past decade the approach of surveying gene expression has been
taken with AUD. These studies include postmortem analysis of specific brain regions of
alcoholic and non-alcoholic individuals (Lewohl et al., 2000; Mayfield et al, 2002), and
examining the genetic differences between inbred strains of mice that have opposite
ethanol behavioral phenotypes such as initial sensitivity, acute tolerance and alcohol
consumption (Xu et al., 2001, Tabakoff et al., 2003; Mulligan et al., 2008, 2011;
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Treadwell and Singh 2004; Wolstenholme et al., 2011, Kerns et al., 2005). The latter of
the studies has taken an approach to study a specific phenotype or endophenotype that
is related to alcohol dependence to uncover specific mechanisms involved in ethanol
responses. In addition, these studies have implicated the importance of basal gene
expression differences that contribute to ethanol induced gene expression.
Low level of response (LR) to the initial acute effects of ethanol has been shown
to correlate with abuse liability and dependence in humans (Schuckit, 1994). This
phenotype is significantly influenced by genetics (Heath et al., 1999) and has been
under intense investigation to understand how genetic differences can contribute to
alterations in levels of response. LR is a composite phenotype consisting of at least two
components, initial sensitivity and the development of AFT (Hu et al., 2008; Ponomerev
et al., 2002).
The nematode worm, C. elegans, has been increasingly exploited as a
behavioral model for understanding the genetic contributions to ethanol responses
(Bettinger and McIntire, 2004; Davies et al., 2003, 2004; Davis et al., 2008; Graham et
al., 2009; Kapfhamer et al., 2008; Lee et al., 2009; Mitchell et al., 2007, 2010; Morgan
and Sedensky, 1995; Speca et al., 2010). In C. elegans, acute behavioral responses to
ethanol are influenced by genetics. In particular, genetic differences in neuropeptide Y
receptor-like protein, npr-1, results in differences in the magnitude of AFT. AFT reflects
a neuronal compensatory response that reduces the depressive effects of the drug
(Davies et al., 2004).
In this study, we compared the basal gene expression response of npr-1(ky13)
animals with gene expression changes in npr-1(ky13) and wild type animals treated with
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acute ethanol and then looked at the contribution of these differences in acute ethanol
response behaviors. We found a significant overlap of ethanol gene expression
between wild type and npr-1(ky13) mutants that related to a variety of biological
processes including lipid metabolism. We focused on characterizing the role of acs-2, a
gene involved in fatty acid activation for mitochondrial #-oxidation, in acute behavioral
responses to ethanol and show that loss of function of acs-2 results in reduced AFT.
This work implicates the role of fatty acid metabolism and mitochondrial #-oxidationin
cellular response to ethanol.

Materials and Methods
Nematode Culture and Strains
C. elegans were maintained using standard methods (Brenner, 1974). Strains
used in this study were: N2 (var. Bristol), npr-1(ky13) (6x outcrossed), acs-2(ok2457)
(2x outcrossed), npr-1(ky13); acs-2(ok2457) and gpls1[hsp-16-2::GFP]. We generated
double mutants by standard genetic crosses. Genotyping was as follows: the ky13 allele
generates a restriction fragment length polymorphism (RFLP) and the locus was
amplified using ky13_SNP_F: 5’ AGTGCGCTACAGCTTACTGACACCC 3’ and
ky13_SNP_R: 5’ CGGTGCGATTGCTTTGGATCGGTA 3’. The amplicon was
enzymatically digested using DraI. The wild type copy of npr-1 is negative for digestion
and produces a 592 base pair band after gel electrophoresis. The ky13 allele is positive
for digestion and produces a 592 base pair band. The ok2457 allele of acs-2 is a 1868
base pair deletion and was amplified using acs-2_F1: 5’
CCAAATGGCGTTCTCTGCTCAGT 3’ and acs-2_R1: 5’
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CAATCATGTCACGAGTTCTACCG 3’. Animals carrying the wild-type copy of acs-2
produce a 2367 base pair band and animals carrying acs-2(ok2457) produce a 499
base pair band.

Microarray Analysis
RNA Preparation for Microarray
Prior to performing the microarray analysis, we outcrossed npr-1(ky13) animals 6
times to our laboratory wild-type N2 strain to any reduce potential noise that may arise
in the downstream analysis due to extraneous mutations in each genetic background.
These animals were tested behaviorally for their response to ethanol and were not
significantly different than non outcrossed npr-1(ky13) animals (data not shown). Age
matched first day adult animals were exposed to either 0mM or 500mM ethanol for 2
hours. We chose 2 hours to capture gene expression changes because we predicted
that this population of mRNA might represent the genes regulated by the early response
genes to ethanol such as transcription factors. Whole animals were homogenized in
TRIzol Reagent (Life Technologies, Carlsbad, CA) by freezing and thawing and total
RNA was isolated according to the manufacturer’s protocol. Total RNA was
subsequently purified using RNeasy Mini Kit (Qiagene, Valencia, CA). RNA
concentrations were determined by absorbance at 260 nm using NanoDrop 2000
(Thermo Scientific, Waltham, MA) and RNA quality and integrity was assessed by using
Experion Automated Electrophoresis System (Bio-Rad, Hercules, CA). Total RNA
samples were then prepared for hybridization according to manufacture’s protocol using
GeneChip 3’ IVT Express Kit (Affymextrix, Santa Clara, CA). Briefly, total RNA was
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converted into single stranded cDNA using T7-Oligo(dT) primers followed by a second
strand synthesis step. The double stranded cDNA was then transcribed into
complementary RNA (cRNA). cRNA is amplified and biotinylated for 16 hours. Amplified
biotinylated cRNA was then purified using magnetic RNA binding beads and cRNA
binding buffer to remove enzymes, salts and unincorporated nucleotides. Purifed cRNA
was fragmented and both unfragmented and fragmented cRNA was analyzed using the
Experion Automated Electrophoresis System (Bio-Rad). We observed size distributions
in the range recommended (100-120 nucleotides) by the manufacturer, indicating
successful amplification and fragmentation.

Hybridization and Scanning
Each sample (n=16) was hybridized to an individual GeneChip C. elegans
Genome Array (Affymetrix, Santa Clara, CA) that contains greater than 22,500
transcripts for 16 hours in a hybridization oven at 45 °C using the GeneChip
Hybridization, Wash and Stain Kit (Affymetrix). Microarrays were washed and stained
using a Fluidics Station 450 (Affymetrix) and the corresponding fluidics protocol for
C. elegans genome arrays. The microarrays were then scanned using the GeneChip
Scanner 3000 (Affymetrix) according to manufactures protocol.

Microarray Data Analysis
Prior to statistical analysis of data, we analyzed a series of quality control metrics to
ensure data quality as previously described (Kerns et al., 2005; O’Brien et al., 2012).
Frist, we processed our data using Microarray Suite software version 5.0 (Affymetrix) to
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determine the overall percentage of probes called present. Probes are given a p-value
that assesses the reliability of detection. This is done by using a singed rank test to
consider the significance of the difference between the perfect-match probe signal value
and the mismatch probe signal value. We observed that regardless of treatment and
genotype about 54% of probes were called present (data not shown). We then
processed our data using Robust Multi-array Analysis (RMA) algorithim to increase
sensitivity of detecting small changes between samples (Irizarry et al., 2003). To
monitor the entire amplification and labeling process, samples were spiked with ploy-A
RNA controls that were provided by the manufacturer. All of the ploy-A controls were
called present at the expected order of signal magnitude. We also included hybridization
controls supplied by the manufacture to evaluate the sample hybridization efficiency.
Hybridization controls were spiked into samples independent of the poly-A controls. All
hybridization controls were called present. Both hybridization and labeling controls
validated the detection sensitivity of 1:100,000 of the microarrays. We also performed
pair-wise linear correlation plots between all microarrays and found a very high
Pearson’s correlation coefficient value of r2 $ 0.985 indicating very low technical error
(Figure 10). We then filtered our data for all probes sets that were called absent across
all microarrays. We used TIGR MultiExperiment Viewer (TMeV) (version 4.8) (Saeed at
al., 2003, 2006) and performed a statistical analysis of microarrays (SAM) to identify
probe sets with intensity values that were significantly different. We performed a two
class SAM for: N2 untreated and N2 treated to produce the N2 ethanol response; npr1(ky13) untreated and npr-1(ky13) treated to produce the npr-1(ky13) ethanol response;
and N2 untreated and npr-1(ky13) untreated to produce the npr-1(ky13) basal response.
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Figure 10. Pearson’s correlation coefficient for signal intensity across all microarrays. Correlation coefficients were
greater than 0.985 suggesting low technical error (O’Brien et al., 2012). Correlation values are scaled from 0.984 – 1 and
are shaded degrees of blue and red to represent the correlation values. A perfect correlation is 1. Squares shaded red
indicate correlation values greater than 0.994. Squares shaded blue indicate correlation values less than 0.990 but
greater than 0.984.
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We used a false discovery rate of (FDR) ! 5 %. Genes that showed significant changes
were further analyzed for gene ontology and degree of similarity across each treatment.

Bioinformatics Analysis
We analyzed each transcriptional profile to identify any over represented
biological themes using the Database for Annotation Visualization and Integrated
Discovery (DAVID) (Dennis et al., 2003). We uploaded 442 probe set extensions to
DAVID and 441 were accepted for analysis. We used a P ! 0.05 as a cut-off for
significant terms. To determine the degree of similarity between transcriptional profiles
we used the geneset comparison tool in GeneWeaver (Baker et al., 2012). We also
used GeneWeaver to convert Affymetrix probe identifiers (IDs) into Wormbase gene
IDs.

Internal Ethanol Concentration
Internal ethanol concentrations were assessed as previously described (Alaimo
et al., 2012, Chapter 2, Appendix A). Briefly, age matched worms were photographed
and exposed to ethanol for 10 or 30 minutes. Exactly 200 worms were picked into 20 µL
ddH20 and homogenized. Homogenates were tested for ethanol concentration
according to the manufacturer’s protocol using an Alcohol Reagent Kit (Pointe Scientific,
Canton, MI). 1.5 µL of worm homogenate was added to 300 µL alcohol reagent and
incubated for 5 minutes at 30°C. To stop the reaction, the tubes were placed on ice and
absorbance was measured at 340 nm using a spectrophotometer (Bio-Rad). The
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volume of the animals was determined from the photographs by calculating the volume
of a cylinder and the C1V1=C2V2 formula was used to calculate the final concentration.

Real-Time Quantitative PCR
Whole animals were homogenized in TRIzol Reagent (Life Technologies) and
total RNA was extracted and purified using the RNeasy Mini Kit (Qiagene). 1 ug of total
RNA was DNase I treated to remove any contaminating DNA (Life Technologies) and
converted into cDNA using an iScript cDNA Synthesis Kit (Bio-Rad). Designed primers
were tested for efficiency (See Appendix C) and used in the detection of message levels
using SensiMix SYBR green (Bioline, Taunton, MA) and the iCycler iQ system. (BioRad). The following primers were use for qRT-PCR for detection of dlc-2 and ech-6: dlc2_F1 5’ ATGGAAGATCCACAACGAGA 3’ , dlc-2_R1 5’ GACTCCCGAAACACTTTCA 3’
and ech-6_F2 5’ CCCACTGTGGCTTTCTCTTC 3’ , ech-6_R2 5’
TCGCTGATCAATCTCCACTG 3’ . Final fold changes were calculated using 2-!!Ct .

Analysis of Speed
Speed of animals was assessed as previously described (Davies et al., 2003,
2004, Kapfhamer et al., 2008, Alaimo et al., 2012 Bettinger et al., 2012 and Appendix
A). Briefly, nematode growth media (NGM) plates were dried at 37°C for 2 hours.
Copper rings were melted into the surface of the plates and 100% ethanol was added 2
hours prior to the assay to a final concentration of 0mM, 200mM, or 400mM. Age
matched animals were acclimated to assay conditions 30 minutes prior to assay. Ten
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worms of each test strain were moved into a copper ring on an assay plate and 2minute movies of their movement were recorded at 10 and 30 minutes of exposure. All
assays were recorded using a Retiga4000R camera (Qimaging, Canada) and ImagePro
Plus (6.2) (Media Cybernetics, Bethesda, MD) software was used to record and analyze
movies.

RNA Interference
RNA interference (RNAi) was performed as previously described (Kamath et al.,
2003). Briefly, bacteria containing the L4440 plasmid plus insert from the RNAi feeding
library generated by J. Ahringer at the University of Cambridge (Geneservice,
Cambridige, UK) were grown with shaking at 37°C in Luria broth supplemented with 50
µg/ml ampicillin salt (LB+AMP) for 18 hours. Cultures were then streaked on NGM
plates supplemented with 50 µg/ml ampicillin and 12.5 µg/m tetracycline. Plates were
incubated at 37°C for 24-48 hours and single colonies were picked and grown in
LB+AMP for 18 hours at 37°C with shaking. RNAi plasmids were isolated using an
alkaline lysis miniprep. Briefly, 1.5 mL of pelleted RNAi containing bacteria was
incubated in a glucose/tris/EDTA solution for 5 minutes at room temperature.
NaOH/SDS was added to the samples, mixed, and incubated on ice for 5 minutes. 5 M
potassium acetate was added to the sample, mixed, and incubated for 5 minutes on ice.
Samples were incubated for 2 minutes in 95% ethanol to precipitate DNA. Samples
were microcentrifuged and resulting pellets were washed with 70% ethanol and
resuspended in ddH20. Isolated plasmids were sequenced using the U19 primer.
BLAST was used to confirm the identity of the insert. Once the identity of the insert was
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confirmed, NMG plates supplemented with 1 mM IPTG and 25 µg/ml carbinicillin were
seeded with bacteria containing L4440 (control) or the RNAi construct to be tested 24
hours prior to use. Three to five L4 stage wild-type N2 animals were placed on seeded
plates and incubated for 36 to 40 hours at 20°C. Adult animals were moved to a new
RNAi plate and first-day adults from their progeny were assayed.

Transcriptional Inhibition
Age matched adult animals carrying hsp-16.2::GFP were heat shocked at 35°C
for 1 hour in M9 buffer. Animals were allowed to recover for 60 minutes on NGM plates
without food and whole worm images were taken using a GFP microscope. We
measured the intensity of GFP expression in the posterior blub, isthmus, and
metacorpus of the pharynx using ImagePro Plus (6.2) (Media Cybernetics, Bethesda,
MD) software. We choose these three regions because hsp-16.2 is known to be
expressed in the pharynx (Strayer et al., 2003) and the structures were easily
disguisable.
To determine if actinomycin D inhibited transcription we pretreated hsp16.2::GFP animals with 100 µg/mL of drug for 30 minutes in M9 prior to and during
heat shock and allowed animals to recover for 60 minutes on NGM plates without. We
chose 100 µg/mL based reports from other studies that have used other transcriptional
inhibitors in worms (Rogalski et al., 1990).
Next, we treated both N2 and npr-1(ky13) mutants with 100 µg/mL of actinomcyin
D for 30 minutes in M9 buffer. Immediately after drug exposure animals were placed on
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an acclimation plate for 30 minutes and the speed of locomotion was measured as
described above.

Statistics
To determine statistical significance (P! 0.05) in studies comparing two or more
groups, t tests, one- and two-way analysis of variance (ANOVA) (Prism, GraphPad, San
Diego, CA, USA), followed by Bonferroni multiple comparison tests were performed as
appropriate. The SAM was performed as described in Microarray Data Analysis.

Results
Microarray Analysis of Ethanol Responsive Genes in C. elegans
Previous studies have shown that NPR-1 antagonizes the development of acute
functional tolerance (AFT) to ethanol and that extended exposure to ethanol can alter
the function of this pathway (Davies et al., 2004, Bettinger et al., 2012). Prior to
performing a microarray analysis of ethanol responsive genes we hypothesized that
transcriptional changes that occur during acute ethanol exposure may be required to
observe acute behavioral responses to ethanol. Therefore, we globally blocked
transcription including the acute ethanol response genes and measured acute
behavioral responses to ethanol. We used animals carrying a hsp-16.2::GFP to
determine the time course of GFP expression of animals heat shocked for 1 hour at
35°C and found a significant increase in GFP expression after 60 minutes post heat
shock (data not shown) and therefore used this time point to measure the degree of
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transcription. We pretreated hsp-16.2::GFP animals with actinomycin D for 30 minutes
and during the 60 minute heat shock incubation. We found that GFP expression was
significantly reduced in actinomycin D treated heat shocked hsp-16.2::GFP animals
relative to untreated and heat shocked animals (Figure 11A) (P < 0.001) suggesting that
100 µg/mL of actinomycin D can inhibit transcription. Next, we treated wild-type N2 and
npr-1(ky13) mutants with 100 µg/mL of actinomcyin D and found that both animals did
not display any differences in initial sensitivity or the development of AFT (Figure 11BC). These results suggest that transcription is dispensable for the initial response to
ethanol. Furthermore, these results also suggest that basal gene expression may play
an important role in behavioral responses to ethanol. Therefore, we hypothesized that
basal gene expression differences between N2 and npr-1(ky13) may reveal genes that
are involved in the acute behavioral differences to ethanol between these animals.
Ethanol regulation of gene expression may also provide insights into the
biological mechanisms of cellular responses to ethanol. Identifying ethanol responsive
genes may uncover genes involved in a process in a cell that is specific to ethanol.
Furthermore, when the basal or initial functional of the gene involved in a specific
cellular process is altered it may lead to differences in acute behavioral response to
ethanol.
To identify differences in mRNA levels, we performed a whole-genome
expression analysis using Affymetix GeneChip C. elegans Genome Arrays on wild-type
N2 and npr-1(ky13) animals exposed to 500 mM exogenous ethanol for two hours. We
identified changes in gene expression by performing a two class SAM for: N2 untreated
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Figure 11. Inhibition of transcription does not alter the development of
acute functional tolerance to ethanol. (A) Animals carrying hsp-16.2::GFP were heat
shocked at 35°C for 60 minutes in the presence or absence of 100 µg/mL actinomycin D
and allowed to recover for 30 minutes. 60 minutes post recovery, heat shocked animals
had a significant increase in GFP intensity and animals treated with 100 µg/mL of
actinomcyin D had similar a GFP intensity as untreated animals and significantly
reduced GFP intensity compared to heat shock. The vehicle for actinomycin D, DMSO
had a similar GFP intensity compared to untreated (n = 3). (B) Wild type N2 animals
were treated for 30 minutes with 100 µg/mL actinomycin D. Inhibition of transcription did
not alter the initial sensitivity or the development of AFT relative to untreated (n =3). (C)
npr-1(ky13) mutant animals treated with 100 µg/mL actinomycin D also did not display a
significantly different initial sensitivity or AFT (n = 3). * P < 0.05 ** P < 0.01 *** P <
0.001. n.s., not significant. Error bars are SEM.
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and N2 treated to produce the N2 ethanol response; npr-1(ky13) untreated and npr1(ky13) treated to produce the npr-1(ky13) ethanol response; and N2 untreated and
npr-1(ky13) untreated to produce the npr-1(ky13) basal response., We found that npr1(ky13) had 221 basal gene expression differences (214 up regulated and 7 down
regulated) and ethanol treatment of these animals resulted in expression changes in
611 genes (493 up-regulated and 118 down-regulated). Ethanol treatment of N2 caused
changes in 499 genes (442 up regulated and 57 down regulated). Next, we performed
an analysis of similarity between all three gene expression profiles (N2 ethanol, npr1(ky13) ethanol, and npr-1(ky13) basal) using the geneset comparison tool in
Geneweaver (Baker et al., 2012). Ethanol response profiles between N2 and npr1(ky13) had significant overlap of 408 genes (P = 1.332E-15) and 22 of these genes
were also basally regulated by npr-1(ky13) (Figure 12). In addition, 15 genes were
basally different in npr-1(ky13), but regulated ethanol only in N2 (Figure 12).

Assessing neuronal expression
Prior to performing our candidate gene selection analysis, we investigated the
sensitivity of the microarray detailing the expression of genes that have expression that
is restricted to the nervous system. Since previous studies have implicated a role for
neurons in the acute behavioral response to ethanol, we confirmed that we are able to
detect neuronally expressed genes in our analysis (Davies et al., 2003, 2004).
We utilized a publically available database that contains the annotations for a broad
range of neuronally expressed genes and a literature search for genes with expression
that is either pan-neuronal, specific to subsets of neurons, or specific to single neurons
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(Lockery Lab Neuron-Specific Promoters Database, 2001,
http://chinook.uoregon.edu/promoters.html). The Lockery database contains 218
neuronal markers and studies by Ruvinsky et al (2007) have confirmed the expression
of 234 broadly expressed neuronal genes. Some of the genes identified in the Ruvinsky
et al., 2007 were present in the Lockery Lab database, however the Lockery Lab
database contained genes that were expressed in tissues other than neurons.
We tested 28 probe set IDs for detection on wild-type N2 gene expression microarrays
and found that 19 of the probes were called present by the MAS5 detection algorithm
(Table 4). A majority of neuronally expressed genes that we examined were panneuronal or broadly expressed. We were also able to detect genes expressed in neuron
pairs AFS, ASI, and BAG. In addition, the probe set IDs for nhr-38 and daf-7 are entirely
unique for these genes, but the probe set for gcy-33 is not unique and therefore cross
hybridization of genes homologous to gcy-33 may also be represented to achieve a
signal intensity that allows detection. However, we did not observe detection for some
probe set IDs known to be expressed in neurons. This group of genes included both
pan-neuronal and individual neurons. There are a variety of explanations for why we
may have been unable to detect expression of these genes. One possible explanation is
that these particular genes are expressed below detectable levels. These data indicate
that we have neuron only gene expression represented in our results and we were able
to detect these genes at the level of only two cells for AFD, ASI and BAG neurons.

93

!"#$%&'(%)*
#$%&!'(

!"
#$%&!'(

.,/

,-

"01

"0
0

-.
-,,
!"#$%&'(%)*)
*&+&(

Figure 12. Gene expression overlap between N2 ethanol responsive gene
expression, npr-1(ky13) ethanol responsive expression, and npr-1(ky13) basal
gene expression differences profiles. Ethanol treatment resulted in expression
changes in 499 genes and 611 genes in N2 and npr-1(ky13) respectively. 408 genes
were present in both ethanol profiles and the degree of overlap was very significant
(P=1.332E-15). npr-1(ky13) had 221 genes differentially expressed basally and 20 of
these genes were ethanol responsive in both N2 and npr-1(ky13). Additionally, 13
genes that were basally different in npr-1(ky13) were also ethanol responsive in only
N2.
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Table 4. Detection of neuronally expressed genes by microarray analysis for wild-type N2
Gene Symbol
Neuronal Location
Probe ID
jnk-1
All Neurons
175640_at
190415_s_at
rab-3
All Neurons
192427_s_at
unc-13
Ventral and dorsal nerve cord, nerve ring, head, tail, and touch neurons
171998_x_at
191489_s_at
unc-76
Ventral and dorsal nerve cord, nerve ring, HSNL, HSNR, CANL, CANR
191703_s_at
175598_at
unc-104
Ventral and dorsal nerve cord, AWC, nerve ring, tail
175742_at
188472_s_at
ehs-1
Ventral and dorsal nerve cord, nerve ring
188120_at
mec-3
Touch cells, FLP, PVD
194097_s_at
unc-14
VD and DD – Motor Neurons
174402_at
188044_s_at
175683_s_at
flp-10
AIM, ASI, AUA, BAG, BDU, DVB, PQR, PVR and URX
188393_at
odr-10
AWA, CEP
187746_at
ocr-1
AWA, ADL
189270_at
nhr-38
AFD
193582_at
daf-7
ASI
193876_at
gcy-33
BAG
191874_s_at
174520_s_at
str-2
AWC
175756_s_at
jkk-1
All Neurons
188020_s_at
sng-1
All Neurons
191339_at
unc-75
All Neurons
193998_at
183050_at
gcy-5
ASER
191609_at
gcy-6
ASEL
193179_at
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Detection
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
No
No
No
No
No
No

Gene ontology enrichment analysis of ethanol responsive genes reveals similar
biological processes are induced in wild type and npr-1(ky13)
To gain biological insight into the similarity between ethanol response profiles, we
performed a gene ontology enrichment analysis for biological process and molecular
function using DAVID (Dennis et al., 2003). We found that the overlap between N2 and
npr-1(ky13) ethanol responsive genes were significantly enriched (P < 0.05) for
biological processes involved in oxidation reduction, lipid glycosylation and metabolism,
transcription, and others (Table 5). The oxidation reduction group included genes from
the cytochrome P450 family, flavin-containing monooxygenase family, and multiple
types of dehydrogenases. Interestingly, we have previously examined the two
dehydrogenases, D2063.1 and K12G11.4 in C. elegans for their role in ethanol
metabolism and behavior. We found that knockdown by RNAi of either gene did not
confer resistance to an allyl-alcohol toxicity assay (Alaimo et al., 2012; Chapter 2). This
assay has been used to identify mutants with defects in alcohol dehydrogenase activity
(Williamson et al., 1991) suggesting that animals are unable to metabolism alcohol
(Chapter 2). The lipid glycosylation and metabolism group consisted of only UDPglucuronosyltransferases, suggesting that ethanol induces changes in the expression of
genes regulating fatty acid modification of lipids. The transcription and regulation of
transcription group included genes from the nuclear hormone receptor family.
We also used DAVID to determine if there was over representation of a particular
molecular function between both ethanol response profiles. We found that iron ion
binding was the most enriched function and 25 of 37 of the genes in this category
belonged to the cytochrome P450 family (Table 5). The cytochrome P450 family was
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Table 5. Gene ontology enrichment analysis for biological process and molecular function.
Biological Process
Genes
Category Total
P-value
Oxidation reduction
41
382
4.3E-16
Lipid glycosylation, modification
13
44
2.1E-10
Response to xenobiotic stimulus
4
6
2.4E-04
Regulation of transcription
24
495
1.2E-03
Cellular homeostasis
7
91
2.0E-02
Glycerol and alditol metabolic process
3
15
4.7E-02
Molecular Function
Iron ion binding
Electron carrier activity
Heme and tetarapyrole binding
Metal ion binding
Steroid hormone receptor activity
Cofactor binding
Flavin-containing monooxygenase
activity
Carbohydrate binding
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Genes
37
32
27
86
24
19
4

Category Total
262
206
145
1910
282
226
7

P-value
3.0E-15
2.5E-14
5.3E-04
4.0E-08
6.1E-05
1.1E-04
8.1E-04

19

177

2.1E-03

also represented in the electron carrier activity, heme binding, and cation binding
categories. Carbohydrate binding and steroid hormone receptor activity were also
significantly represented. These categories were enriched for genes encoding nuclear
hormone receptors (Table 5).

Selection of gene candidates for behavioral testing
We used npr-1(ky13) basal gene expression differences as a tool to enrich for
candidate genes predicted to be involved in ethanol responsive behaviors. Altering the
basal function of npr-1 results in an enhanced AFT phenotype. This suggests that the
functions of the cells in these animals are fundamentally different in their response to
ethanol than wild-type animals. Therefore, these genes represent a population of
putative candidate genes involved in ethanol responses. 221 genes were differentially
expressed in npr-1(ky13). We performed a similarity analysis between the npr-1(ky13)
basal gene expression profile and both ethanol response profiles and found that 20
genes were differentially expressed basally in npr-1(ky13), but were also regulated by
ethanol in both N2 and npr-1(ky13) (Figure 11 and Table 6). These genes are the basis
of our list of candidate genes that influence ethanol response behaviors because they
are basally different, but also ethanol responsive. Additionally we found that 12 genes
were differentially expressed basally in npr-1(ky13), but only regulated by ethanol in N2.
These genes may represent another class of genes involved in AFT. For example, npr1(ky13) animals may respond differently to ethanol because their basal gene expression
differences has altered the intrinsic properties of their cells. Therefore, they adapt better
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Table 6. Candidate genes from similarity analysis of all expression profiles.
Gene
N2 Basal
N2 Ethanol
npr-1 Basal
npr-1 Ethanol
N2 Ethanol
Symbol
RMA Value
RMA Value
RMA Value
RMA Value
Fold Change
0.466
acs-2
8.876
7.793
9.878
8.267
0.472
B0564.3
6.190
5.116
7.129
5.571
2.123
C15C8.3
9.630
10.728
10.328
11.191
0.444
C25H3.10
7.532
6.382
9.370
6.525
18.328
cdr-2
6.293
10.498
7.057
10.835
0.250
dct-7
8.048
6.053
9.393
6.352
0.361
F15E6.3
9.081
7.616
10.266
7.879
6.146
F37H8.3
5.765
8.420
6.759
9.051
7.890
F49C12.7
6.113
9.099
6.783
9.315
31.983
fmo-2
6.081
11.105
7.207
11.393
5.490
hpd-1
7.922
10.264
8.567
10.107
3.246
hrg-1
7.619
9.331
8.562
9.888
4.248
irg-2
6.673
8.589
7.390
9.324
2.924
pgp-14
6.813
8.353
7.539
9.128
pqn-31
8.319
9.020
8.904
9.547
1.629
0.492
scl-22
6.787
5.766
7.834
6.490
2.887
T12D8.5
8.637
10.197
9.459
10.372
1.782
T19D12.4
5.934
6.745
6.516
7.199
3.572
ugt-5
6.627
8.452
7.243
8.705
1.794
Y73F4A.2
8.727
9.581
9.444
10.168
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npr-1 Basal
Fold Change
1.9831
1.9519
1.6184
3.5789
1.6938
2.6897
2.2685
2.0110
1.5947
2.1921
1.5637
1.9135
1.6521
1.6489
1.5036
2.1490
1.8229
1.5047
1.5392
1.6249

npr-1 Ethanol
Fold Change
0.3291
0.3303
1.8193
0.1369
13.7928
0.1167
0.1946
4.7460
5.7561
17.3623
2.9332
2.5100
4.1932
3.0081
1.5571
0.3801
1.7937
1.6036
2.7408
1.6524

Table 7. Candidate genes from similarity analysis between N2 ethanol response gene expression profile and npr1(ky13) basal gene expression profile
Gene
N2 Basal RMA
N2 Ethanol RMA
npr-1 Basal RMA
N2 Ethanol
npr-1 Basal Fold
Symbol
Value
Value
Value
Fold Change
Change
catp-3
6.027
7.437
7.999
3.007
3.962
cnc-2
5.527
7.331
7.495
3.473
4.822
cth-2
9.490
10.119
10.080
1.550
1.508
nlp-29
8.488
9.859
9.373
2.554
2.129
nlp-30
7.837
8.617
8.705
1.721
1.879
pgp-5
5.755
6.370
6.682
1.526
1.898
ttr-44
8.692
9.277
9.471
1.507
1.725
ugt-29
6.326
7.264
7.092
1.991
1.709
C05D12.3
7.174
7.815
7.867
1.614
1.700
F41E6.5
7.382
8.047
8.066
1.566
1.592
F54B8.4
6.607
7.348
7.205
1.680
1.567
T19B10.2
6.808
7.465
8.471
1.567
1.991
ZK228.4
6.198
7.193
7.132
2.137
1.927
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to ethanol exposure. Wild type animals may change their cellular function only after
being exposed to the ethanol by modifying gene expression that may result in a more
efficient or different adaptive response, like npr-1(ky13). Therefore, genes in common in
this class may be good candidates for AFT. We predict that the remaining basal gene
expression differences in npr-1(ky13) are likely involved in other npr-1 functions such as
pheromone attraction, nociceptive avoidance, oxygen avoidance and feeding behavior.
Another interesting class of genes are the 204 genes that are solely regulated by
ethanol in npr-1(ky13). This class represents ethanol changes in gene expression only
when npr-1 is non-functional, suggesting that this group may be involved in the npr1(ky13) pathway and may also provide insight into how these animals behaviorally
respond to ethanol.
Next, we prioritized our list of 22 candidate genes by allele availability and known
phenotypes reported to the C. elegans online database, Wormbase. In addition, we
looked for any gene candidates that had a strong mammalian homolog and neuronal
expression. Using this ranking system, acs-2, an acyl-CoA synthetase, emerged as our
top candidate gene. Previous studies have reported that acs-2 mutant animals have an
increase in lipid content (Zhang et al., 2011; Ashrafi et al., 2003). Our laboratory has
demonstrated that lipid biology plays an important role in the development of AFT
(Bettinger et al., 2012). Animals that have an increase in triacylglycerides (TAGs) are
less sensitive to ethanol and display an enhanced development of AFT (Bettinger et al.,
2012). In addition, acs-2 is directly regulated by nhr-49 (Van Gilst et al., 2005; Taubert
et al., 2006). nhr-49 loss of function mutants have an increase in fat content (Ashrafi et
al., 2003; Horikawa et al., 2008; Xu et al., 2011) and display blunted AFT (Bettinger et
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al., 2012). Taken together, these data suggest that lipid biology and metabolism are
important in ethanol responsive behaviors.
Next, we confirmed the changes in gene expression for acs-2 found by the
microarray analysis using qRT-PCR. We extracted total RNA from independent samples
and used primers that were designed to amplify the region captured by the acs-2 signal
on the microarray. Our qRT-PCR results agreed with our microarray findings. acs-2
gene expression is up regulated in npr-1(ky13) mutants. We measured a 1.91 fold up
regulation by microarray analysis (Table 6) and 1.95 fold by qRT-PCR (Figure 13).
When N2 and npr-1(ky13) animals are treated with ethanol, acs-2 gene expression is
down regulated, 0.47 fold in N2 and 0.37 fold in npr-1(ky13). We also observed down
regulation for acs-2 by qRT-PCR. We measured a down regulation of 0.35 fold in N2
ethanol-treated animals, and 0.1886 fold in npr-1(ky13) ethanol treated animals (Figure
13). This analysis validates the changes of gene expression for acs-2 in our microarray
studies.

acs-2 modifies the development of AFT in C. elegans
acs-2 encodes an acyl-CoA synthetase that activates fatty acids in a two-step
irreversible reaction that requires ATP (Li et al., 2010). Loss-of-function of this gene
disrupts fatty acid activation and results in fat accumulation(Zhang et al., 2011; Ashrafi
et al., 2003). Fatty acids are incorporated into fat stores such as TAGs and genes
involved in metabolizing TAGs show altered responses to the effects of acute ethanol
(Bettinger et al., 2012). We asked if disruption of fatty acid activation caused by loss-offunction of acs-2 could alter acute responses to ethanol. Using a locomotion assay
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Figure 13. Gene expression confirmation of acs-2. We confirmed gene expression of
acs-2 by qRT-PCR in an independent set of samples. A one-way ANOVA showed
significant differences between npr-1(ky13) basal and N2 ethanol (P < 0.05) and npr1(ky13) basal and npr-1(ky13) ethanol (P < 0.05) by qRT-PCR. N2 ethanol and npr1(ky13) ethanol qRT-PCR results were not significantly different from each other (P >
0.05). (n = 4). Error bars are SEM
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Figure 14. acs-2 modifies AFT and does not alter ethanol metabolism (A) At
400mM exogenous ethanol, acs-2(ok2457) display a similar initial sensitivity to N2, but
develop significantly less AFT. acs-2(ok2457);npr-1(ky13) animals also have a similar
initial sensitivity relative npr-1(ky13) and acs-2(ok2457), but have a reduced AFT that is
significantly different than npr-1(ky13), but not acs-2(ok23457) or N2. (n = 9)(B). Internal
ethanol concentrations are similar across all mutants suggesting the observed
behavioral effects are not due to ethanol metabolism. (n = 4). Error bars are SEM. * P <
0.5 , ** P < 0.01, *** P < 0.001
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(Davies et al., 2003, 2004, Appendix A), we found that animals carrying a
deletion of acs-2(ok2457) display similar initial sensitivity to ethanol as wild-type N2.
However, during a continuous exposure to ethanol, acs-2(ok2457) mutants have a
significantly decreased development of AFT (Figure 14A, right panel) (P < 0.05). N2
recovers 10.84% of its untreated speed, but acs-2(ok2457) only recovers 4.03% of its
untreated speed. This suggests that loss of acs-2 function modifies the adaptive
response of AFT to acute ethanol.
Next, we asked if acs-2(ok2457) can alter the development of AFT in npr-1(ky13)
mutants. Since acs-2 is basally up regulated in npr-1(ky13) mutants relative to N2
(Table 6, Figure 13), and npr-1 animals have enhanced development of AFT, we
predicted that altering acs-2 levels in the opposite direction may result in AFT levels
similar to acs-2. We found that acs-2(ok2457);npr-1(ky13) double mutants displayed
similar initial sensitivity to npr-1(ky13) and acs-2(ok2457) alone (Figure 14A) (P > 0.05).
Double mutants developed significantly less acute functional tolerance than npr-1(ky13)
(P < 0.01), but similar levels of AFT to acs-2(ok2457) and N2 (P > 0.05) (Figure 14A,
right panel). These results demonstrate that acs-2 can modify the fast AFT phenotype of
npr-1(ky13) and it may suggest an this effect is additive.
Paralogs of acs-2, acs-20 and acs-22, have been reported to play a role in cuticle
formation of animals (Kage-Nakadai et al., 2010). The cuticle is a waxy outer surface
that protects animals from the environment and many pharmacological agents (Burns et
al., 2010; Cox et al., 1981). The reduced AFT phenotype of acs-2(ok2457) may be due
to an increase in ethanol entry due to disruption of the cuticle. To test this, we measured
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internal ethanol concentrations and found that the acs-2(ok2457) animals had similar
internal ethanol concentrations as wild type (P > 0.05)(Figure 14B). In addition, npr1(ky13) and acs-2(ok2457);npr-1(ky13) all displayed similar tissue ethanol
concentrations (P > 0.05)( (Figure 14B). This suggests that the behavioral effects of
acs-2 are likely to be due to a difference in the pharmacodynamics effects to ethanol.

Impaired mitochondrial !-oxidation may alter acute responses to ethanol
Previous studies have found that loss of function of acs-2 results in a decrease in
mitochondrial !-oxidation rates and loss of function mutations in nhr-49, an upstream
regulator of acs-2, displayed abnormal mitochondrial morphology shown by high
pressure freezing transmission electron microscopy (Pathare et al., 2012) To determine
if the failure to develop AFT in the acs-2(ok2457) mutant is due to a decrease in
mitochondrial !-oxidation function, we inhibited gene expression in the mitochondrial !oxidation pathway using RNAi. We identified genes in the mitochondrial !-oxidation
pathway by performing literature searches (Van Gilst et al., 2005a; Van Gilst et al.,
2005b; Brock et al., 2007, Zhang et al., 2013) and adapted these finding to show genes
involved in the mitochondrial !-oxidation pathway (Figure 15).
First, we asked if inhibiting fatty acid entry into the mitochondria would alter
ethanol responses. We tested two genes that encode carinitine palmitoyl transferases,
cpt-2 and cpt-5. cpt-2 is predicted to localize to the inner membrane of the mitochondria
and cpt-5 is positively regulated by nhr-49 (Van Gilst et al., 2005a; Van Gilst et al.,
2005b). We found that when animals were treated with RNAi for cpt-2 and cpt-5, initial
sensitivity and AFT were similar to controls (Figure 16A). This suggests that altering the
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Figure 15. Mitochondrial !-oxidation pathway in C. elegans. Fatty acids become
activated by the addition of CoA by acyl-CoA synthetase. Activated fatty acids enter the
mitochondria from the cytoplasm by carnitine palmitoly transferase and are
dehydrogenated by acyl-CoA dehydrogenase. Enoyl-CoA hydratase and 3-hydroxy
acyl-CoA dehydrogenase breakdown the fatty acid further where ketoacyl-coA thiolase
catalyzes the release of acetyl-CoA from the mitochondria. In bold are the genes tested
in acute ethanol responses.
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Figure 16. Mitochondrial !-oxidation may influence acute ethanol
behaviors. (A) At 400mM exogenous ethanol cpt-2(RNAi) and cpt-5(RNAi) animals
displayed similar initial sensitivity and development of AFT relative to control (n = 4). (B)
ech-2(RNAi), ech-4(RNAi), and ech-1(RNAi) mutant animals also display similar initial
sensitivity and AFT relative to control (n = 4). (C) T08B2.7 (RNAi) animals were not
different than control for initial sensitivity or AFT. ech-6(RNAi) mutants displayed an
enhanced AFT relative to wild type, but initial sensitivity was not significantly different (n
= 8). Error bars represent SEM * P < 0.05, ** P < 0.01, ***P < 0.001.
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Figure 17. ech-6(RNAi) mutants have significantly decreased mRNA levels and do
not have altered ethanol metabolism. (A) qRT-PCR of ech-6 in ech-6(RNAi) mutants
shows that messages levels are significantly reduced (n = 4). (B) ech-6(RNAi) animals
have similar internal ethanol concentrations relative to control (n = 3). Error bars
represent SEM. * P < 0.05
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entry of fatty acids into the mitochondria through cpt-2 and cpt-5 does not modify
behavioral responses to ethanol. We did observe large viability in the development of
AFT for ctp-2(RNAi) animals, suggesting that the behavior was not consistently
observed and more trials are needed. However, there are many reasons that can
explain why we were unable to see an effect. One possibility may be that our method of
knockdown did not reduce message levels adequately enough to have an effect. Any
remaining message that was not degraded may have been enough to provide normal
function.
Next, we examined knockdown by RNAi of 4 different enoyl-coA hydratases; ech1, ech-2, ech-4 and ech-6. ech-1(RNAi), ech-2(RNAi), and ech-4(RNAi) animals
displayed similar initial sensitivity and AFT to controls. However, ech-6(RNAi) animals
displayed enhanced AFT to the depressive effects of ethanol. This suggests that the
lost of this specific enoyl-CoA hydratase can alter acute behavioral responses to
ethanol. In addition this results suggests that mitochondrial !-oxidation may also be
involved in acute behavioral responses to ethanol.
Lastly, we tested the effects of knock down of the hydroxyl acyl-CoA
dehydrogenase, T08B2.7, for acute behavioral responses to ethanol. These animals do
not have altered ethanol responses relative to wild type.
We were intrigued by the ech-6(RNAi) ethanol response and further examined
ech-6(RNAi) animals for knockdown of mRNA levels by qRT-PCR. We found that
animals treated with RNAi by feeding had significantly less ech-6 message (0.40 fold)
than the L4440 control (paired t-test, P = 0.0388). We also tested ech-6(RNAi) animals
for altered ethanol metabolism and found that they do not display any differences from
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controls (Figure 17). Taken together, this suggests that knockdown of ech-6 can alter
acute behavioral responses to ethanol.

Discussion:
In this study, we performed an unbiased survey of gene expression across the
whole genome of Caenorhabditis elegans for ethanol responsiveness. There is
increasing evidence in the literature that ethanol responsive genes are excellent
candidates to gain insights into the underlying cellular and physiological mechanisms in
ethanol response behaviors (Mulligan et al., 2008, 2011; Treadwell and Singh 2004;
Wolstenholme et al., 2011, Kerns et al., 2005). More importantly, studies have shown
that some of these genes, when genetically altered, can affect acute behavioral
responses to ethanol (Bhandari et al., 2012, Costin et al., 2013, Wolstenholme et al.,
2011, Cozzoli et al., 2012). We captured gene expression at a sedative dose of ethanol.
We found that we were able to detect tissue specific transcripts down to the level of two
neurons suggesting that the microarray analysis was very sensitive (Table 4).
We determined the ethanol responsive gene profile of N2 and animals mutant for
npr-1 and found a significant number of genes commonly regulated by ethanol between
both genotypes (Figure 12). A gene ontology enrichment analysis revealed that the
common ethanol response was enriched for a variety of biological processes including
genes involved in oxidative stress, lipid modification and glycosylation, and transcription
(Table 5). Previous work has shown that lipid metabolism is involved in ethanol
responsive behaviors (Bettinger et al., 2012). Furthermore, the lipid environment has
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shown to affect the function of BK channels (Crowley et al., 2005; Yuan et al., 2008,
2007; Lin et al., 2006, Bettinger et al., 2012)
Recently, Peltonen et al., (2013) determined the ethanol responsive genes of
chronic low dose ethanol treatment of worms developing from embryo to L4 stage by
RNA seq analysis. Interestingly, they report similar gene ontology categories for
biological process as our study, including oxidation-reduction, lipid glycosylation, and
lipid modification. This provides further evidence that lipid homeostasis may play an
important role in ethanol responses. Additionally, our microarray data set and the
Peltonen et al., (2013) RNA seq data set are enriched for similar molecular functions
such as monooxygenase activity, heme and tetrapyrrole binding, iron ion binding, and
electron carrier activity. This suggests that ethanol may be acting on similar cellular
processes during acute and chronic exposure. Another study by Kwon et al., (2004)
also looked for ethanol responsive genes, but at a lethal dose of 7% ethanol at 15
minutes and 30 minutes and this data set only showed similarity to 20 genes produced
by the RNA seq study by Pheltonen et al., When we compared our wild type ethanol
response profile to Kwon et al., 2004, we found 85 genes overlaped between data sets.
We predict that these genes may be involved in the stress response. However, it must
be noted that the Kwon studies were performed with very limited power.
We determined the basal gene expression profiles of npr-1(ky13) animals and
used these changes in gene expression to select for candidates for genes involved in
ethanol responses. This resulted in 20 candidate genes (Table 6) and we focused on
acs-2 because of its association with lipid metabolism. We found that acs-2 function is
required for normal development of AFT (Figure 14A) and we sought to clarify the
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mechanism by which acs-2 is regulating this process. First, we show that acs-2
mediated disruption of fatty acid activation in npr-1(ky13) animals can modify the rate of
AFT. However, acs-2(ok2457);npr-1(ky13) still have an intermediate phenotype of each
individual mutant suggesting that acs-2 and npr-1(ky13) together produce an additive
response (Figure 14A). Since acs-2 can modify AFT in a sensitized background, it
suggests that the effects of acs-2 may be an important regulator of adaptive responses.
Second, nhr-49, a transcriptional regulator of acs-2, when mutated results in the failure
to develop AFT (Bettinger et al., 2012). nhr-49 loss of function mutants have a
significant increase in fat content which is caused by a repression of acs-2 expression
(Van Gilst et al., 2005a). nhr-49 is a transcription factor that regulates a variety of
energy metabolic processes and mutant animals have an abnormal mitochondrial
morphology. It is not known whether acs-2(ok2457) mutants have altered mitochondrial
morphology, but studies have shown they have reduced rates of β-oxidation relative to
wild type. This information suggests that mutants in acs-2 may cause mitochondrial
dysfunction and this dysfunction may result in defects in AFT. To test this, we examined
genes in the mitochondrial !-oxidation pathway (Figure 15 and Figure 16) for their acute
responses to ethanol. None of the genes that we tested altered ethanol responses,
except for ech-6(RNAi), which displayed an enhanced AFT (Figure 16C). This result led
us to a few possible explanations. First, if loss of ech-6 function results in a decrease in
mitochondrial !-oxidation and mitochondrial dysfunction, we would predict that animals
would have displayed responses to ethanol similar to nhr-49 and acs-2 loss of function.
The opposite phenotype for loss of ech-6 function may result from an accumulation of
its precursor trans-2-enoyl CoA and this precursor may be utilized in other pathways in
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the mitochondria, such as mitochondrial fatty acid synthesis (Gurvitz 2009) Taken
together, our results indicate that altered mitochondrial !-oxidation alters acute adaptive
responses to ethanol and warrants further investigation.
One other possible explanation into the mechanisms of acs-2 regulating AFT
could be through its increase in fat stores. Previous work has investigated the role of fat
stores induced by mutations of different genes in the development of AFT or initial
sensitivity. These studies concluded that fat stores do not regulate AFT (Bettinger et al.,
2012). One could speculate that since acs-2 mutants have a decrease in mitochondrial
!-oxidation (likely due to a decrease in activated fatty acids specific for !-oxidation), that
excess fatty acid cellular pools are being utilized by other acyl-CoA synthetases. The
C. elegans genome is annotated for 23 different actyl co-A syntheases, each of which
may activate specific chain length. Activated fatty acids have been shown to be involved
in a variety of different cellular process such as vesicle trafficking, signaling, fatty acid
desaturation and elongation and TAG synthesis (Ashrafi et al., 2009). Additionally,
activated fatty acids also modify ATP-sensitive K+ channels and protein kinase C
function (Lester et al., 1990).
Our results implicate a role for lipid homoeostasis in the acute responses to
ethanol. In addition to our previous work, we have shown that alterations in different
lipid metabolic pathways can influence acute responses to ethanol and may warrant
further work elucidating mechanisms in which lipids can alter cellular responses to
ethanol.
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Chapter 4
Across Species Characterization of Genes Involved in Ethanol-Response
Behaviors

A portion of this material has appeared in the article “Chloride Intracellular Channels
Modulate Acute Ethanol Behaviors in Drosophila, Caenorhabditis elegans and mice” by
P. Bhandari, J.S. Hill, S.P. Farris, B. Costin, I. Martin, C.-L. Chan, J.T. Alaimo, J.C.
Bettinger, A.G. Davies, M.F. Miles, M. Grotewiel (2012) in Genes, Brain and Behavior
11(4): 387-397 and is used here by permission.

Introduction
Over the last decade, a variety of studies from different species have identified
numerous chromosomal regions, single nucleotide polymorphisms (SNPs), and gene
expression changes that are correlated with alcoholism and individual traits associated
with the etiology of the disease (Reich et al., 1998, Hill et al., 2004, Hitzermann et al.,
2004, Kerns et al., 2005, Hoffman and Tabakoff et al., 2005, Johnson et al., 2006, Kuo
et al., 2006, Morozova et al., 2007, Rodd et al., 2008, Mayfield et al., 2008). This wealth
of information has led to the creation of a comprehensive ethanol-related gene resource
(ERGR) and other computation tools such as Geneweaver to help analyze and integrate
these different types of data for researchers (Guo et al., 2008; Baker et al., 2012).
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These tools provide a great platform for identifying possible candidate genes involved in
alcohol responses.
Alcohol dependence is a complex disorder consisting of different components,
some of which are physiological and some are psychological. Some of these
components, particularly the physiological ones, can be modeled using animal systems.
Many studies have shown that a variety of ethanol behavioral responses in humans also
are observed in vertebrates and invertebrate animals, including monkeys, mice, rats,
honey bees, flies, zebrafish, and worms. (Vivian et al., 2001; Corl et al., 2009, Crabbe et
al., 2006; Varlinskaya et al., 2001, Maze et al., 2006; Bhandari et al., 2008, Gerlai et al.,
Davies et al., 2003, 2004) suggesting that conserved mechanisms exist.
Humans that display a LR to acute ethanol have a significant increase in alcohol
abuse liability and this response is strongly influenced by genetics (Schuckit 1994;
Schuckit and Smith, 2006). Animal models display conserved acute behavioral
responses to ethanol and are very amenable to genetic manipulation. Therefore,
utilizing model organisms can facilitate defining genes involved in behavioral responses
to ethanol. Furthermore, identifying genes that influence ethanol behavioral phenotypes
may give insight into how a particular gene function is involved in cellular responses to
the drug.
One approach to uncovering such basic mechanisms of alcohol response is to
study the role of a gene in ethanol responsive behaviors across multiple species. This
approach is based on the principle that important biological processes are frequently
conserved between organisms. To date, only a few studies have taken this approach
(Cori et al., 2009; Kapfhamer et al., 2008; Lasek et al., 2011a,b; Schumann et al., 2011,
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Bhandari et al., 2012; Jee et al., 2013) and additional studies are needed because it
may provide validation of a gene being involved in acute ethanol response behaviors
and future risk for dependenace in humans.
We have performed two different sets of experiments that have arisen from a
series of cross species collaborative studies at the Virginia Commonwealth University
Alcohol Research Center (VCU-ARC). In the first experiment, Dr. Michael Miles
analyzed the overlap in several microarray studies designed to identify ethanolresponsive genes in mice and humans. These studies identified gene expression
changes in: post mortem samples of frontal and motor cortices of human alcoholics vs.
non-alcoholic controls (Mayfield et al., 2002, Liu at al., 2008), brains of isogenic strains
of ethanol-preferring and non-ethanol-preferring mice that were voluntary consuming
alcohol (Mulligan et al., 2006), and ventral tegmental area, prefrontal cortex, and
nucleus accumbens brain regions in response to acute ethanol in DBA/2J and C57BL/6
mice (Kerns et al., 2005). Using Geneweaver, an overlap analysis identified the
Chloride Intracellular Channel 4 (Clic4) as being differentially expressed across all of
these studies. Clic4 also was located within a confirmed quantitative trait locus (QTL) for
ethanol drinking behavior in mice (Tarantino et al., 1998). Therefore, Clic4’s association
with consumption and ethanol response made it the top candidate gene for investigation
in this analysis.
Behavioral analysis performed by Drs. Poonam Bhandari and Michael Grotewiel
demonstrated that Drosophila melanogaster carrying a partial loss of function of the fly
Clic4 homolog, Clic, has reduced sensitivity to the acute sedative effects of ethanol
(Bhandari et al., 2012). In mouse studies performed by Jennifer Hill, Dr. Sean Farris,
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and Dr. Blair Costin, overexpression of Clic4 in the prefrontal cortex brain region
resulted in a decreased sensitivity to high-dose ethanol as tested by the LORR assay
(Bhandari et al., 2012). The C. elegans genome encodes two Clic homologs, exc-4 and
exl-1 (Berry et al., 2003), and we demonstrated that the involvement of Clic in ethanol
responses is conserved in worms.
Our second experiment was inspired by results from a human genome wide
association study (GWAS) for loci that are associated with alcohol dependence that has
recently been completed in the laboratory of Brien Riley. We analyzed the 5 most
significantly associated genes from the alcohol dependence GWAS for those genes that
had strong homologs in C. elegans. Krüpple-Like Transcription Factor 12 (Klf12), the
second most significantly associated gene from the GWAS, is orthologous to klf-3 in
C. elegans. Multiple lines of evidence have implicated Klf12 in alcohol responses. First,
Klf12 gene expression is significantly correlated with Clic-4 expression in the prefrontal
cortex of saline-treated BXD mice (Bhandari et al., 2012). Second, Klf12 also interacts
with C-terminal binding proteins, Ctbp1 (Schuierer, et al., 2001) and Ctbp2 (Lomberk
and Urrutia, 2005). The homolog of Ctbp1 and Ctbp2 in worms is ctbp-1, and loss of
function of ctbp-1 results in altered acute ethanol responsive behaviors (Bettinger et al.,
2012). Ryanodine receptor 3 (Ryr3) was the fifth most significantly associated gene,
and is orthologous to unc-68 in worms. CLIC proteins interact with RYR3 to inhibit
calcium release in musculature in humans (Board et al., 2004). In addition, Ryr3 was
also represented in a gene set enrichment analysis of a GWAS of variables of LR
(Joslyn et al., 2010). Therefore, we examined the roles of unc-68 and klf-3 in acute
behavioral responses to ethanol in C. elegans.
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Methods:
C. elegans genetics
C. elegans were maintained using standard methods (Brenner, 1974). Strains
used were: N2 var. Bristol, Clic mutant strains exc-4(rh133) and exl-1(ok857) exc4(rh133),exl-1(ok857), unc-68(r1161), which is homologous to human Ryr3, and klf3(ok1975) which is homologous to Klf12 mutant strain klf-3(ok1975). The double mutant
exc-4(rh133);exl-1(ok857) was generated using standard genetic crosses, using the
recessive excretory canal phenotype that is associated with exc-4(rh133) to detect
animals that were homozygous for exc-4, and detection of the deletion in exl-1(ok857)
using PCR. We used these primers to detect the exl-1(ok857) deletion mutation:
exl-1(ok857)_F: 5"-GTGCAATCTCGTCAGGACCAGGC-3",
exl-1(ok857)_R: 5"-ATGCGTTACGATGCCCCGACAC-3".

Ethanol-response behaviors
Ethanol-response assays were carried out as previously described (Davies et al.,
2003, 2004), see Appendix A for detailed methods. Briefly, 6 cm petri plates containing
standard nematode growth media were dried at 37°C for two hours with no lids. Plates
were weighed, and copper rings were embedded into the surface of each plate to act as
corrals for each genotype. 100% ethanol was added to each ethanol assay plate to
achieve a final concentration of 0mM, and 200 mM or 400 mM (w/v). The ethanol was
allowed to equilibrate for two hours at room temperature. 10 age-matched first day adult
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animals were moved to plates without ethanol and without food to allow for acclimation
to the lack of food for 30 minutes before they were transferred to either a 0 mM or
ethanol containing assay plate. When performing assays for exc-4(rh133), exl-1(ok857),
and the double mutants, we recorded a ten-minute movie followed by 2-minute movies
at 15, 20, 25, 30, 40, and 50 minutes of continuous ethanol exposure. We analyzed the
10-minute movie in 2-minute segments at 2, 4, 6, 8 and 10 minutes. These conditions
were imposed because exc-4(rh133) has a defective excretory canal and to avoid any
potential delay in the intoxicating effects because of drug entry issues, we expanded the
analysis to more time points. For example, onemight expect that the defect in the canal
may cause ethanol to take longer for it to affect all tissues to produce a response.
Therefore, behaviorally, the animals may look resistant earlier time points of the assay
and become intoxicated at a later time point. Behavioral assays for unc-68(r1161) and
klf-3(ok1975) consisted of 2-minute movies recorded at 10, 30, and 50 minutes. All
assays were recorded using a Retiga400R camera (Qimaging, Canada). Movies were
analyzed using ImagePro Plus (v6) (Media Cybernetics, Bethesda, MD) using the
recognition function to detect worm-sized objects based on pixel intensity. We used the
Track Object function to measure the changes in position of the centers of mass for
each consecutive frame of the movie. Speed was calculated as distance traveled per
unit time.

Internal ethanol measurements
Age-matched first day adult worms were reared at 20°C and placed on unseeded
plates containing 0 or 400 mM ethanol for 5, 10, or 30 minutes. Internal ethanol was
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measured as previously described (See Chapter 2 and Appendix A for details). Briefly,
200 animals were collected by picking into a microcentrifuge tube and were frozen at
#80°C and homogenized in ddH2O. Ethanol concentration was determined in the
homogenates using a commercially available alcohol reagent (Pointe Scientific, Canton,
MI, USA) by generating a standard curve by spectrophotometric analysis. The volume
of tissue contributed to the samples was quantified by tracing images of animals for
their length and diameter and solving the equation for the volume of a cylinder. We
multiplied the ethanol concentration of the homogenates found from the standard curve
by the dilution factor to calculate the final internal ethanol concentration for each
genotype (volume of worm / volume of worm + 20 µL).
Statistical analyses

To determine statistical significance (P$ 0.05) in studies comparing two or more
groups, t tests (Prism, GraphPad, San Diego, CA, USA), one- and two-way analysis of
variance (ANOVA) (JMP, SAS Institute, Cary, NC, USA) followed by Bonferroni multiple
comparison tests were performed as appropriate.

Results
Functional analysis of Clic orthologs in C. elegans
In order to determine if the clic gene orthologs in worms play a role in behavioral
responses to ethanol, we assessed the response of two null alleles in the worm Clic
homologs, exc-4(rh133) (Berry et al., 2003) and exl-1(ok857) (Berry & Hobert 2006), to
the acute effects of 400mM ethanol using an established locomotor behavioral assay
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(Davies et al., 2004). We measured the onset of intoxication over the first 10 minutes of
drug exposure; the degree of intoxication at 10 minutes of exposure is our measure of
the initial sensitivity of the animals. Worms harboring exc-4(rh113) had reduced
sensitivity to ethanol in the first 5 minutes (Repeated measures of two-way ANOVA;
time F10,120 = 14.66, P = 0.0244 , genotype F3,120 = 11.06, P = 0.0009 on locomotor
behavior in the presence of ethanol with no interaction between the factors, F10,120 =
1.78, P = 0.177, #, Bonferroni multiple comparison; t(7) = 2.91–4.92, P < 0.05), however
exl-1(ok587) mutants displayed wild-type initial sensitivity (Figure 18A). We measured
the development of AFT by assessing the increase in locomotor speed after the initial
intoxicating effects of ethanol for each mutant over the course of 30 minutes. Animals
carrying exc-4(rh113) trended towards reduced AFT, but exl-1(ok587) mutants
displayed an enhanced AFT phenotype (†, Bonferroni multiple comparison; t(7) = 2.91–
4.92, P < 0.05, Figure 18A). This suggests that mutations in exc-4 and exl-1 cause
effects that are exclusive for initial sensitivity and acute tolerance, meaning that the
function of these channels do not completely overlap for their effects on acute behaviors
responses in worms. Next, we asked if both exc-4 and exl-1 work together and
measured the behavioral response of exc-4(rh113);exl-1(ok587) double mutants to
ethanol. We found that these animals displayed wild-type initial sensitivity, similar to exl1(ok587) single mutants and reduced AFT similar to exc-4(rh113) single mutants
(Figure 18A). This suggests that the effect of loss of exc-4 function on initial sensitivity
requires normal exl-1 expression and also that the effect of loss of exl-1 function on AFT
requires normal exc-4 expression. To determine if there were any drug uptake and
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Figure 18. Ethanol sensitivity and acute functional tolerance in C. elegans with
mutations in Clic orthologues. (a) Effect of 400mM exogenous ethanol on relative
locomotor speed (percent of untreated animals) in N2 control (open circles), exl1(ok857) (light gray squares), exc-4(rh133) (dark gray triangles), exc-4(rh133);exl1(ok857) (black diamonds). (b) Internal ethanol concentrations in N2 control and Clic
mutants exposured to 400mM exogenous ethanol. Neither clic ortholog significantly
alters tissue concentrations (Bhandari et al., 2012) (n = 6). Error bars are SEM.
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metabolic causes of these changes in ethanol responses, we measured internal ethanol
concentrations for each mutant. Mutations ineither exc-4, exl-1, or both genes did not
alter internal tissue concentrations relative to wild type, despite increased tissue ethanol
concentrations during the time course of exposure, suggesting that the behavioral
changes observed are likely to be due to differences in the pharmacodynamic response
to ethanol (two-way ANOVA; duration, F2,60 = 29.19, P < 0.0001; genotype, F3,60 = 3.07,
P = 0.0439; interaction between duration and genotype, F3,60 = 0.1143, P = 0.951, n.s.;
Bonferroni multiple comparisons between N2 and other genotypes, t(11) = 0.0824–1.94,
P > 0.05, n.s., n = 6) (Figure 18B).
Functional analysis of RYR3 orthologs in C. elegans
Human Ryr3 is expressed in the brain (Hertle and Yeckel, 2007) and is
responsible for mediating Ca2+ release from the endoplasmic reticulum that is required
for neuronal viability and synaptic plasticity (Fitzjohn and Collingridge, 2002). C. elegans
have a single ryanodine receptor gene , unc-68, and we tested mutant animals carrying
the loss of function mutation, r1161, (Maryon et al., 1996) for altered responses to
ethanol. We assayed unc-68(r1161) mutants at 200mM exogenous ethanol and found
that the animals were significantly resistant to ethanol at 10 minutes of exposure relative
to wild type(Figure 19A) (Repeated measures of two-way ANOVA; time F2,56 = 3.664, P
= 0.032 , genotype F1,56 = 18.52, P = 0.0002 interaction between the factors, F2,28 =
0.6652 P = 0.5182, *, Bonferroni multiple comparison; t(3) = 3.00 – 4.120, P < 0.05).
Internal ethanol concentrations for unc-68(r1161) at 10 minutes were not significantly
different than N2 (two-way ANOVA; time F1,12 = 8.283, P = 0.0139 , genotype F1,12 =
13.84, P = 0.00029 interaction between the factors, F1,12 = 0.2469 P = 0.1421, **,
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Figure 19. Altered ethanol sensitivity in C. elegans with mutations in the
mammalian RYR3 orthologue unc-68. (A) Effects of 200 mM exogenous ethanol on
relative locomotor speeds of wild-type N2 (circles) and unc-68(r1161) (squares) (n = 15)
(B) Internal ethanol concentrations in N2 control and unc-68(r1161) (n = 3). * P< 0.05,
** P<0.01, *** P<0.001. Error Bars are SEM.

128

Bonferroni multiple comparison; t(2) =3.742, P < 0.01). In addition, unc-68(r1161)
mutants remained significantly resistant throughout the assay despite accumulating
higher concentrations of internal ethanol by 30 minutes (Figure 19B). This suggests that
the behavioral consequences observed due to loss of unc-68 function are likely to be
due to altered pharmacodynamic responses to ethanol.
Functional analysis of KLF12 orthologs in C. elegans
Human Klf12 encodes a Krüpple-Like Factor zinc-finger transcription factor that
is critical for cell differentiation and various physiological functions (Danga et al., 2000,
Kaczynski et al., 2003). Worms have multiple Krüpple-Like factors and the worm gene
klf-3 is most closely homologous to human Klf12.
We assessed the response of mutant worms carrying the klf-3(ok1975) deletion
to the acute effects of 400mM ethanol on locomotion (Davies et al., 2003, Appendix A).
In this assay, wild-type N2 and klf-3(ok1975) animals displayed similar levels of initial
sensitivity at 10 minutes (paired T-test P = 0.8352), suggesting that klf-3 does not alter
the initial sensitivity to ethanol (Figure 20A). After 30 minutes of continuous exposure,
N2 was moving significantly faster than at the previous 10-minute time point (paired Ttest P = 0.0059), indicating that they had developed AFT. However, worms harboring
klf-3(ok1975) failed to increase speed over the time of exposure (paired T-test P =
0.9481). We calculated the degree of AFT for each strain and found that N2 recovered
17.89 % +/- 2.544 and klf-3(ok1975) recovered -0.21 % +/-2.969 of their untreated
speed (Figure 20A: right panel). A paired T-test indicated a significant difference
between wild-type N2 recovery and klf-3(ok1975) (P = 0.0029). This suggests that the
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loss of klf-3 function disrupts normal cellular responses to ethanol that results in the
failure to develop AFT.
To determine if the ability of klf-3(ok1975) to develop AFT was due to an ethanol
metabolic defect or entry issue, we performed measurements of internal tissue ethanol
concentrations at 10 and 30 minutes. N2 animals accumulated 31.36 mM internal
ethanol at 10 minutes and the internal concentration at 30 minutes was 41.1 mM. klf3(ok1975) accumulated similar internal ethanol as N2 at 10 minutes, 35.34 mM and, at
30 minutes, 39.53 (Figure 20B) (two-way ANOVA; genotype F1,18 = 2.107, P = 0.1639,
time F2,18 = 3.615, P = 0.0479, interaction between genotype and time F2,18 = 2.74, P
= 0.6858, Bonferoni posttest n.s.) This suggests that klf-3 does not alter the entry of the
drug nor does it modify ethanol metabolism and the observed behavioral responses due
to the loss of klf-3 are pharmacodynamic.

Discussion
Using a cross species approach to identify genes that influence ethanolresponsive behaviors using the large number of existing data sets has led to uncovering
single gene effects on ethanol responses in C. elegans. This approach holds great
value for understanding basic mechanisms of ethanol response and provides further
evidence for a conserved role of a gene in ethanol responses.
Starting with ethanol-related data sets, mammalian Clic4 was selected as a
candidate gene in ethanol response behavior and genetic manipulations of the gene
resulted in altered ethanol responsive behaviors in mice, flies and worms. In C. elegans,
loss of function of exc-4 reduced ethanol sensitivity during the first 5 minutes of drug
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Figure 20. Ethanol sensitivity and acute functional tolerance in C. elegans with
mutations in the mammalian KLF12 ortholog klf-3. (A) Effects of 400 mM exogenous
ethanol on relative locomotor speeds of wild-type N2 and klf-3(ok1975) (n = 4). (B)
Internal ethanol concentrations do not differ between N2 control and klf-3(ok1975) at 10
and 30 minutes of exposure (n = 4)
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exposure where as the loss of function in another Clic ortholog, exl-1, enhanced the
development of AFT. Genetic manipulation of either Clic ortholog caused no alterations
to ethanol uptake and metabolism.
Utilizing a different set of ethanol-related data, we focused on the results of a
human GWAS that identified loci associated with alcohol dependence. We studied the
effects of loss of function of two genes, Rry3 and Klf12 because they have shown to
interact with other genes mediating acute responses.
Ryr3 encodes an intracellular calcium ion release channel with low Ca2+
sensitivity (Nakashima et al., 1997) and is expressed in a variety of tissues including
muscle and brain (Hertle and Yeckel, 2007). In vertebrates, ryanodine receptors are
known to interact with CLIC proteins and our previous results have shown that altered
clic-4 function affects acute behavioral responses to ethanol (Jalilian et al., 2008,
Bhandari et al., 2012 Figure 18). We have shown that the C. elegans ortholog of Ryr3,
unc-68, is resistant to the low-dose effects of ethanol despite having a higher tissue
ethanol concentration at later time points (Figure 19B). Interestingly, unc-68 is known to
be a major source of Ca2+ release required for synaptic vesicle release and muscle
contractions (Liu et al., 2005). unc-68 and a known binding partner, csq-1, were found
to be significantly up regulated by ethanol in our microarray experiments (see Chapter
3). csq-1 encodes calesquestrin, a high capacity and low affinity calcium binding
protein. This suggests that ethanol may alter calcium release and signaling. This is
interesting because a major target of ethanol is the BK channel, which requires calcium
for activation and many studies have shown that ryanodine receptors stimulation can
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lead to BK channel activation (Xin et al., 2012; Petkov and Nelson 2005; Hristov et al.,
2008)
Klf12 encodes a zinc-finger transcription factor and its ortholog in worms, klf-3,
when non-functional, results in the failure to develop AFT. Internal ethanol data
suggests that this behavioral effect is not due to drug uptake or metabolism. In humans,
Klf12 has been shown to bind other Klf-family members and the C-terminal binding
proteins, Ctbp1 and Ctbp2, to repress transcription (Lomberk and Urrutia, 2005;
Schuierer et al., 2001). Interestingly, Ctbp2 has been identified in an independent
GWAS for alcohol dependence (Lind et al., 2010). Ctbp1 and Ctbp2 are homologous to
C. elegans ctbp-1. Previous studies from our lab have shown that animals carrying a
loss-of-function of ctbp-1 have reduced AFT (Bettinger et al., 2012). In addition, a
binding partner of CTBP-1, PAG-3, also mediates AFT and animals that carry a loss-offunction mutation of pag-3 fail to develop AFT (Bettinger et al., 2012). This suggests
that binding partners of CTBP-1 that form a transcriptional repressor complex may be
involved in mediating AFT. However, it is currently unclear if KLF-3 is acting with CTBP1 to mediate AFT through similar mechanisms. CTBP-1 regulates approximately 200
genes and represses lips-7 expression (Chen et. al 2009). lips-7 encodes a lipase that
metabolizes triacylglycerides (TAGs). Loss of function of this gene increases TAGs and
results in an enhanced AFT phenotype. This supports the idea that TAG levels are
important for the development of AFT (Bettinger et al., 2012). To determine if klf-3
mediates AFT though TAG levels, one simple experiment could be to measure lips-7
mRNA levels in a klf-3 mutant. Levels similar to ctbp-1 would suggest that klf-3 and
ctbp-1 are acting through similar mechanisms.
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Taken together, these data suggest that using a cross species characterization is
a powerful approach to identify genes involved in ethanol responsive behaviors. In
addition, we show that genes associated with alcohol dependence can modify acute
ethanol phenotypes related to LR and these genes, when genetically altered, result in
acute behavioral differences in mice, flies and worms.

134

Chapter V
Discussion and Future Perspectives

Ethanol metabolism is an evolutionarly conserved mechanism across species.
This process is governed by at least two enzymes, alcohol dehydrogenase (ADH) and
aldehyde dehydrogenase (ALDH). In the first step of alcohol metabolism, ethanol is
oxidized by ADH to form acetaldehyde. In the second step, acetaldehyde is further
oxidized into acetate by ALDH. Both steps, which are reversible, require the reduction of
the cofactor NADH.
Multiple studies have shown that genetic variation of these enzymes correlate to
AUDs (Chen et al., 2009; Crabb et al., 2004; Edenberg et al., 2006; Kuo et al., 2008).
The variants for both ADH and ALDH result in different levels of enzyme activity and
therefore differences in the rates of ethanol metabolism. The most notable associations
of ADH and ALDH are found amongst individuals of Asian decent. 75% of these
individuals carry an allele of ADH (ADH1B*2) that increases the rate of conversion of
ethanol to acetaldehyde promoting adverse effects such as facial flushing and vomiting
(Eng et al., 2007; Li et al., 2007; Edenberg et al., 2006). Carrying either one or both
copies of ALDH1B*2 significantly reduces an individual’s risk for alcohol dependence
(Chen et al., 2009). In addition, about 30% of the Asian population carries an allele of
ALDH (ALDH2*2) that decreases the rate of conversion of acetaldehyde to acetate.
Individuals carrying one or both copies of ALDH2*2 are almost completely protected

135

from developing an AUD (Chen et al., 2009). Conversely, variation at the ADH4 locus is
associated with AUDs and has been widely replicated across different populations
providing support that variations in ethanol metabolism can differentially influence risk
(Endenberg et al., 2006; Luo et al., 2006).
Altered metabolism in other species also affects behavioral responses to ethanol.
Adh-1 knockout mice accumulate more blood ethanol and have an increased sensitivity
to the drug as evaluated by loss of righting reflex (Deltour et al., 1999). Mice containing
a knock out of Aldh2 in the high alcohol preferring C57BL/6 background consumed less
ethanol and had higher acetaldehyde levels than wild type litter mates (Toyohi et al.,
2002; Isse et al., 2005). Studies in high drinking rats have shown that animals carrying
both the ADH1B*2 and ALDH2*2 alleles of the ethanol metabolism machinery cause a
60% decrease in consumption, suggesting the aversive effect of excessive
accumulation of acetaldehyde can alter consumption (Rivera-Meza et al., 2012). In
Drosophila, ADH null animals accumulate higher amounts of ethanol and display an
increased sensitivity to the drug (Wolf et al., 2002; Ogueta et al., 2010). ALDH null flies
also display an increased sensitivity to ethanol, suggesting a role for acetaldehyde in
behavioral responses (Fry and Saweikis 2006). Our work has extended the analysis of
the role of ADH and ALDH function in acute ethanol response behaviors in C. elegans.
By phylogenetic analysis we identified two ADHs, sodh-1 and H24K24.3.
Inactivation of either one of these genes resulted in an increase in initial sensitivity, but
no alterations to the development of AFT (Figure 5A) Chapter 2. sodh-1(ok2799)
deletion mutant animals accumulated a significantly higher amount of internal ethanol
suggesting that this particular ADH is a key enzyme in ethanol metabolism (Figure 4C).
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Internal ethanol concentrations of animals did not change over the time course of
exposure, supporting that the AFT observed is likely to be a compensatory response
that is limiting the effect of ethanol. Additionally, we resolved a conflict in the literature
over the measurement of internal tissue ethanol concentrations in C. elegans. Animals
exposed to 500mM exogenous ethanol accumulate about 10 – 15% of the exogenously
applied dose and our new method accurately accounted for the amount of worm tissue
contributed to each sample. Other studies did not account correctly for tissue volumes
and reported different internal ethanol concentrations that were both lower and higher
than our results (Davies et al., 2003, 2004; Mitchell et al., 2007; Kapfhamer et al.,
2008).
We also have explored the role of ALDH function and found that inactivation of
either alh-6 or alh-13 confers an increase in ethanol sensitivity (Figure 6A). There is
currently a controversy in the field of the biological role of acetaldehyde in behavior,
particularly in the brain. One model which is not widely accepted is that acetaldehyde
may act as the molecule responsible for the rewarding and reinforcing effects of ethanol
(Rodd-Henriks et al., 2002, Rodd et al., 2005, Hahn et al., 2006, Deng and Ditrich,
2008, Karahanian et al., 2011). Studies in mice and rats have shown that acetaldehyde
impairs mobility, coordination, and memory (Dudek and Fuller 1978; Dudek et al., 1984;
Tampier and Quintanilla 2003; Quertemont et al., 2004). Our work suggests that
knockdown of ALDH results in behavioral sensitivity because of higher internal ethanol
concentrations (Figure 6B-C). We interpret this to mean that ADH is oxidizing the
excess acetaldehyde that builds up due to the defects in the ALDHs into ethanol, which
then exerts behavioral effects. However, our results are not entirely definitive of the role
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of acetaldehyde in behavioral responses to ethanol in worms. Ethanol metabolism in the
human brain is thought to occur by a combination of the activities of ADH, catalase, and
cytochrome P4502E1. Some studies have reported that mammalian brain catalase
accounts for 60-70% of ethanol to acetaldehyde conversion (Zimatkin et al., 2006). In
Drosophilia, 90% of ethanol metabolism occurs by ADH and the remaining 10% by
catalase (Geer et al., 1985, 1993). However, ethanol responsive behaviors for catalase
mutants in flies have not been characterized. The C. elegans genome encodes three
catalases, ctl-1, ctl-2, and ctl-3 that may contribute to ethanol metabolism (Petriv and
Rachubinski, 2004). In addition, exploring ways to increase the level of acetaldehyde in
neurons may shed light on the role of the molecule in behavioral responses to ethanol in
the worm.
From this work, there are still many unanswered questions in understanding the
pharmacokinetics of ethanol metabolism in our model system. Chiefly, the sites of
ethanol entry are unknown. Experiments directed at modifying worm anatomy may help
answer this question. For example, the worm cuticle is a dynamic structure during
development. If environmental cues are unfavorable, animals will go into dauer arrest
and produce a thicker cuticle than normal (Golden and Riddle 1982; Cox et al., 1981). If
the cuticle acts as a barrier to entry of the drug than less ethanol should be detected in
these animals during ethanol exposure. However, the cuticle is not only avenue to
explore. There are 4 major exterior openings that may provide a conduit for ethanol
entry; the anus, excretory pore, vulva, and the mouth. Work presented in Chapter 4 may
provide some insight into the role of the excretory system in ethanol entry. exc-4
encodes a highly conserved chloride intracellular channel that is required for normal
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excretory cell tubulogenesis. When mutated, the excretory canal swells forming a fluid
filled vacuole (Berry et al., 2003). The excretory pore itself is structurally normal and
presumably still allowing ethanol access into the canal (Buechner 2002). The internal
ethanol concentration of this mutant animal is not significantly different than wild-type
(Chapter 4), but it is not clear if the altered canal structure causes changes in the
distribution of ethanol to other tissues. Providing a basis of ethanol entry will become
extremely valuable when performing forward genetic screens or using reverse genetic
approaches to detect genes that alter the pharmacodynamics to ethanol.
The exogenous dose used to intoxicate worms is considerably higher than in
other model organisms. We predict that the drug must enter through some opening or
combination of openings before it can take its effects, but we do not know if ethanol gets
distributed equally or is compartmentalized to specific regions in the worm. For
example, the intestine is one of the largest organs in the animal and these cells may be
exposed to higher concentrations of the ethanol than other cells such as neurons. It is
nearly impossible to dissect out specific tissues in C. elegans because of their size. .
However, recent advances in imaging techniques have shown that live imaging mass
spectrometry (IMS) can be used to visually detect the spatial distribution of
biomolecules. IMS is a technique bases on two-dimensional mass spectrometry that
does not require separation, purification or labeling of target molecules(Kimura et al.,
2009). IMS has been used in C. elegans to show the differences in biomolecule
distribution in wild type animals and fat-6(tm331) mutants that lack %-9 fatty acid
desaturase (Kimura et al., 2009). This technique can also provide answers to other
pharmacokinetic questions in a high throughput manner for drug absorption rate,
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metabolism, and excretion. Using IMS to characterize mutants of interest will provide a
better understanding of that genes role in ethanol pharmacokinetics.
Identifying genes that are causative for complex disorders such as alcoholism
has been a difficult challenge. The multiple genetic and environmental factors that can
influence the development of this disorder have applied a layer of complexity in defining
suitable drug targets (Chesler et al., 2005, Koob and Volkow 2010, Schuckit 2002;
Schuckit and Smith 2004, Dick and Foroud 2003). This is mainly because most human
studies only reveal regions that are associated with the disease or endophenotypes.
Looking beyond the level of associated loci can help uncover the mechanisms in which
these genes may act to influence behavioral responses. Gene expression microarrays
have been extensively used to study a variety of alcohol use traits (Xu et al., 2001,
Tabakoff et al., 2003; Mulligan et al., 2008, 2011; Treadwell and Singh 2004;
Wolstenholme et al., 2011, Kerns et al., 2005).). The goal of these studies is to identify
genes whose expression correlated with the disease. These expression changes
represent a measure of the genetic differences in ethanol induced gene expression,
which may influence predisposition to developing alcoholism (Nestler and Aghajanian
1997; Kerns et al., 2005). Individual differences in the initial acute effect of ethanol are
correlated with abuse liability and dependence. Therefore, variations in ethanol-induced
expression may also underlie predisposition.
We used gene expression microarrays to uncover ethanol responsive genes in
N2 and npr-1(ky13). We mined these gene expression profiles for candidate genes that
may be involved in modifying acute ethanol response behaviors and used basal gene
expression differences between N2 and npr-1(ky13) to identify testable candidate
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genes. npr-1(ky13) animals display an enhanced development of AFT(Figure 14A) and
transcription inhibition of these animals did not alter this behavior (Figure 13C)
suggesting that npr-1(ky13) animals have altered basal gene expression differences
that are contributing to its ethanol response behavior. Therefore, we used basal gene
expression differences of npr-1(ky13) to select candidate genes for behavioral testing.
We found that ethanol responsive gene expression changes in both N2 and npr1(ky13) were similar for a variety of biological processes such as lipid metabolism,
transcription, and oxidation reduction. We focused on ethanol responsive genes that
were also basally regulated by npr-1(ky13) because we predicted that these genes may
be involved in mechanism in which cells are compensating to limit the effects of ethanol.
We chose acs-2, an acyl-CoA synthase, which is required for fatty acid activation (Van
Gilst et al., 2005). Loss of function of acs-2 resulted in significantly reduced AFT (Figure
14A) suggesting that basal levels of this gene are important in the acute responses to
ethanol. acs-2 has been shown to activate fatty acids that are transported into the
mitochondria for degradation by a process called !-oxidation (Van Gilst et al., 2005).
Animals that are mutant at the acs-2 locus have reduced mitochondrial !-oxidation rates
and we examined the genes downstream of acs-2 in the mitochondrial !-oxidation
pathway (Figure 15) to determine if this process can influence acute behavioral
responses to ethanol. We chose to test 7 genes in the mitochondrial !-oxidation (Figure
15) because of their strong homology to mammals and reagent availability. We used
RNAi to alter mRNA levels and found that only one gene, ech-6, had a significantly
enhanced development of AFT (Figure 16C). This Is an interesting result because acs2(ok2457) mutants have the opposite phenotype and one might predict that alteration to

141

the mitochondrial !-oxidation pathway may result in similar acute behavioral responses
to ethanol. One possible explanation is that the accumulation of trans-2-enoyl CoA due
to the decrease in ech-6 function may be utilized in other pathways that are involved in
the development AFT. For example, other studies in worms have shown that the
mitochondria can participate in fatty acid synthesis and trans-2-enoyl CoA is a molecule
that can be utilized and converted into fatty acid in this pathway (Gruvitz, 2009). Other
work has implicated that fatty acids are important to the development of AFT in worms.
Work in our laboratory has shown that animals deficient in monounsaturated fatty acid
synthesis have an enhanced development of AFT (Bettinger et al., 2012). Taken
together these results implicate the role of mitochondria !-oxidation pathway in acute
behavioral responses to ethanol.
Our microarray work and behavioral analysis has revealed a role for fatty acid
metabolism in ethanol responses. However, there are still many other interesting
experiments that need to be completed before we can start to understand the role of
this complex process in acute ethanol response behaviors. We show that loss of
function of acs-2 results in reduced AFT. It would be interesting to see the effects of
acs-2 overexpression on ethanol response behaviors. This would reveal the relationship
of the gene to AFT. For example, we would predict that acs-2 overexpression may
result in an enhanced AFT phenotype, suggesting that acs-2 can regulate AFT and may
not just be required to observe the behavior. Therefore, the opposite phenotypes where
loss of function mutants display decreased development AFT, but the gain of function
mutants display an enhanced development would suggest that the functional level of
acs-2 can either represses and promotes AFT.
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Another experiment that would provide insight into the role of acs-2 in behavior is
to perform tissue specific gene expression experiments. acs-2 is widely expressed in all
tissues of worms including neurons. Restoring acs-2 expression to wild type levels in all
neurons of acs-2(ok2457) mutants would provide evidence that AFT has a neuronal
basis and may identify the cells that are required to produce this response. If animals
display wild type AFT it would suggest that acs-2(ok2457) is required in these cells to
produce an adaptive response to ethanol. Follow up experiments could then focus on
specific neurons that are required for the behavioral rescue. These results would
implicate a specific subset of neurons that are mediating the adaptive response and
future work exploring how acs-2 modifies the function of these neurons may reveal new
mechanisms into the development of AFT. For example, acs-2 may be required in
neurons that communicate with each other forming a small neuronal network or circuit.
acs-2 may alter the communication of this circuit or the intrinsic properties of these
neurons that are involved in the development of AFT.
Our work has shown the genes downstream of acs-2 in the mitochondria !oxidation pathway alters the development of AFT. Our experiments relied on RNAi to
determine if a reduction in the mRNA levels alters ethanol responses. However, there
are some drawbacks to using RNAi, especially when treatment does not result in a
behavioral effect. Frist, neurons are resistant to the effects of RNAi by feeding in worms
(Calixto et al., 2010) and therefore gene expression levels of the target gene are
normal in this tissue. In our work, treatment of worms with RNAi targeted to cpt-2 or cpt5 did not alter the behavioral response to ethanol (Figure 16A). One interpretation of
this result could be that these genes are not involved in ethanol responsive behaviors. .
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Another interpretation could be that we were unable to knock down the mRNA enough
to have effect on gene function and any residual message in the cell is enough to
maintain normal function. To circumvent this issue, using loss of function or null alleles
instead of RNAi may result in a different effect since the function of gene is eliminated.
acs-2 is required to activate fatty acids in the cell for a variety of different cellular
processes and loss of function of this gene results in fat accumulation (Van Gilst et al.,
2005; Ashrafi et al., 2003). This is interesting because it suggests that the fatty acids
destined for mitochondrial !-oxidation are being utilized in other pathways in the cell.
There is a possibility that the accumulation of fatty acids being produced because of the
lack of activation by acs-2 are only being utilized in the synthesis of TAGs and this
would explain why animals stain positive for an increase in fat stores. However, there
are at least two other possibilities that can be explored to determine the role of other
fatty acid utilization pathways.
First, we can ask the question if altering the fatty acid pool or population in
animals alters behavioral responses to ethanol. It has been previously shown that
animals carrying a loss of function for lips-7 have an increase in TAGs (Chen et al.,
2009). lips-7 encodes a lipase that enzymatically cleaves fatty acids from TAGs allowing
the fatty acids to be utilized in other cellular pathways such as cell signaling. lips-7
mutant animals display an enhanced development of AFT to ethanol (Bettinger et al.,
2012). Epistasis analysis of lips-7 and acs-2 may reveal if the fatty acid pool or
population is important in ethanol responses. One possible prediction would be that the
acs-2 mutantion might restore particular fatty acids to the fatty acid population that are
otherwise unable to be freed from a TAG and utilized in the cell in a lips-7 mutant
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because of the animals deficient lipase function. We would then predict that lips-7;acs-2
mutant animals would display ethanol response behaviors like wild-type suggesting that
acs-2 is modifying the fatty acid population. The double mutants may not display
ethanol response behaviors like wild type and may display behavioral response like the
individual mutant, which would suggest that they produce their behavioral effects by
different pathways.
Second, we can also look at other acyl-CoA synthetase pathways. Presumably,
the loss of acs-2 function may allow fatty acids to be utilized by other acyl-CoA
synthetases in the cell. In mammals, some acyl-CoA synthetases have a broad range of
fatty acids preference, while other synthetases do not and will only activate a select type
(Fulgenico et al., 1996). This is important, because it implies that there is a level of
specificity for a particular fatty acid in a pathway. Many studies have implicated the role
of activated fatty acids in a variety of cellular process and pathways such as signaling,
vesicle trafficking, fatty acid desaturation and elongation, and sphingolipid synthesis
(Coleman et al., 2002). Furthermore, studies have shown that pharmacological
inhibition of acyl-CoA synthetases disrupts the budding and fusion process of protein
transport from the endoplasmic reticulum to the Golgi (Pfanner et al., 1989). This
suggests that determining the identity of these molecules may reveal specific roles for
fatty acids in cellular responses and may provide insights into acute ethanol responses.
Overall, the work presented here has shown that the basal expression level of
genes is important in behavioral responses to acute ethanol. Furthermore, our data
indicate that genes that are ethanol responsive can also identify genes and cellular
pathways that are involved in acute behavioral responses to ethanol. Our behavioral
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data has validated this approach and this leaves us with a massive resource of gene
expression changes that can be mined to uncover novel gene involved in the acute
ethanol response, which may have an implication in future risk for developing
dependence.
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Appendix A
Detailed Protocols

Analysis of Locomotion:
Plate setup and assay
1.) 12-18 hours before prior to the analysis of locomotion pick 30 L4 staged worms to an
OP50 seeded nematode growth media (NGM) plate. Be sure to make the
appropriate accommodations for mutant animals that are developmentally delayed
relative to wild type animals.
2.) Prior to performing analysis of locomotion dry 4 – 6 NGM plates in the 37°C
incubator for 2 hours.
3.) Record the weight of the plates and determine the volume of 100% ethanol to add
using the ethanol weight table (Table 8) to achieve your desired concentration.
4.) Heat copper rings for 3-5 seconds over a Bunsen burner using forceps and place on
a dried NGM plate.
5.) Melt the appropriate number of rings per plate for your assay. Ensure that the ring
has formed a complete seal with the NGM plate surface by looking under the
microscope. Also, ensure that the assay area (within the ring) is free and clear of all
or any debris.
6.) Next, evenly distribute ethanol throughout the experimental plate and Parafilm both
the ethanol and non-ethanol containing plates.

180

Table 8. Ethanol plate weight calibration for behavioral analysis
Weight (g) Agar (mL)
50
100
150
200
250
18.1
10.0
30.1 60.2
90.3
120.4
145.5
18.0
9.9
29.8 59.6
89.4
119.3
144.1
17.9
9.8
29.5 59.0
88.6
118.1
142.7
17.8
9.7
29.2 58.4
87.7
116.9
141.3
17.7
9.6
28.9 57.9
86.8
115.7
139.8
17.6
9.5
28.6 57.3
85.9
114.5
138.4
17.5
9.4
28.3 56.7
85.0
113.4
137.0
17.4
9.3
28.0 56.1
84.1
112.2
135.5
17.3
9.2
27.7 55.5
83.2
111.0
134.1
17.2
9.1
27.5 54.9
82.4
109.8
132.7
17.1
9.0
27.2 54.3
81.5
108.6
131.3
17.0
8.9
26.9 53.7
80.6
107.4
129.8
16.9
8.8
26.6 53.1
79.7
106.3
128.4
16.8
8.7
26.3 52.5
78.8
105.1
127.0
16.7
8.6
26.0 52.0
77.9
103.9
125.5
16.6
8.5
25.7 51.4
77.0
102.7
124.1
16.5
8.4
25.4 50.8
76.2
101.5
122.7
16.4
8.3
25.1 50.2
75.3
100.4
121.3
16.3
8.2
24.8 49.6
74.4
99.2
119.8
16.2
8.1
24.5 49.0
73.5
98.0
118.4
16.1
8.0
24.2 48.4
72.6
96.8
117.0
16.0
7.9
23.9 47.8
71.7
95.6
115.6
15.9
7.8
23.6 47.2
70.8
94.5
114.1
15.8
7.7
23.3 46.6
70.0
93.3
112.7
15.7
7.6
23.0 46.0
69.1
92.1
111.3
15.6
7.5
22.7 45.5
68.2
90.9
109.8
15.5
7.4
22.4 44.9
67.3
89.7
108.4
15.4
7.3
22.1 44.3
66.4
88.5
107.0
15.3
7.2
21.8 43.7
65.5
87.4
105.6

181

300
180.7
178.9
177.1
175.3
173.6
171.8
170.0
168.3
166.5
164.7
162.9
161.2
159.4
157.6
155.9
154.1
152.3
150.5
148.8
147.0
145.2
143.4
141.7
139.9
138.1
136.4
134.6
132.8
131.0

350
206.8
204.7
202.7
200.7
198.6
196.6
194.6
192.6
190.5
188.5
186.5
184.5
182.4
180.4
178.4
176.3
174.3
172.3
170.3
168.2
166.2
164.2
162.1
160.1
158.1
156.1
154.0
152.0
150.0

400
232.9
230.6
228.3
226.0
223.7
221.4
219.2
216.9
214.6
212.3
210.0
207.7
205.4
203.2
200.9
198.6
196.3
194.0
191.7
189.5
187.2
184.9
182.6
180.3
178.0
175.8
173.5
171.2
168.9

450
262.0
259.4
256.8
254.3
251.7
249.1
246.5
244.0
241.4
238.8
236.3
233.7
231.1
228.6
226.0
223.4
220.8
218.3
215.7
213.1
210.6
208.0
205.4
202.9
200.3
197.7
195.2
192.6
190.0

500
291.1
288.2
285.4
282.5
279.7
276.8
273.9
271.1
268.2
265.4
262.5
259.7
256.8
254.0
251.1
248.2
245.4
242.5
239.7
236.8
234.0
231.1
228.3
225.4
222.5
219.7
216.8
214.0
211.1
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7.) . After 1 hour and 30 minutes begin to acclimate animals to assay conditions by
moving 10 worms per ring to two non-ethanol containing plates and Parafilm.
8.) After 30 minutes, move the animals to the appropriate assay plate and Parafilm.
Move animals in the same order for each plate within a single assay, but alternate
the order every assay to control for any bias effect. If you are recording the first 10
minutes of intoxication you will need to offset your acclimation plates by 12-15
minutes, however if you are recording two-minute movies, then you will need to
offset each acclimation plate by no less than 2 minutes.
9.) To begin recording locomotion, turn on the camera and open ImagePro.
10.)

Adjust the light source to between 70-90 for optimal resolution.

11.)

Adjust setting of the software to 2x2 binning at 2 frames per second for 120

frames (two minute movie) or 600 frames (ten minute movie) using a 0.5x objective
lens and 0.8x magnification.
12.)

At the appropriate time points place plates on the light source under the

microscope and click record.
13.)

Save the file to the external hard drive with a .seq extension.

Computer Analysis
1.) Open the Image Pro software and select file and open.
2.) Select the videos that you will analyze.
3.) Select macro and select flatten magnify add ring.
4.) Using the mouse drag the newly created white ring over a copper ring on the video.
5.) Select measure and track objects. A new window will open. Select track objects
automatically.
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6.) Select ranges on the count/size window and adjust the intensity of object detection
to a level in which all worms within the ring are clearly detectable.
7.) Select count and ensure all worms are included. Next, select continue. When the
macro is completed quantitating locomotion, select YES followed by NO.
8.) All detected tracks will appear in the tracking data table. Examine each track
individually and ensure that the macro hasn’t analyzed extraneous objects and
delete any tracks with proper justification
9.) Export data into excel

RNA interference:
Plate preparation
RNA clone selection plates:
The following steps will produce 25 20 cm plates. In a round bottom or Erlenmeyer flask
combine the following:
1.) 0.243 L dH2O
2.) 0.75 g NaCl
3.) 4.0 g Bacto-Agar
4.) 0.625 g Bacto-Peptone
5.) Add stir bar
6.) Cover with aluminum foil and mark with autoclave tape
7.) Use stir plate to dissolve contents
8.) Autoclave using a 30 minute sterilization
9.) Return autoclaved agar to stir plate and allow to cool for 15 minutes
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10.)

Add 6.25 mL of 1 M K3PO4

11.)

Add 0.25 mL of 1 M MgSO4

12.)

Add 0.25 mL of 1 M CaCl2

13.)

Add 0.25 mL of 5 mg/mL cholesterol dissolved in 100% ethanol

14.)

Add 125 µL of 100 mg/mL ampicillin dissolved in ddH2O

15.)

Add 500 µL of 5 mg/mL tetracycline HCl dissolved in 70% ethanol

16.)

Pour 20 mL into 20 cm plates

17.)

Allow 24 hours for plates to dry before use

18.)

Store plates at 4°C for up to 1 month

RNA interference plates:
The following steps will produce 75 10 cm plates. In a round bottom or Erlenmeyer
flask combine the following:
1.) 0.722 L dH2O
2.) 2.25 g NaCl
3.) 12.0 g Bacto-Agar
4.) 1.875 g Bacto-Peptone
5.) Add stir bar
6.) Cover with aluminum foil and mark with autoclave tape
7.) Use stir plate to dissolve contents
8.) Autoclave using a 30 minute sterilization time
9.) Return autoclaved agar to stir plate and allow to cool for 30 minutes
10.)

Add 0.75 mL of 1 M MgSO4
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11.)

Add 0.75 mL of 1 M CaCl2

12.)

Add 0.75 mL of 5 mg/mL cholesterol dissolved in 100% ethanol

13.)

Add 18.75 mL of 1 M KPO4

14.)

Add 0.1875 mL of 100 mg/mL carbenicillin dissolved in 100% ethanol

15.)

Add 0.750 mL of 1 M IPTG dissolved in ddH2O

16.)

Pour 10 mL into 10 cm plate

17.)

Allow 24 hours for plates to dry before use

18.)

Store in 4°C for up to 1 month

Culture Inoculation and Storage
Prior to inoculation prepare the growth media by combining the following:
1.) Autoclave 50 mL of Luria Broth
2.) Add 25 µL of 100 mg/mL ampicillin dissolved in ddH2O
Inoculation from Library:
1.) Locate coordinates of clone in library
2.) Using a P2 pipette with tip attached gently scrap the well and eject the tip into a
culture tube containing growth media
3.) Grow cultures for 12 – 18 hours in a shaker set at 200 RPM and 37°C
4.) Heat an inoculation loop and dip the loop into the newly grown culture
5.) Streak the contents into quadrant 1 (Figure X) of a tetracycline/ampicillin plate
6.) Flame your loop and cool it by touching an area of agar
7.) Streak down from quadrant 1 into quadrant 2 and fill the quadrant
8.) Repeat steps 6 and 7 until all 4 quadrants are filled
9.) Parafilm and label the tetracycline/ampicillin plate
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Figure 21: Streaking bacteria. Dip inoculation loop into grown culture and spread in
quadrant 1. Heat the inoculation loop and cool by touching agar. Next, streak from
quadrant 1 into quadrant 2. Repeat for quadrant 3 and quadrant 4. Single colonies
should be visible in quadrant 4 after 24 hours of incubation at 37°C
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10.)

Incubate the plate at 37°C for 24 – 36 hours or until large single colonies appear

11.)

Inoculate a single colony from the plate in 3 mL of growth media

12.)

Grow cultures for 12-18 hours in a shaker set at 200 RMP and 37°C

13.)

Remove 1.5 mL of culture into a freezing tube

14.)

Add 300 µL of 100% glycerol

15.)

Mix well and place in -80°C

16.)

See insert Verification protocol below for the remaining 1.5 mL of culture

Inoculation from Frozen Stock
1.) Add 2 -3 mL of growth media to culture tubes
2.) Remove frozen culture from -80°C
3.) Using a P2 pipette with tip attached scrap the frozen culture and eject the tip into the
culture tube
4.) Incubate cultures in a shaker at 200 RPM at 37°C for 12-18 hours
5.) If only one frozen culture is found in the -80°C, freeze another culture. Follow
inoculation from Library protocol steps 13 -15.
6.) Inoculated culture is stored at 4°C and good for 1 week
Insert Verification
Solution Preparation:
Solution 1
Combine the following into a 100 mL autoclaved bottle:
1.) Add 450.4 mg glucose
2.) Add 50 mL of ddH20
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3.) Mix to dissolve
4.) Add 1.25 mL of 1 M Tris pH 8.0
5.) Add 1 mL of 0.5 M EDTA pH 8.0
6.) Add 0.1 mL of 10 mg/mL RNase A
7.) Store at 4°C
Solution 2
Make this solution fresh and store at room temperature
1.) Add 40 µL of 5 N NaOH per 1 mL of final volume of solution
2.) Add 100 µL of 10% SDS per 1 mL of final volume of solution
Solution 3
Combine the following in a 100 mL autoclaved bottle:
1.) 30 mL of 5 M potassium acetate (49.07 g/100 mL ddH2O)
2.) 5.75 mL of glacial acetic acid
3.) 14.25 mL ddH2O
Plasmid Isolation
1.) Using the remaining 1.5 mL of culture from the inoculation from Library protocol
pellet the culture in a 1.5 mL tube
2.) Remove the supernatant and resuspend pellet in 100 µL of cold Solution I and
vortex
3.) Add 200 µL of Solution 2 and invert to mix
4.) Incubate at room temperature for 3-5 minutes
5.) Add 150 µL of cold Solution 3 and invert to mix
6.) Incubate at room temperature for 3 -5 minutes
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7.) Spin sample at 13,000 RPM for 5 minutes
8.) Move supernatant to new tube and equal volume of phenol:chloroform and vortex
9.) Spin sample at 13,000 RMP for 2 minutes
10.)

Remove the aqueous layer to a new tube and precipitate the DNA by adding 1

mL of 95% ethanol
11.)

Vortex for 30 seconds

12.)

Incubate at room temperature for 5 minutes

13.)

Spin sample at 13,000 RPM for 5 minutes

14.)

Look for a clear/white pellet

15.)

Carefully remove the supernatant

16.)

Add 1 mL of 70% ethanol and invert the tube 4 times

17.)

Spin sample at 13,000 RPM for 2 minutes

18.)

Carefully remove the supernatant

19.)

Dry the pellets by place the tubes with their caps open upside down on a level

surface for 20 minutes
20.)

Dissolve the pellet in 25 µL of dH2O and incubate at 37°C for 10 minutes

21.)

Quantitate the concentration of DNA of the sample by measure the absorbance

at 260 nm
22.)

Dilute sample to 100 ng / µL

23.)

Send sample to the VCU sequencing center with the U19 primer

24.)

When results return, use BLAST to identify if the insert is correct

Generating RNA inactivated strains
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When generating knockdown strain also include an L4440 control and a culture that
induces a visible phenotype.
1.) 24 hours prior to treatment seed an RNA plate with 50 – 70 µL of culture
2.) Uncover plates halfway and allow them to dry for 15 minutes
3.) The next day plate 3 – 5 L3 or L4 animals
4.) Repeat steps 1-2
5.) 36 – 42 hours later move animals from the first RNA plate to the new RNA plate
6.) Allow animals to develop to desired age
7.) Prior to using animals check your visible control to ensure the plates are working.

Internal Ethanol Concentration Analysis:
Egg Laying
1.) 4 days prior places 8-10 L4 animals on 5 heavily seed NGM plates
2.) Remove adult animals 2 days later
3.) Seed 6 plates per strain to be tested
4.) The next day plate 30-40 gravid adults per plate for 6 plates
5.) Allow animals to lay eggs for 2 hours and remove
6.) Record the time and allow worms to develop to desired hour age
Ethanol Exposure
Prior to ethanol exposure label all tubes needed before starting the assay. Aliquot 20 µL
of ddH2O into each tube and place on ice until collection.
1.) Dry plates for 2 hours at 37°C
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2.) Record the weight of the plates and determine the volume of 100% ethanol to add
using the ethanol weight table (Table X) to achieve your desired concentration.
3.) Parafilm and allow ethanol to equilibrate for 2 hours
4.) After 2 hours move 10-30 animals to an unseeded plate
5.) Using Image Pro snap pictures of the strain to be tested using the microscope light
source set to II, a 1x objective lens at 4x magnification.
6.) Select calculate auto exposure to achieve optimal resolution
7.) Snap picture of 10 different worms and save as a ,tiff file extension
8.) Immediately pellet 3 plates of animals using M9 and a wide bore tip into a tube
9.) Wash the pellet with 1 mL of M9
10.)

Remove supernatant and leave about 40 µL of liquid

11.)

Using wide bore non-stick pipette tips aliquot 20 µL of worms to one non-ethanol

and one ethanol containing plate
12.)

Allow 2-3 minutes for the liquid to be absorbed by the plate

13.)

Parafilm and start timer

14.)

Repeat steps 8-13 for the remaining 3 plates

15.)

At collection time, pick 200 worms in 2-3 minutes.

16.)

Store worms at -80°C

Spectrometric Analysis
Wear gloves at all times. Keep all reagents on ice unless otherwise noted. Turn heat
block to 30°C and fill half way with H20. Set centrifuge to 4°C. Label all tubes
1.) Create a 1 M ethanol standard (0.584 mL 200 proof ethanol to 9.416 mL ddH2O)
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2.) Perform serial dilutions and make the following standards: 10 mM (100 µL of 1 M
ethanol to 9.9 mL ddH20) 5 mM (5 mL of 10 mM standard to 5 mL ddH20), 2mM (4
mL of 5 mM standard to 6 mL ddH20), and 1mM (5 mL of 2 mM standard to 5 mL
ddH20)
3.) Mix each standard and place on ice
4.) Homogenize worms using cleaned and autoclaved blue pestle while samples reside
on ice
5.) Spin all samples at full speed fro 1 minute at 4°C
6.) Reconstitute alcohol reagent with 15mL of ice cold ddH20 and swirls flask to dissolve
contents
7.) Aliquot 300 µL of alcohol reagent into 1.5 mL labeled tubes for each sample being
tested
8.) Pipette 1.5 µL of homogenized worm sample to 300 µL of alcohol reagent
9.) Mix by flicking twice and immediately place the sample in the heat block for 5
minutes
10.)

Keep pace of one sample every 20 seconds

11.)

Remove samples and place on ice

12.)

Turn on spec and set the wavelength to 340nm

13.)

Blank with ddH20

14.)

Spec 100 µL of sample three times and record

15.)

Spec the remaining 200uL of sample 1-2 times.

Internal ethanol concentration calculation
1.) Open all images previously recorded in Ethanol exposure in ImagePro
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2.) Connect the tracing pad via the USB cord
3.) Magnify the image to 100%
4.) Select measure
5.) Using the pen provide with he tracing pad determine the length of the animal by
tracing at the head and ending at the whip
6.) Next determine the diameter by tracing the width of the worm at the head, vulva, and
tail (Figure 3)
7.) Repeat steps 4-5 3 times for a single worm and average each measure
8.) Repeat steps 4-6 for 10 worms total.
9.) Calculate the volume worm by using the volume equation for a cylinder (!r2H)
10.)

For a single worm, use the average length reordered as the height, average all 3

diameters recorded and divide by 2 and use as the radius
11.)

Average the volume of each of the 10 worms

12.)

Convert the averaged volume from µm3 to µL by multiplying 10e-9

13.)

Multiply the converted number by 200

14.)

Calculate the dilution factor by dividing the total volume (20 µL + the volume in

step 13) divided by the volume of step 13
15.)

Enter the absorbances from spectrometric analysis into excel and average all

absorbance for each standard and strain
16.)

Construct a standard curve and use it to determine the amount of ethanol of each

sample.
17.)

Multiply the internal ethanol from the curve of each sample by the dilution factor

calculated in step 14
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18.)

This is the internal ethanol of the worm in mM.

Real Time Quantitative PCR:
Primer Design
1.) Access Wormbase and look up gene of interest
2.) Asses how many isoforms exists for the gene and design primers to capture all
isoforms
3.) Using the spliced mRNA sequence count back 1 kilobase from the 3’UTR
4.) Copy that portion of the sequence
5.) Access the following website: http://frodo.wi.mit.edu/primer3/
6.) Paste the sequence into the input box
7.) Change the product size range to 75 – 200
8.) Change the number to return to 10
9.) Change the GC clamp to 1
10.)

Select “Pick Primers”

11.)

Select primer pairs that have the following: equal length, melting temperatures

less than 2°C apart, 45-65% GC content, low complementarity (Any and 3’ columns),
and a GC clamp
12.)

Record where the primer pairs fall relative to the exons of the gene

13.)

BLAST primers using Wormbase to ensure primers are unique

14.)

Access the following website: http://www.premierbiosoft.com/qpcr/index.html

15.)

Select “Launch Free Edition”

16.)

Log in or create an account

17.)

Select “Launch Free Edition” again
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18.)

Choose SYBR Green and paste the primers into the correct boxes

19.)

Change free Mg from 3 to 6

20.)

Select “Analyze”

21.)

Make sure the primers pairs have low "G for Cross Dimer, Self Dimer, and Hair

Pin. Do not use any primer with a "G greater than 3
Primer Verification and Optimization
Depending on where the primers are located within the gene, you will have to alter the
template input from either DNA or cDNA. Use cDNA for optimization when a primer
spans an intron-exon junction.
1.) Combine the following reagents into a master mix: For 1 reaction: 2.0 µL 10X
reaction buffer, 0.3 µL of X mM MgCl, 0.2 µL of 25 mM dNTP, 0.1 µL of 25 uM
Forward primer, 0.1 µL of 25 uM Reverse primer, 0.1 µL Taq, 200 ng/µL final
concentration of genomic DNA or 1 µL of cDNA, bring up to 10 µL with nuclease free
water
2.) To determine annealing temperature range subtract 5°C from the primer with the
lowest melting temperature
3.) On the thermal cycler select the program “Mapping Optimized” and “Edit”
4.) Change the initial temperature to the number you calculated in step 2 and change
the end temperature to the number from step 2 plus 11°C
5.) Write down the temperature/column you will use. Ideally use 1°C difference between
columns

195

6.) Go back to the amplification program and change the number of amplification cycles
to 35, the 94°C separation step to 15 seconds, the annealing step to 15 second, and
the elongation step to the appropriate time.
7.) Run samples on 1.5 – 2.0% agarose gel and score for size
8.) Determine the best band and proceed with that temperature for qPCR Standard
Curve
RNA Isolation
Worm Growth
1.) One day prior to growth seed 10 NGM plates with 50 µL of OP50 24 per strain
2.) Plate 15 gravid adults per plate
3.) Allow worms to lay eggs for 5-8 hours
4.) When populations reach adult hood begin Extraction protocol
Extraction
Wear gloves at all times. Wipe all surfaces and pipettes with 70% ethanol. Wipe down
all surfaces, gloves, and pipettes with RNase Zap. Label all tubes needed for isolation
process. Turn water bath to 37°C. Make 70% ethanol using RNase free water and store
on ice. Only use filtered pipette tips. Keep everything on ice unless instructed otherwise.
1.) Wash each plate with 2 mL of M9
2.) Pellet worms in a 15 mL RNase/DNase free conical
3.) Remove supernatant
4.) Wash the pellet with 5 mL of M9
5.) Remove as much supernatant as possible
6.) Add 1mL of TRIzol reagent to each sample
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7.) Place samples in liquid nitrogen for 30 seconds to 1 minute
8.) Thaw samples in the water bath at 37°C for 1 minute
9.) Repeat steps 9-10 until sample contains no intact worms. Check for the level of
intact worm tissue under a dissecting microscope. Usually 8-10 freeze thaws will
shear all the animals
10.)

Let samples sit at room temperature for 5 minutes

11.)

While samples are sitting at room temperature transfer the contents to a 2 mL

tube
12.)

Add 200 µL of chloroform while in a fume hood

13.)

Shake samples vigorously for 15 seconds

14.)

Let samples incubate at room temperature for 3 minutes

15.)

Spin at 10,000 RPM for 15 minutes at 4°C

16.)

Remove top/clear phase (about 600 µL) to a new 1.5 mL tube

17.)

Add equal volume (600 µL) of 70% ethanol

18.)

Vortex samples for 30 seconds

19.)

Transfer 700 µL of the sample to a RNeasy Mini spin column with a 2 mL

collection tube
20.)

Spin samples for 15 seconds at 10,000 RPM at room temperature

21.)

Discard flow-though and place the column back into the 2 mL collection tube

22.)

Repeat steps 19-21 until the entire volume has been pasted through the column

23.)

Add 700 µL of Buffer RW1 to column

24.)

Spin for 15 seconds at 10,000 RPM at room temperature

25.)

Discard flow-through and place the column back into the 2mL collection tube
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26.)

Add 500 µL of Buffer RPE to the column

27.)

Spin samples for 15 seconds at 10,000 RPM at room temperature

28.)

Discard Flow-through and place the column back into the 2 mL collection tube

29.)

Add 500 µL of Buffer RPE to the column

30.)

Spin samples for 2 minutes at 10,000 RPM at room temperature

31.)

Discard 2 mL collection tube and place column into new 2 mL collection tube

32.)

Spin at full speed at room temperature for 1 minute

33.)

Discard 2 mL collection tube and place column into a labeled 1.5 mL collection

tube
34.)

Add 30 µL of RNase-free water directly to the center of the column membrane

35.)

Spin for 1 minute at 10,000 RPM to elute RNA

36.)

Pass the eluted volume thought the column membrane again by spinning for 1

minute at 10,000 RPM at room temperature
37.)

Store RNA at -80°C

RNA quantification and cDNA synthesis
Wear gloves at all times. Wipe all pipette and surfaces with 70% ethanol. Wipe down all
surfaces, gloves, and pipettes with RNase Zap. Label all tubes need for quantification,
treatment, and synthesis process. Remove total RNA, DNase I, and cDNA synthesis kit
for the -20°C and place on ice. Keep everything on ice unless instructed otherwise.
1.) Dilute 5 µL of total RNA in 5 µL of RNase free water
2.) Mix and place on ice
3.) Pipette 2 µL of diluted RNA onto the loading chamber of the NanoDrop
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4.) Record the concentration (Dilution Factor of 40 ug/µL), 260/280 ratio, and 320/280
ratio.
5.) Dilute the reaming 8 µL of total RNA to 500 ng/µL
6.) Combine the following into a master mix for DNase I treatment: For 1 reaction; 1 µL
of reaction buffer, 1.0 µL of DNase I, and 6.0 µL of RNase free water
7.) Pipet 8 µL into a 0.5 mL tube
8.) Pipet 2 µL of 500 ng/µL total RNA into each tube
9.) Mix by pipetting
10.)

Incubate samples at room temperature for 15 minutes

11.)

While the samples are incubating set the thermal cycler to 65°C

12.)

Add 1 µL of 25 mM EDTA to each sample

13.)

Incubate samples at 65°C for 10 minutes

14.)

Combine the following into a master mix for cDNA synthesis (Bio-Rad iScripts):

For 1 reaction; 4.0 µL of reaction mix, 1.0 µL of reverse transcriptase, and 5.0 µL of
RNase free water
15.)

Pipet 10 µL into each tube

16.)

Place samples in thermal cycler and run cDNA synthesis: 5 minutes at 25°C, 30

minutes at 42°C, 5 miutes at 85°C , and hold at 4°C
17.)

To test for successful conversion combine the following into a master mix: For 1

reaction: 1.0 µL 10X reaction buffer, 0.3 µL of X mM MgCl, 0.2 µL of 25 mM dNTP,
0.1 µL of 25 uM Froward primer (dlc-2 or act-1), 0.1 µL of 25 uM Reverse primer,
dlc-2 or act-1) 0.1 µL Taq, 1 µL of cDNA, bring up to 10 µL with nuclease free water
18.)

Run samples
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Detection of mRNA levels by SYBR Green
Wear gloves at all times. Label all tubes needed for PCR. Use tape to lock pipettes. Mix
samples by inverting only unless otherwise instructed. Remove SYBR Green and
primers from -20°C and store on ice. Keep everything on ice unless instructed
otherwise. Turn lamp on 30 minutes before loading samples.
Standard Curve
Refer to Figure Y
1.) Perform a serial dilution of wild type cDNA to the following range: 1:8 (10uL cDNA to
70uL DEPC treated water), 1:16 (40 µL of 1:8 cDNA to 40 µL DEPC treated water),
1:32 (40 µL of 1:16 cDNA to 4 µL DEPC treated water), 1:64 (40 µL of 1:32 cDNA to
40 µL of DEPC treated water), 1:128 (40 µL of 1:64 cDNA to 40 µL of DEPC treated
water
2.) Combine the following into a 7.5x master mix for PCR: For 1 reaction 5.0 µL of
cDNA, 5.5 µL DNase free water, and 12.5 µL of SYBR Green. Master mix: 37.5 µL
of cDNA, 41.25 µL L DNase free water, and 93.75 µL SYBR Green.
3.) Mix sample by pipetting a few times and briefly spin
4.) Aliquot 3.5x of the master mix (80.5 µL) into to tubes. One tube is for detection of the
internal control and the other for the target gene of interest
5.) Add 3.5 µL of 5 µM primer to the appropriate tubes
6.) Mix by pipetting and briefly spin
7.) Aliquot 25 µL from each master mix tube into 3 wells of the qPCR plate
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Figure 22. qRT-PCR standard curve work flow. Serially dilute cDNA starting with 1/8 and ending with 1/128. Pipet each
dilution into qRT-PCR master mix tube. Split the qPT-PCR master mix into two reactions. Add the appropriate primers to
each tube. Next, aliquot 25 µL from each gene specific qRT-PCR master mix into the corresponding well. If you are not
performing a standard curve instead of performing serial dilutions you can dilute your cDNA samples 1/8 and proceed with
the remainder of the protocol.
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8.) Apply PCR film to the plate
9.) Open the Icycler program and use the following conditions for detection: 95°C for 10
minutes, 95°C for 10 seconds and Annealing temperature for 1 minutes for 40 cycles
(real-time collection should be enabled during the 1 minute), and 70 cycles of
increasing the temperature by 0.5°C every 2 cycles starting at 60°C (melt curve data
collection should be enabled during this time)
10.)

Select “Plate Setup” and highlight the wells on the plate that contain sample

11.)

In the next column select “FAM 490”

12.)

In the next column select “Green”

13.)

Select “Save” and select “Run Selected Plate Setup”

14.)

Change the reaction volume from 50 µL to 25 µL

15.)

Review the screen and make sure the amplification profile and plate setup is

correct
16.)

Select “Start” and save your run

17.)

When the run is complete, select “Generate Report” and chose “PCR Baseline”

18.)

Print Report

mRNA level
1.) Dilute each cDNA sample 1:8 (5 µL of cDNA to 35 µL of DNase free water)
2.) Mix and briefly spin
3.) Combine the following into a 7.5x master mix for PCR: For 1 reaction 5.0 µL of
cDNA, 5.5 µL DNase free water, and 12.5 µL of SYBR Green. Master mix: 37.5 µL
of cDNA, 41.25 µL DNase free water, and 93.75 µL SYBR Green.
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4.) Mix sample by pipetting a few times and briefly spin
5.) Aliquot 3.5x of the master mix (80.5 µL) into to tubes. One tube is for detection of the
internal control and the other for the target gene of interest
6.) Add 3.5 µL of 5 µM primer to the appropriate tubes
7.) Mix by pipetting and briefly spin
8.) Aliquot 25 µL from each master mix tube into 3 wells of the qPCR plate
9.) Apply PCR plate film
10.)

Spin plate and ensure no bubble are present

11.)

Open the Icycler program and use the following conditions for detection: 95°C for

10 minutes, 95°C for 10 seconds and Annealing temperature for 1 minutes for 40
cycles (real-time collection should be enabled during the 1 minute), and 70 cycles of
increasing the temperature by 0.5°C every 2 cycles starting at 60°C (melt curve data
collection should be enabled during this time)
12.)

Select “Plate Setup” and highlight the wells on the plate that contain sample

13.)

In the next column select “FAM 490”

14.)

In the next column select “Green”

15.)

Select “Save” and select “Run Selected Plate Setup”

16.)

Change the reaction volume from 50 µL to 25 µL

17.)

Review the screen and make sure the amplification profile and plate setup is

correct
18.)

Select “Start” and save your run

19.)

When the run is complete, select “Generate Report” and chose “PCR Baseline”

20.)

Print Report
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Calculation of PCR efficiency and correlation coefficient – Standard Curve
1.) Open excel and label six columns the following: Dilution, Input, Log of Input, Ct
values Primer Pair 1, Ct Values Primer Pair 2.
2.) In the dilution column enter the value in triplicate of your standard curve dilutions
3.) In the input column, convert your standard curve dilutions to nanograms by
multiplying your dilution by 1000
4.) In the log of input column, calculate the log of input
5.) In the Ct value columns, enter in the obtained Ct values from the standard curve
report
6.) Create an XY scatter plot and set the x-values as the Log of Input and your y-values
and the Ct values obtained for each primer pair
7.) Add a trendline to the graph and display equation and R2 values
8.) To calculate the PCR efficiency select the slope of the line (from the equation) into
the following efficiency equation: ((10-1/slope) -1) x 100
9.) In order to compare to separate primer pairs using the Livak method the PCR
efficiency of both the internal control and the experimental must but in a range of 90
– 110%.
10.)

The R2 values will display your correlation coefficient. This assesses the

variability within your triplicate. To be able to compare primer pairs, R2 values must
be > 0.98
Calculation of mRNA levels using Livak Method
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1.) Open excel and label six columns the following: Sample, Internal Control Gene (act1 or dcl-2), Experimental Gene, ! Ct, Mean ! Ct, ! ! Ct, and Expression Ratio
2.) Fill in the appropriate genotype under the sample column in triplicate. Fill in the Ct
values observed from the qRT-PCR report for each gene.
3.) Calculate the ! Ct by subtracting the internal control gene Ct values from the
experimental gene Ct values
4.) Calculate the mean Ct values for each sample
5.) At the bottom of the excel sheet calculate the mean N2 ! Ct by averaging all N2
mean ! Ct values.
6.) To calculate the ! ! Ct subtract your newly calculated mean N2 ! Ct from the mean
! Ct of each experimental sample
7.) To calculate the expression ratio for both the N2 samples and the experimental
sample, use the following equation: 2 – (! ! Ct)
8.) Average all expression ratios of each sample genotype together and calculate the
SEM. Your control expression ration will always be 1.

Microarray
Prior to growing animals for microarray analysis, set up experimental design to avoid
any particular bias or batch effects that may complicate downstream analysis. In the
case of Chapter 3, an A.M. exposure and P.M. exposure was performed each day
(Monday – Friday) for 3 weeks. During the 2 hour A.M. and P.M. exposure N2 0mM and
500mM and npr-1(ky13) 0mM and 500mM under went supervised randomization. For
example in the A.M. exposure if N2 500mM was selected first, the second exposure
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was N2 0mM, the third exposure was npr-1(ky13) 0mM and the fourth exposure was
npr-1(ky13) 500mM. In the P.M. exposure, npr-1(ky13) was selected for the first
exposure. The randomization will need to be performed prior to egg laying to ensure
proper developmental timing.
RNA collection and Quality Control
1.) 30 gravid adult animals were placed on 15 seeded NGM plates and removed after 2
hours.
2.) After 65 hours, adults were washed into an RNase free tube with M9 and pipetted
using a wide bore tip onto large plates for 2 hours.
3.) Large plates were dried for 1 hour. Ethanol was added using Table X except the
volume of ethanol was doubled to account for the amount of agar.
4.) After 2 hours of exposure animals were washed with M9 into RNase free tubes and
flash frozen in liquid nitrogen
5.) To isolate RNA see protocol in Real-Time Quantitative PCR section
6.) After capture of purified total RNA remove the Experion kit from 4°C and allow the
contents to equilibrate to room temperature (20 minutes)
7.) Remove the RNA ladder from the 4°C and store on ice
8.) Fill a cleaning chip with 800 µL of Experion electrode cleaner and place in
electrophorese station of machine
9.) Close lid and leave chip in for 2 minutes
10.)

Fill another clean chip with 800 µL of DPEC-treated water. Place chip in

electrophoresis station.
11.)

Close lid and leave chip in for 5 minutes
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12.)

Open the Experion program on the computer and select “New Run”

13.)

Enter your sample names for each well

14.)

Remove cleaning chip and empty out the DEPC-treat water

15.)

Refill the chip with 800 µL of DEPC-treated water and place in electrophoresis

station
16.)

Close lid and leave chip in for 1 minute

17.)

Remove chip, empty out contents, and close lid

18.)

Pipet 600 µL of RNA gel (green cap) into a spin filter tube

19.)

Spin at 1,500 g for 10 minutes. Repeat spin if all gel has not passed through the

column. Filter gel is good for 1 month.
20.)

Finger flick RNA ladder and RNA samples to mix and briefly spin

21.)

Dilute RNA samples 1:10 in DEPC-treated water and pipet 3 µL of RNA ladder

from the stock tube into a RNase free tube. If you think you have low RNA
concentration you may not have to dilute. Check the concentration range of the kit
you are using.
22.)

Heat samples to 70°C for 5 minutes

23.)

Place samples on ice for 5 minutes

24.)

Vortex RNA strain (blue cap) and loading buffer (yellow cap) for 5 seconds

25.)

Spin all samples, RNA ladder, stain, and loading buffer briefly

26.)

Remove 70 µL of loading buffer (yellow cap) into a RNase free tube

27.)

Mix 65 µL of filtered gel and 1 µL of RNA strain (cover with foil, light sensitive) to

make gel stain. This is enough for 3 chips and must be made fresh each time
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28.)

Pipet 9 µL of gel stain into highlighted GS lane on the chip. Make sure there are

no bubbles
29.)

Place the chip primly into the priming station set the pressure setting to B and the

time setting 1. Press start to prime the chip
30.)

Remove the chip from the priming station and check the backside for any air

bubbles. If you find any air bubbles prime a new chip.
31.)

Pipet 9 µL of gel stain into the GS lane

32.)

Pipet 9 µL of filtered gel into the G lane

33.)

Pipet 5 µL of loading buffer into lanes 1-13 and L lane

34.)

Pipet 1 µL of RNA ladder into L lane

35.)

Pipet 1 µL of each diluted RNA sample into the corresponding well. If you are not

using all the wells, pipet 1 µL of DEPC-treated water into the wells.
36.)

Place chip in the electrophoresis station and wait for the computer to recognize

that the chip has been loaded. Select “Start”
37.)

Wait 10 minutes and make sure the assay will run to completion. There are many

reason an assay would fail however if the program detects all peaks of the RNA
ladder, then the assay will run to completion.
38.)

When the assay is complete, select “Generate Report” and make sure the first

three boxes are checked
39.)

Select “Print to PDF” and save file

40.)

Each land will have its own report. You will find the concentration of the RNA, the

28s/18s ratio, and the RQI value. Do not rely on the concentration of the RNA from
this assay. Use only the values from the NanoDrop for downstream application.
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41.)

Proceed with samples that have 2:1 28s/18s ratio and an RQI value 9.5 or

higher.

aRNA amplification
Poly-A controls, First and Second-strand cDNA synthesis
1.) Thaw all -20°C reagents on ice and allow 4°C reagents to come to room temperature
2.) Add 100% ethanol to the bottle labeled aRNA wash solution concentrate, mix, and
store at room temperature
3.) Make serial dilutions of poly-A RNA control stock if using 100 ng of total RNA input
amount as follows: 2 µL of Play-A control stock to 38 µL of poly-A control dilution
buffer , add 2 µL of the first dilution to 98 µL of poly-A control dilution buffer, add 2
µL of the second dilution to 98 µL of poly-A control dilution duffer , add 2 µL of the
third dilution to 18 µL of poly-A control dilution buffer
4.) Thaw first-strand synthesis reagents and place on ice
5.) Assemble the first strand master mix in a nuclease-free tube using the following: 4
µL of first strand buffer mix, 1 µL first strand enzyme mix (do not vortex), and 2 µL of
your 4th poly-A dilution.
6.) Flick mix and centrifuge briefly
7.) Aliquot 7 µL to 3 µL of 100 ng RNA
8.) Mix thoroughly
9.) Incubate samples for 2 hours at 42°C in a thermal cycler
10.)

Place second strand reagents on ice

11.)

After 2 hours briefly centrifuge samples and place on ice
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12.)

Construct the second strand master mix on ice using the following: 13 µL

nuclease free water, 5 µL second strand buffer mix, and 2 µL second strain enzyme
mix (do not vortex).
13.)

Aliquot 20 µL of second strand mix to 10 µL of first strand mix

14.)

Mix thoroughly

15.)

Pre-heat the thermal cycler block to 16C and place samples at 16C for 1 hour

followed by 65C for 10 minutes
16.)

Centrifuge samples briefly

17.)

Samples can be stored at -20C or proceed with IVT

In Vitro Transcription to Synthesize labeled aRNA
1.) Remove IVT master mix reagents and allow reagents to equilibrate at room
temperature
2.) Contracture the IVT master mix at room temperature by combining the following: 4
µL IVT Biotin label, 20 µL IVT label buffer, and 6 µL IVT enzyme mix.
3.) Mix thoroughly and spin briefly
4.) Transfer 30 µL of IVT master mix to the double stranded cDNA samples
5.) Incubate the IVT reaction for 16 hours at 40°C in a thermal cycler, followed by 4°C
hold.
6.) Remove samples and freeze immediately. Samples can only be stored overnight.
aRNA Purification
1.) Preheat the aRNA elution solution to 60°C
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2.) Remove the aRNA binding mix reagents and assemble at room temperature by
combining the following: 10 µL RNA binding beads and 50 µL of aRNA biding buffer
concentrate.
3.) Add 60 µL aRNA binding mix to each sample and pipet up and down to mix.
4.) Transfer each sample to a well of a U-Bottom plate
5.) Mix by pipetting up and down until solution is brown
6.) Add 120 µL 100% ethanol to each sample
7.) Mix by pipetting
8.) Gently shake for 2 minutes using setting 1 of plate shaker. Tape plate to shaker.
9.) Move plate to the magnet stand and capture the beads. Wait 5 minutes or until the
solution in each well is clear.
10.)

Carefully aspirate and discard the supernatant without disturbing the magnetic

beads
11.)

Remove plate from stand

12.)

Add 100 µL of aRNA wash solution to each sample and shake using setting 2 on

the shakers for 1 minute. Tape plate to shaker
13.)

Move plate to the magnetic stand and capture RNA binding beads again. Wait 5

minutes.
14.)

Remove aspirate and discard supernatant with disturbing the RNA binding

beads.
15.)

Remove plate from stand.

16.)

Repeat steps 12-15
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17.)

Move the plate to a shaker and shake the dry plate using setting 3 on the shaker

for only 1 minute. Tape down the plate. Start slow, and then ramp to setting 3.
18.)

Elute the purified aRNA from the beads by adding 50 µL of preheated aRNA

elution solution directly to each pellet
19.)

Using the shaker on setting 3-5 shake the plate for 3 minutes. Tape the plate to

the shaker
20.)

If not all the RNA binding beads are not fully dispersed shake for an additional 5

minutes. If that does not work, use a pipette to dissociate.
21.)

Move the pate to the magnetic stand and capture the RNA binding beads for 5

minutes
22.)

Transfer the supernatant to a 1.5 mL nuclease free tube

23.)

Store aRNA at -80°C or place on ice and proceed with quantitation and

fragmentation
24.)

Purified a RNA can be stared at -20°C for up to 1 year

Evaluation and Fragmentation of aRNA
1.) Use the NanoDrop to determine the concentration of aRNA
2.) Assemble the aRNA fragmentation mixture to the correct format (C. elegans uses
100 Format) using the following: 12 µg aRNA, 6.4 µL 5x array fragmentation buffer,
bring up to a final volume using 32 µL of nuclease-free water.
3.) Incubate the fragmentation reaction at 94°C for 35 minutes
4.) Place the reaction on ice immediately, spin if any condensation
5.) Use the Experion to asses RNA quality See “Experion protocol” in this section. Load
the unfragmented sample next to the fragmented sample. You should see a
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distribution of 35-200 nt in the aRNA fragmented profile with large peak at
approximately 100-120 nt
6.) Fragmented aRNA can be stored at -20°C or -70°C for long term or proceed with
hybridization
Hybridization
1.) Bring arrays to room temperature
2.) Set heat blocks to 99°C and 65°C
3.) Set hybridization oven to 45°C
4.) Remove DMSO and 2x hybridization mix from Hybridization, Wash, and Stain Kit in
the 4C and thaw. Store DMSO at room temperate
5.) Remove control oligonucleotide B2 and 20X hybridization controls from -20°C
6.) Head the 20x hybridization controls to 65°C for 5 minutes before using.
7.) Mix the following for each target hybridization (For C. elegans use 49 Format): 12.5
µg (33 µL) fragmented and labeled aRNA, 4.2 µL control oligonucleotide B2, 12.5 µL
20x hybridization controls, 125 µL 2x hybridization mix, 25 µL DMSO, 50 µL
Nuclease-free water.
8.) Heat the hybridization cocktail to 99°C for 5 minutes
9.) Fill array with 200 µL of Pre-hybridization mix by filling it through one of the septa.
10.)

Incubate the array at 45°C for 10 minutes with rotation in the hybridization oven

11.)

Transfer the hybridization cocktail that has been heated at 99°C to the 45°C heat

block for 5 minutes.
12.)

Spin the hybridization cocktail at max speed for 5 minutes
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13.)

Remove arrays from hybridization oven and remove pre-hybridization mix by

venting one septa with a clean pipette tip and extract the mix with a pipette. Ensure
no bubbles remain. Remove tip
14.)

Add the hybridization cocktail to the array. Avoid any insoluble material at the

bottom of the tube
15.)

Cover septas with lab tape

16.)

Place probe array into the hybridization oven and balance appropriately

17.)

Rotate at 60 RPM for 16 hours.

Bleaching
1.) 24 hours prior to priming, clean the fluidics station by using the bleaching protocol.
2.) First register your sample information in the Affymetrix GeneChip Command
Console (AGCC)
3.) Turn on the fluidics station using the toggle switch on the lower left side of the
machine
4.) In the AGCC launcher, click the AGCC fluidics control icon
5.) Make sure both fluidics stations are registered
6.) Select the bleach protocol
7.) Make 500 mL of 0.525% Bleach in a designated container and place all 3 lines into
the container
8.) Place an empty container under the waste line
9.) Run the bleach protocol
10.)

Follow the prompts on the fluidics station
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11.)

After the bleach cycler is complete remove the hoses from the bleach container

and place them into a container containing 500 mL of deionized water.
12.)

Follow the prompts on the fluidics station

Priming, Washing, Staining, and Scanning
1.) To prime the station place hose line A into Wash buffer A and hose line B into Wash
buffer B and the waste line into an empty bottle
1.) Place 3 empty 1.5 mL microfuge tubes into the stain holder positions 1,2, and 3
2.) Place the wash block lever into the engaged/closed position. Push the needle lever
into the down position
3.) Run the Prime-50 maintenance protocol from the AGCC fluidics control
4.) Prepare the following reagents for using a 49 format array volume (250 µL): stain
cocktail 1, stain cocktail 2, and array holding buffer
5.) Gently tap the bottles and mix well
6.) Aliquot 600 µL of stain cocktail1 into a 1.5 mL amber microcentrifuge vial, 600 µL of
stain cocktail 2 into a 1.5 clear microcentrifuge vial, and 800 µL of array hold bugger
into a 1.5 mL clear microcentrifuge vial
7.) Spin down to remove bubble
8.) Start the AGCC fluidics Control software
9.) Load your saved sample files
10.)

Select your protocol, and select compatible, genechip IVT labeling kit, and gene

chip HWS kit.
11.)

Select Run

215

12.)

Insert the probe arrays into the designed module of the fluidics station while the

lever is in the down position
13.)

Monitor the levels of your solutions during this process. Make sure there are no

bubbles.
14.)

When the process is complete, fill the arrays with array holding buffer and wrap

in aluminum foil
15.)

Turn the scanner on 10 minutes prior to use

16.)

Open AGCC scan control software

17.)

Select the sample fine name for he probe array you want to scan from the

sample file name drop-down list
18.)

Click start and load array

19.)

Select OK

20.)

After scan check in AGCC viewer and check if the array passed internal QC by

selecting pass grid alignment. To manually check hit F5,F6,F7,F8 to see all 4
corners. If it failed rescan.

Microarray Analysis
QC reports
1.) In AGCC viewer process samples using the MAS 5 Algorithm.
2.) Select files you want to review in the study dialog box
3.) Select Report followed by View Full Report
4.) Make sure all files are within bounds under the threshold test column
5.) Export and save Full Report
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6.) Select Report followed by View Probe Level Summarization Report
7.) Select edit followed by Probe Level Summarization Report Option
8.) Select signal, detection p-value, and detection
9.) Export and Save file
10.)

Select Graph and generate the following graphs: signal histogram, box plot –

probe cell intensity, box plot – relative probe cell intensity, box plot – signal, box platrelative signal, MvA plot, Pearson’s correlation for signal and detection p-value, and
spearman rank correlation for signal and detection of p-value
11.)

Export and save all graphs

12.)

Reopen your files and process them with RMA

13.)

Repeat steps 10 - 11 for the RMA values

14.)

Save and export file

Data Analysis - RMA and MAS5
1.) Using excel open the MAS 5 file
2.) Sort your data by probe set ID and Absent Call
3.) Copy the Probe set ID’s with an absent call into a new excel spreadsheet
4.) Open the RMA file.
5.) Using the function VLOOKUP in excel remove the probe set IDs from the RMA file
that had an absent call in the MAS 5 file
6.) Save the file as a .txt
TMeV
1.) Open TMeV and select file and select load data
2.) Select browse in the select expression data file row
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3.) Load your .txt file
4.) Select single color array
5.) Under load annotation data select automatically download Ceanorhabditis elegans
and underneath select C. elegans again
6.) Also check Load Annotation
7.) In the Expression table scroll and select the first RMA value and select load
8.) Under Adjust Data select Gene/Row Adjustments and select Normalize Gene/rows
9.) Under Adjust Data select Sample/Column Adjustments and select Normalize
sample/columns
10.)

Select Display followed set color scale limits

11.)

Under gradient style select Double Gradient

12.)

Under color Range Selection set the midpoint value = 0, set the low limit and

upper limit values to match. The lower limit will be negative and the upper limit will
be positive. MeV will suggest values for you.
13.)

Select update limits. Under the color saturation statistics, this will tell you how

many probes will be left out because they are out of the range of your scale
14.)

Select OK

Statistical Analysis of Microarrays (SAM)
1.) Select analysis followed by statistics followed by SAM
2.) Depending on your comparisons select the apropritte SAM analysis. If you are just
comparing to groups of microarrays (control vs. experimental) then perform a twoclass unpaired SAM
3.) Assign the control to group A and the experimental to group B

218

4.) Select yes to calculate q-values
5.) Select construct hierarchical trees for significant genes only
6.) Select OK
7.) If a permutation window pop up select the first option and select OK
8.) Select Pearson’s Uncentered
9.) Select OK
10.)

When the SAM graph appears select OK

11.)

Under Analysis Results select the SAM(1) icon

12.)

Under SAM(1) select Delta Table

13.)

Determine the FDR(%) Mean you want for your data and record the delta value

associated with it in the first column.
14.)

Select Analysis, Statistics, followed by SAM

15.)

Select the first option and select OK

16.)

When the SAM Graph appears enter the delta value for the correct FDR mean

17.)

Select OK

18.)

Under Table view select ALL significant genes

19.)

Copy the Probe ID, the fold change, and the q-value into an excel spreadsheet

Geneweaver
To get a better idea of what genes are actually significant, you can use Geneweaver to
convert the probe ID into a Wormbase gene symbol. Currently, this is the best
bioinformatics tool to extract precise gene symbols. You can use Geneweaver for a
variety of other important tasks such as to identify the similarly between data sets and
access a wide variety of genomic data sets across different species.
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1.) Access www.geneweaver.org
2.) Create an account
3.) Select manage Gene Sets and upload gene sets
4.) Enter descriptive information in each box
5.) Select species and the appropriate microarray
6.) Paste the probe IDs and the fold change (optional, RMA value is ideal)
7.) Upload gene set
8.) Geneweaver will collapse genes with multiple probe IDs. Select the option show
original data to view which genes have multiple probe IDs
9.) Select export data
10.)

Save the file

11.)

Add the newly uploaded gene list to a Gene set Project for future reference

Hypoxia:
Cobalt Chloride Treatment
Cobalt chloride (CoCl2) is light sensitive. Wrap tubes with aluminum foil when handling
the chemical dry or in solution.
1.) Make a 100 mM CoCl2 solution by adding 1.3 grams to 100 mL ddH20
2.) Filter sterilize the contents into a light protected bottle
3.) Seed a 3-5 day old NGM plate with 50 µL of OP50 24 hours prior to addition of
CoCl2
4.) Add 500 µL of 100 mM CoCl2 Allow the solution to equilibrate for 2 hours
5.) Move 50 animals to a plate
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6.) Parafilm plates and incubate at 20°C for 16 hours
7.) Move animals to a freshly seeded NGM plate
8.) Score lethality 24 hours post removal of CoCl2
9.) When scoring lethality tap the plate or use your pick to stimulate locomotion. If
worms are unable to move then they are scored dead.
Environmental Chamber
1.) 24 hours seed small NGM plates with 20 µL of OP50
2.) Pick 50 worms a plate
3.) Place plates into Bio-Bag
4.) Place an anaerobic indicator, anaerobic generator, and catalysis container into the
Bio-bag
5.) Arrange so the arrows shown on the labels of the indicator and generator are
pointed up towards the open position of the bag. Position the catalyst so the grid is
not in contact with bag
6.) Expel any air form the Bio-bag and use a heat sealer to seal close the contents
7.) Hold bag up right and locate the anaerobic indicate ampule
8.) Crush the indicator ampule using your index finger and thumb
9.) After 30 seconds the indicator should turn pink, if not repeat step 8
10.)

Locate the generator ampule

11.)

Crush the ampule using your index and thumb.

12.)

Gently tap the generate to allow the contents to mix

13.)

When you see bubbling within the tube the contents is mixing
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14.)

Still holding the bag up right, allow the gas in the bag to evolve and 1 minute. If

you do not wait the contents will spill into the bag
15.)

Place bag at 27°C for 8 hours

16.)

2 hours into the exposure check the bag and make sure the indicator is no longer

pink and has turned white. This indicates oxygen levels are less than 1%
17.)

Remove animals to a new NGM plate

18.)

Score survival 24 hours later

19.)

When scoring lethality tap the plate or use your pick to stimulate locomotion. If

worms are unable to move then they are scored dead.
Hypoxia Cabinet
Prior to exposure bubble 50 mL of M9 with nitrogen gas for 30 minutes
1.) Allow 30 adult animals to lay eggs for 2 hours
2.) Allow animals to grow to desired age
3.) Pellet animals in non-nitrogen M9
4.) Wash the animals three times with nitrogenated M9
5.) Remove supernatant but leave behind 100 µL
6.) Place worms in cabinets and set oxygen control to 0.1%
7.) Incubate worms for 16 hours
8.) Remove worms from liquid and pipette them onto seeded NGM plates
9.) Score survival 24 hours post removal of hypoxia
10.)

When scoring lethality tap the plate or use your pick to stimulate locomotion. If

worms are unable to move then they are scored dead.

222

Allyl-Alcohol Assay:
Plate Preparation:
Refer to Nematode Growth Media plate protocol to generate agar. Add allyl-alochol to
agar and pour plates while under the fume hood. Store seeded plates in a box in the
fume hood.
1.) Combine the appropriate amount of agar into an autoclaved bottle and add allylalcohol to a final concentration 0.35%
2.) Aliquot the allyl-alcohol containing media into plates
3.) Allow plates to solidify for 24 hours
4.) Seed plates with 70 µL of Op50
5.) Leave plates slightly uncovered for 15 minutes to allow food to dry
6.) Allow lawn to grow for 48-72 hours.
Allyl-Alcohol Treatment:
1.) Transfer 25 worms to allyl-alcohol plates
2.) Score survival 24 and 48 hours
3.) To ensure a worm is actually dead tap the plate or tap animals with the pick and
assess for movement. All worms unable to move are counted as dead.
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Appendix B
Quantitative Real-Time Polymerase Chain Reaction Standard Curves
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Figure 23. qPCR standard curves with amplificaiton efficiency for genes of
interest.
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Appendix C
Basal and Ethanol Treated Locomotion Speeds from Mitochondrial β-oxidation
Analysis
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Figure 24. Basal and 400mM ethanol treated speeds for N2, acs-2(ok2457), nr1(ky13), and acs-2(ok2457);npr-1(ky13).
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Table 9. Basal and ethanol treated locomotion speeds for N2, acs-2(ok2457), nr-1(ky13), and acs-2(ok2457);npr1(ky13).

N2

acs-2(ok2457)

npr-1(ky13)

10

30

50

10

30

50

10

30

50

216.4863
211.5918
175.9334
182.9513
222.8247
230.1341
191.3117
205.8668

207.2469
187.9251
197.0206
183.3317
195.6285
217.3868
232.9581
213.0350

217.6313
197.8545
190.4412
175.0890
176.2952
177.4747
214.4544
207.7867

211.8726
219.9262
222.9811
221.6371
203.5562
211.8614
228.6324
211.2527

253.6191
227.5532
221.6074
234.3231
198.4062
205.9586
225.8644
226.1762

239.8671
218.3555
201.9263
207.0946
170.5336
206.5642
235.8575
219.6535

263.0674
264.1708
234.4437
243.7129
230.7863
214.8074
260.6960
252.2887

257.2743
235.0555
231.5840
227.4526
213.8287
232.2957
244.5199
242.3962

248.1266
229.7523
241.7696
209.8827
221.2226
206.5642
235.8575
242.7555

acs-2(ok2457);
npr-1(ky13)
10
30
50
252.4730
248.3924
238.2390
232.3678
228.8513
222.0735
260.2394
263.1291

243.2182
248.7700
225.0053
235.8549
193.4325
215.3724
248.1235
231.6943

234.5098
255.8309
238.2327
226.7354
204.6477
200.3795
238.3481
244.8679

Untreated Speeds (µm/sec)
N2

acs-2(ok2457)

10

30

50

10

30

63.0933
83.0754
80.9126
55.3509
80.6701
82.9474
93.8128
91.3309

89.0706
99.0884
106.179
87.3857
91.5989
97.6662
122.034
112.037

101.4540
103.7877
84.08150
88.72846
91.56701
76.33218
94.45406
86.89993

134.8133
89.65605
75.12360
55.88299
37.00095
83.25901
81.84748
101.7836

157.5663
100.6690
90.98722
80.71304
54.67430
89.07432
80.04528
106.8915

npr-1(ky13)

50
135.7179
81.95131
90.28391
88.99951
71.26112
67.71488
75.17120
104.0266

10

30

50

117.3564
172.2827
108.3784
132.1134
111.4447
88.54777
155.0675
127.5487

168.0549
200.7651
152.5554
162.0141
141.5022
120.4315
189.1819
152.1997

127.0079
146.1612
119.6006
134.5305
94.93507
98.09972
143.1183
136.2232

400mM Treated Speeds (µm/sec)
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acs-2(ok2457);
npr-1(ky13)
10
30
50
108.9024
140.6712
126.6675
134.8133
60.23233
99.02154
137.5475
129.9242

114.6849
151.2995
128.5483
157.5663
88.15572
117.7731
148.9519
137.5575

119.6731
135.3994
121.8228
135.7179
89.17549
99.55617
146.9451
131.9408
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Figure 25. Basal and 400mM ethanol treated speeds for L4440, ech-6(RNAi),
T08B2.7(RNAi)
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Table 12. Basal and ethanol treated locomotion speeds for L4440, ech-2(RNAi), ech-4(RNAi), and ech-1(RNAi)

10
220.29
203.02
207.37
245.20

L4440
30
219.43
184.00
193.11
218.00

50
211.05
186.56
207.47
213.13

ech-2(RNAi)
10
30
50
239.10
189.94
218.28
217.81

214.86
198.25
188.49
211.70

212.45
184.29
199.53
192.07

ech-4(RNAi)
10
30
50
195.03
189.49
203.03
214.33

180.27
183.74
189.08
192.42

155.33
174.69
174.75
193.32

ech-1(RNAi)
10
30
50
177.10
183.61
197.45
230.59

207.38
188.44
172.12
204.66

234.5098
255.8309
238.2327
226.7354

Untreated Speeds (μm/sec)

10

L4440
30

43.27
31.25
64.75
56.94

69.05
46.22
96.25
80.22

50

ech-2(RNAi)
10
30
50

ech-4(RNAi)
10
30
50

ech-1(RNAi)
10
30
50

79.24
46.35
73.67
69.28

54.62
49.76
62.44
42.14

44.41
40.22
41.89
68.88

46.13
35.47
42.91
67.76

67.68
55.56
76.34
72.07

82.79
43.13
62.99
65.44

400mM Treated Speeds (μm/sec)
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58.41
60.64
51.95
69.54

61.91
68.57
51.72
65.44

72.83
41.90
45.17
79.03

72.83
60.80
50.91
63.57

Table 10. Basal and 400mM ethanol treated speeds for L4440, ech-6(RNAi),
T08B2.7(RNAi)

10

L4440
30

50

220.3640
225.6069
212.9348
208.6303
204.3809
231.4317
271.2894
204.1935

195.2196
195.4158
192.6493
189.9309
187.7423
223.0682
233.9797
204.6103

196.7132
208.9918
201.7841
177.8582
206.0131
205.2702
229.1633
224.0458

10

ech-6(RNAi)
30
50

229.11
200.36
217.10
200.25
190.24
232.82
167.36
167.87

216.99
189.97
222.08
204.93
173.06
221.74
165.60
167.28

213.88
190.61
199.00
200.60
197.08
200.25
144.06
172.23

10

T08B2.7(RNAi)
30
50

185.89
176.37
188.49
223.46
192.61
208.85
226.46
235.45

217.57
223.29
214.22
209.51
196.47
207.26
224.16
234.28

234.29
195.89
230.91
210.14
194.34
209.20
210.05
236.60

Untreated Speeds (μm/sec)
10

L4440
30

50

67.7600
58.3600
58.9200
56.7800
88.4100
50.3100
72.4900
97.4100

93.0200
71.8600
75.0300
68.0800
111.9600
62.9200
89.0100
107.3400

83.5800
83.1800
73.1500
80.4100
129.8000
59.6100
89.6000
103.2000

ech-6(RNAi)
10
30
50
66.99
85.49
119.80
72.37
46.24
111.11
48.94
87.14

137.61
116.24
165.25
95.24
84.49
138.61
72.17
114.58

Treated Speeds (μm/sec)
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110.32
128.13
144.61
88.81
101.09
113.77
48.63
92.61

T08B2.7(RNAi)
10
30
50
63.33
86.25
74.82
72.07
39.38
104.26
69.63
67.63

112.31
133.67
123.57
93.39
82.25
101.12
68.35
77.09

108.69
137.04
110.53
113.94
96.27
98.39
61.69
83.45
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Figure 26. Basal and 400mM ethanol treated speeds for L4440, cpt-2(RNAi), and
cpt-5(RNAi)
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Table 11. Basal and ethanol treated speeds for L4440, cpt-2(RNAi), and cpt5(RNAi)

10
209.84
197.06
211.71
204.68

L4440
30
191.84
189.46
195.98
218.12

50
187.86
196.08
188.52
235.65

10

cpt-2(RNAi)
30

196.95
199.22
222.97
178.11

185.75
187.75
208.06
180.27

50
181.07
191.18
200.19
180.18

10

cpt-5(RNAi)
30

211.90
200.80
179.92
218.12

185.75
181.64
180.25
188.35

50
184.31
190.55
179.38
180.72

Untreated Speeds (μm/sec)

10
57.91
52.24
76.74
86.87

L4440
30
111.64
92.18
97.87
118.87

50
187.86
196.08
188.52
235.65

10

cpt-2(RNAi)
30

82.54
51.10
54.54
54.38

112.89
77.42
66.37
61.75

400mM Treated Speeds (μm/sec)
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50
102.66
67.32
78.00
74.00

10

cpt-5(RNAi)
30

57.03
50.14
86.39
62.74

97.14
75.78
74.72
70.02

50
87.85
73.48
76.59
63.91
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Figure 27. Basal and 400mM ethanol treated speeds for L4440, ech-2(RNAi), ech4(RNAi), and ech-1(RNAi)
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Table 12. Basal and ethanol treated locomotion speeds for L4440, ech-2(RNAi), ech-4(RNAi), and ech-1(RNAi)

10
220.29
203.02
207.37
245.20

L4440
30
219.43
184.00
193.11
218.00

50
211.05
186.56
207.47
213.13

ech-2(RNAi)
10
30
50
239.10
189.94
218.28
217.81

214.86
198.25
188.49
211.70

212.45
184.29
199.53
192.07

ech-4(RNAi)
10
30
50
195.03
189.49
203.03
214.33

180.27
183.74
189.08
192.42

155.33
174.69
174.75
193.32

ech-1(RNAi)
10
30
50
177.10
183.61
197.45
230.59

207.38
188.44
172.12
204.66

234.5098
255.8309
238.2327
226.7354

Untreated Speeds (μm/sec)

10

L4440
30

43.27
31.25
64.75
56.94

69.05
46.22
96.25
80.22

50

ech-2(RNAi)
10
30
50

ech-4(RNAi)
10
30
50

ech-1(RNAi)
10
30
50

79.24
46.35
73.67
69.28

54.62
49.76
62.44
42.14

44.41
40.22
41.89
68.88

46.13
35.47
42.91
67.76

67.68
55.56
76.34
72.07

82.79
43.13
62.99
65.44

400mM Treated Speeds (μm/sec)
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58.41
60.64
51.95
69.54

61.91
68.57
51.72
65.44

72.83
41.90
45.17
79.03

72.83
60.80
50.91
63.57
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